Annual Report 2010-11 HLL Life Care Ltd.

- S
CONTENTS
xnE b
+vI E h
+v E Sx
|vx E SS + h
xnE E {]
E{] +x { {]
J{IE E {]
i E xjE B J{IE
E ]{{h
2010-2011 E B ix-{j
il -x J
ix-{j +xS
-x J +xS
Board of Directors
Chairman's Speech
Notice to Shareholders
Management Discussion
and Analysis
Directors Report
Report on Corporate Governance
Auditors' Report
Comments of the Comptroller and
Auditor General of India
Balance Sheet and Profit & Loss
Account for the year 2010-11
Balance Sheet Schedules
Profit and Loss Account Schedules
M x +Wn
Shri Ghulam Nabi Azad
xx l B { Eh P Ex] j
Hon'ble Union Cabinet Minister for Health & Family Welfare
v{ n{v
Shri Sudip Bandyopadhyay
xx l + { Eh P V j
Honble Union Minister of State for Health & Family Welfare
B. Mvx
Shri S. Gandhiselvan
xx l B { Eh P V j
Hon'ble Union Minister of State for Health & Family Welfare
{.E. |vx
Shri P.K. Pradhan
S (l + { Eh)
Secretary (H&FW)
l + { Eh j
MoHFW
Board of Directors
xnE b
B. +{{x
Shri M. Ayyappan
+vI B |v xnE
+.E. Vx
+{ S
&
Chairman & Managing Director
Shri R.K. Jain

B.B, l B { Eh j,
i E
b. B.E. {hb
Dr. A.K. Panda
H S, l B { Eh j,
i E
Joint Secretary, Ministry of Health & Family Welfare,
Government of India
Addl. Secretary & F.A, Ministry of Health & Family Welfare,

Government of India
E.E. E
B.b. E
E |n Jhb
Shri K.K. Suresh Kumar

xnE ({hx)
Shri M.D. Sreekumar

xnE (iExE B |Sx)
Shri Rakesh Prasad Khandelwal

xnE (k)
Director (Marketing)
Director (Technical & Operations)
Director (Finance)
V E{
b. +i V
Shri Sanjiv Kapoor

M-E +EE xnE
Dr. Aarti Vij

M-E +EE xnE
Non-Official Part-time Director
Non-Official Part-time Director
+nC, o]Eh + I
+n-C
l {g EB xxh
o]Eh
BSBB Mi xxh B MiE x E u +{x |J EE{ xx E + +Oh |i` |{i
E M *
={Ci E =k |nx Ex *
{n E xCi xx *
x { {E l J E l E g nx*
I
xMi o]Eh x{ni Ex EB BSBB x 2010 iE BE i l I E{x xx E =q
{J |ii E * V xxJi {S Ij Epi *
10
={Ci xxh ES + VE Ij {
E xii
Mi |iMi E l pi E B i Sx |{i Ex *
E |J =i{n M =iE] ix Jc BE xx *
S E Ex M M`x x Vx *
=tM-S +Ei ni +M+ xx *
={Ci E pi
n Mhk il ={Ci +xn { Epi x *
xxh
+vx + xxh E |G E u |J Mi l{i Ex *
xi xxh E Ei Vx Ex V {i E E E 100%
+xvx B E { |{i Ex *
ES i]
90% Wn gE ES i] E l i {n E xCi xx EB | Ex *
VE Ij {
{xi{nx B l Ij V E |i |iri E l-<x Ij E B {I { E
Exi Ex EB {n E l xE MnE VE M`x E { xi |{i Ex *
MOTTO, VISION & MISSION

MOTTO
Innovating for Healthy Generations
VISION
HLL will establish itself as the Leader in its core activities, through a process of continuous innovation and
participatory approach in order to
Provide best value to the customer.

Be an employer of choice.
Promote the cause of family health in general, and womens health in particular.
MISSION
To accomplish the Corporate Vision, HLL has outlined a Mission to be a World Class Health Care Company
by the year 2010, with focus on five key areas, namely
Business
Social Sector initiatives.
Attain rapid growth and global levels of operations with cost competitiveness.
Be among the top three players in each main product category.
Become the organisation to be benchmarked with.
Become an acknowledged and admired leader at industry forums.
Focus on quality and customer delight at all times

Innovation
Establish core competence through a process of learning and innovation.
Create a culture of continuous innovation resulting in at least 10% of turnover from Research and
Development initiatives.
Employee Satisfaction
Employee and
Customer Focus
Innovation
Business Leadership
Customer
Strive to be the employer of choice in India with employee satisfaction levels of over 90%.
Social Sector Initiatives
Be recognized as the leading social organisation in the field of Reproductive and Womens Health,
with a commitment to the society - a partner of choice for implementing all government and multilateral initiatives in these segments.
11
Mhk xi
BSBB <E ]b |ir :

M E l B J Vx l Ex, l I +i] xE E +x{ =i{n B B |nx Ex*

Ij =k |tME + {ri +{xx u Mi =zi E WB M`xiE ì ={v Ex*
xxh, Mhk il +xvx E, Mi |vx il OE v |vx { E EE OE EB
E i { nx =SS =i{n B {hx Ex*
E +x il E VE ni H =SSi xE E { Ex M`x xx*
I, l B {h xi
BSBB <E ]b xxJi E WB {h E Ih Ex, E VJ
E n Ex + ES + ={ nE E I xSi Ex EB |ir :

+xi +v { <E EE{, =i{n + + E | E +xIh B xjh Ex*

={H vE B +x +{I+ E +x{x Ex*
=Si |Sx {ri +{xx*
ES |Ih + =xE Oii v xx*
=k {ri +{xx u |nh E Ex*
, >V Ii Jx + q E i { E Ex + xEh >V i E |M fx*
I, l B {h |vx |h E +vE I*
|M Mhk xi
BSBB <E ]b |ir :
12
]/+i] xE E VS |h E +x{x EE il +SU E +Sh E |M u x,

Mi il +xMh VS {h xSi Ex*
Mhk |Sx i EE E +< B + 17025 : 2005 E +x{ |vx |h E xi +
Ev E l {Si xx xSi Ex il =E =xE E Exi Ex*
|vx |h E |i xi vx*
QUALITY POLICY
HLL Lifecare Limited is committed to:
Provide products and services, conforming to international standards in healthcare, enabling people
lead healthy and happy lives
Achieve organisational excellence through continual improvement by adoption of best technologies

and practices in all areas
Market products and services globally delivering highest value for customers through focus on
innovation, quality, R&D, cost management and customer relationship management
Be an organisation meeting highest standards in Corporate Governance and Corporate Social

Responsibility
SHE POLICY
HLL Lifecare Limited is committed to protect environment, eliminate occupational hazards and ensure
safety of employees & subcontractors through:
Monitoring and control of the impact of its activities, products and services on a continual basis;
Compliance of applicable legal and other requirements;
Adopting appropriate operating and their involvement:;
Facilitating employee training and their involvement;
Pollution mitigation through adoption of best practices;
Conserving materials, energy and reducing waste at source, and/ encouraging usage of renewable
energy sources;
Periodic review of safety, health and environment management system.
LAB QUALITY POLICY

HLL Lifecare Limited is committed to:
Ensure reliable, consistent and traceable results of testing by using test methods complying to national
/ international standards and by following good professional practices.
Ensure that all personnel involved in the testing operations familiarize with the policies and procedures
of the management system conforming to ISO 17025 : 2005 and implement the same in their works.
Continually improve the effectiveness of the management system.
13
BSBB <E ]b - +vI E h 2011

| +v,
+{ x] E M E 2010-11 BSBB <E EB + BE i{E l*
E{x x Mi E ` 442.00 Eb {k E ix 17 |ii r {VEi EE `517.00 Eb E {k
|{i E + {U E `14.93 Eb E ix ` 18.43 Eb E x +Vi E *
|{h B { |M + +Sx |M u E-{nx E { S Ei B E{x x Mi E
` 1294.00 Eb E ix `1131.00 Eb E *
VxE =t M x 2009-10 EB +{E E{x E x{nx E =iE] E { Ei E +
2010-11 = ]M |{i Ex E |iI E Vi *
xnE x k 2010-11 EB ` 233.03 J E +i E E * E{x E |nk <C]
{V E 15% Mhx Ei *
{U E + BE ZE
E{x x xMi Vx -2010 Exi E l V 2003 {E{i E M * BSBB x +{x J Ii+ E
Wi E + +M Ij i + vEi E M * (xnxE B + |{h B +Sx E |M
B *
E{x E E i/vEh E { +{E E{x x vEi M E |vx Ex v
Sxi E x E l* < Sxi E x Ex EB +{E E{x x MxvE + ]E B ,
+{i =i{n B + B V ix (3) ij ]]VE x] (B ) E Ij
|Sx E {xMì E l*
+{E E{x M`x E +-{ B B { ih { +vi =t vx Vx (< + {) Exi Ex E |G
* < =q EB Ei b] Ep l{i E M , V n E +-{ M`x E |Sx EB <
+ { i |{i |Sx E H Exp E { E EM*
+{E E{x x VxE =t M u V E M E{] +x Mxn E {{i { +xh E l*
E + BE ZE
MxvE ]E =i{n + +{i =i{n V <E |J P]E E Wi Ei , |i
+ +vE vEh E i E vx JE BSBB <E Wx 2020 i E * Wx 2020 E
I BSBB E 2020 iE ` 10000 Eb E l I E{x xx *
b + |v n { E u n M + x` E EiYi{E +Ei Ei , V o] E{x
E +vE Sxi x |h n *
+{E Mi i E |iI Ei B,
+{E,
B.+{{x
+vI B |v xnE
BSBB <E ]b
nxE: 6 i 2011
14
CHAIRMAN'S SPEECH 2011

Dear Shareholders,
You will be pleased to note that 2010-11 was another successful year for HLL Lifecare.
The company has achieved a turnover of ` 517.00 Cr, registering a growth of 17 % compared to the previous
year's turnover of ` 442.00 Cr and earned a net profit of ` 18.43 Cr compared to ` 14.93 Cr during the previous
year.
Considering the value of transactions handled by the Procurement & Consultancy Division and Infrastructure
Division, the company handled a business of ` 1131.00 cr. compared to ` 1294.00 Cr during the previous year.
Department of Public Enterprises rated the performance of your company as 'Excellent' for the year 2009-10
and is expected to achieve the same rating in 2010-11.
The directors have recommended a final dividend of ` 233.03 lakh for the financial year 2010-11. This works
out to 15% of the paid-up equity share capital of the company.
Looking in Retrospect
The company had implemented Corporate Plan-2010 that was conceptualized in 2003. HLL strengthened its
core capabilities and further expanded and diversified into the services domain (diagnostic services and
procurement and infrastructure development services).
Consequent to the expansion/diversification of the company's business, your company had faced various
challenges in managing the diversified businesses portfolio. To meet this challenge, your company had
restructured the business operations into three independent Strategic Business Units (SBUs), viz.
Contraceptives & Pharmaceuticals SBU, Hospital Products' SBU and Services SBU.
Your company is in the process of implementing Enterprise Resource Planning (ERP) based on SAP environment
across the organization. A state-of-the-art data centre has been set up for this purpose, which will function as
the nerve center for the ERP assisted operation for all the functions of the organization across the country.
Your company had substantially complied with Corporate Governance Guidelines issued by Department of
Public Enterprises.
Looking into the future
HLL Lifecare is framing Vision 2020, taking into account recently-commenced businesses and the potential
for further diversification, while strengthening its core segments namely Contraceptives & Pharmaceutical
products and Hospital products. The objective of Vision 2020 is to make HLL a ` 10,000 Crore healthcare
company by year 2020.
I gratefully acknowledge the confidence and faith reposed by the Government on the Board and the Management
team which has, in my view, spurred the Company to take on more challenges.
Looking forward to your continuing support,
Yours Sincerely,
M. AYYAPPAN
CHAIRMAN & MANAGING DIRECTOR
HLL LIFECARE LTD.
Dated: 6th September 2011
15
o BSBB/ B/2-330/2011-3840
1 i 2011
Sx
Binu Sx n Vi E BSBB <E ]b E vE E 45
E x È x< n 6 i, 2011 M vx 12.00 V E
xxJi E xx EB +Vi E VBM *
x E :
1.
xnE E {] il 31 S 2011 E {i EB E{x E J

{Ii Ji, = { J {IE E {] il i E xjE B
J{IE E ]{{h { S Ex + +ME Ex *
2.
k 2010-11 EB +i Pi Ex *
E :
3.
|nk {V + x:E +Ih E +vEi =v x*

b E xnE E |nk {V + x:E +Ii E +vE =v x
EB |vEi Ex E xxJi E{ E x E{ E {
vx E l vx i S Ex + M Z V i {i
Ex*
""E{ E Vi E E{x E xnE b E E{x +vx 1956 E
v 293 (1) (P) E |vx E +vx xEn @h, +O V, xb@h
]]Eh +xl + vE{j u +|ii |ii, E{x E
{{k + {k E SV, vE {j vhvE M, S
+S {k + E{x E E M] E B E BE BE
+vE E{x E E - { vx =v x E + Binu i
M + i n Vi , <E Vn E{x u { =v B
vx E l vx =v Vx (E E vh +xG E{x E
E |{i +l @h E +iH), V E |nk {V + x:E
+vE M, il{ E E V xnE b u =v B MB + E
{ E vx V E UbE E ` 300 Eb +vE x x
+ xnE b +M B vE E J, SV, vE {j, vhvE,
Sx {j ]{{h, V, n + +x J + Ji Jx, V M
Z V + B li + |nB V xnE M Z V, E
x{nx E E Binu |vEi EB Vi *''
16
1st September 2011
No.HLL/CS/2-330/2011-3840
NOTICE
NOTICE is hereby given that the 45th Annual General Meeting of the
Shareholders of HLL Lifecare Ltd. will be held at New Delhi on Tuesday,
the 6th September 2011 at 12.00 Noon to transact the following businesses.
ORDINARY BUSINESS :
1.
To consider and adopt the Directors Report and Audited Accounts of

the Company for the year ended 31st March 2011, the report thereon
of the Auditors and comments of Comptroller & Auditor General of
India.
2.
To declare Dividend for the financial year 2010-11.
SPECIAL BUSINESS :
3.
Borrow in excess of paid-up capital and free reserves

To consider and if thought fit to pass, with or without modification,
the following resolution as ordinary resolution to authorize the Board
of directors to borrow in excess of paid-up capital and free reserves.
"Resolved that the consent of the company be and is hereby accorded
under the provisions of Section 293 (1) (d) of the Companies Act,
1956, to the Board of directors of the company to borrow up to ` 1000
Cr. from time-to-time cash credit, advance or deposits, bonds, loans
or bill discounting or otherwise and whether unsecured or secured
by mortgage, charge, hypothecation or lien or pledge of the company's
assets and properties, whether movable or immovable and all or
any of the undertakings of the company, notwithstanding that the
moneys to be borrowed together with moneys already borrowed by
company (apart from temporary loans obtained from the company's
bankers in the ordinary course of business) will or may exceed the
aggregate of paid-up capital and free reserves, however, that the
total amount up to which the moneys may be borrowed by the Board
of directors and outstanding at any time shall not exceed the sum of
` 1000 Cr. only exclusive of interest, and the Board of directors are
hereby further authorized to execute such deeds of mortgage, charge,
hypothecation, lien, promissory notes, deposit receipts and other
deeds and instruments or writings as they may think fit and containing
such conditions and covenants as the Directors may think fit."
17
4.
+S {{k { vE SV
+S {{k { vE SV E B x E{ E { xxJi E{ { vx E l x
vx E l M Z V i {i Ex*
E{ E Vi E E{x +vx 1956 E v 293 (1) (E) + E{x E l E +ix E +xSUn 22
E +xh , i E ]{i E +xnx E +vx B +< {j . v/B b 465, nxE 1 S 2011
Si i xvx E +x, ]] E + <b xxJi =v vB |{i Ex E B ]] E
+ <b E x {V{{ E{x E x Ex E l 106.447 ] + E{x E +i +S
{{k { |l | E UbE E vE Ex E B E{x E xnE b E i M +
Binu i n Vi *
(`
G
0
1.
2.
3.
4.
5.
6.
7.
v E x
xEn @h
n @h
E |ii
J {j
n n - xi
n n - +i
i{z
E
Eb )
ix
vi
75.00
90.90
20.00
40.00
1.10
0.74
0.17
100.00
90.90
100.00
120.00
1.10
1.21
0.38
227.91
413.59
E{ E Vi E E{x +vx 1956 E v 293 (1) (E) + E{x E l E +ix E +xSUn 22 E

+xh , i E ]{i E +xnx E +vx 5000 C ] E + = E Ex { {]] { +vE {
|l | + ` 6 Eb E i B Bx + () n @h |{i Ex E B {E |ii E { {V{{
Ex E l E{x E 106.447 ] E E vE Ex E B E{x E xnE b E i M +
Binu i n Vi *
+xh , i E ]{i E +xnx E +vx M 15.33 BEc il Ex + ]<b + { +
xh j vi x { |l | + ` 29 Eb E i B Bx + () n @h |{i Ex E
B {E |ii E { {V{{ Ex E l E{x E 106.447 ] E E vE Ex E B E{x
E xnE b E i M + Binu i n Vi *
+xh , i E ]{i E +xnx E +vx +{{, E]] + j 3 B + +< Exp { B + +<
x { |l | + ` 15 Eb E i B Bx + () n @h |{i Ex E B {E |ii E
{ {V{{ Ex E l E{x E 106.447 ] E E vE Ex E B E{x E xnE b E i
M + Binu i n Vi *
+xh , i E ]{i E +xnx E +vx ECExc C], B < <Wb < ] b x + {EM x
18
Item No. 4 : Mortgage or charge on the immovable properties

To consider and if thought fit to pass, with or without modification, the following resolutions as Ordinary
Resolutions to mortgage or charge on the immovable properties.
"RESOLVED THAT pursuant to Section 293 (1) (a) of the Companies Act, 1956, and Article 22 of the Articles
of Association of the company, subject to approval of the President of India, consent be and is hereby given
to the Board of Directors of the company to create equitable mortgage on the 106.447 cents of land with
building in the name of the Company at Poojappura and exclusive first charge over the unencumbered fixed
assets of the company in favor of State Bank of India for securing the following credit facilities from State Bank
of India as per terms and conditions informed vide SBI letter No. Misc./Adv 465 dated 1st March 2011."
(` in Cr.)
Sl.
No.
Name of the Facility
Existing Limits
Enhanced Limits
1.
Cash Credit
75.00
100.00
2.
Term Loan
90.90
90.90
3.
Bank Guarantee
20.00
100.00
4.
Letter of Credit
40.00
120.00
5.
Forward Contract - Export
1.10
1.10
6.
Forward Contract - Import
0.74
1.21
7.
Derivative Limit
0.17
0.38
227.91
413.59
Total
"RESOLVED THAT pursuant to Section 293 (1) (a) of the Companies Act, 1956 and Article 22 of the Articles of
Association of the company, subject to approval of the President of India, consent be and is hereby given to
the Board of Directors of the company to create first charge over the leasehold right over the 5000 sq.ft of land
and the buidling thereon and equitable mortgage of 106.447 cents of company's land with buiding at
Poojappura as collateral security to secure FCNR (B) term loan equivalent to ` 6 Cr."
to the Board of Directors of the company to create first charge over the 15.33 acres of land and the building
and machinery relating to the Steroidal OCP and ARV manufacturing plant at Belgaum and equitable mortgage
of 106.447 cents of company's land with building at Poojappura as collateral security to secure the FCNR (B)
term loan equivalent to ` 29 Cr."
to the Board of Directors of the company to create first charge over the MRI machinery at the 3 MRI Centres
at Alleppy, Kottayam & Trichur and equitable mortgage of 106.447 cents of the company's land with building
at Poojappura as collateral security to secure securing the FCNR (B) term loan equivalent to ` 15 Cr."
19
{ |l | + ` 4 Eb E i B Bx + () n @h |{i Ex E B {E |ii E {
{V{{ Ex E l E{x E 106.447 ] E E vE Ex E B E{x E xnE b E i M
+ Binu i n Vi *
+xh , i E ]{i E +xnx E +vx n n x]E { x { |l | + ` 3.3 Eb E
i B Bx + () n @h |{i Ex E B {E |ii E { {V{{ Ex E l E{x E
106.447 ] E E vE Ex E B E{x E xnE b E i M + Binu i n Vi *
b E +nx
.B.vx x
E{x S B ` ={vI ( B B)
]{{h : E{x +vx E v 173 (2) E +x {]Eh h Mx *

v/EiE xnE/J{I i +vI
|i{ : +xnx & n
xn JE,
Ei, xhE
ixi{
|i{ : ij xnE
20
to the Board of Directors of the company to create first charge over the ETD Machines and Packing Machines
at Kakkanad Factory, CSEZ and equitable mortgage of 106.447 cents of the company's land with building at
Poojappura as collateral security to secure the FCNR (B) term loan equivalent to ` 4 Cr."
to the Board of Directors of the company to create first charge over the machinery at the HINDLABS Network,
in Delhi and equitable mortgage of 106.447 cents of company's land with building at Poojappura as collateral
security to secure FCNR (B) term loan equivalent to ` 3.3 Cr."
By the order of the Board
V. A. SASIDHARAN NAIR
COMPANY SECRETARY & SVP (CAS)
Note : Explanatory Statement as per Section 173 (2) of the Companies Act, 1956 is enclosed.
To
The Shareholders/Functional Directors/Audit Committee Chairman
Copy to : M/s. Ananthan & Sundaram
Chartered Accountants
Sree Karthi, Neeramankara
Thiruvananthapuram
Copy to : Independent Directors
21
Sx E +i {]Eh h
(E{x +vx E v 173 (2) E +x)
n . 3 : |nk {V + xE +Ii E +vEi =v x*
S 2011 iE E +xxi E |nk {V + xE +Ii ` 156 Eb * E{x +vx 1956 E v 293
(1) (P) E +x vE E +xnx E{x E |nk {V + xE +Ii E +vEi =v x EB
+E * < |vx E +xh E{x x 18 i 2009 E +Vi 43 E x È ` 300.00
Eb E iE =v x E B i |nx E l*
]] E + <b u VEi + xnE b u +xni E @h v { ` 413.59 Eb
(E {V - ` 322.69 Eb + E n @h ` 90.90 Eb) +< + b{E {Vx+ E nPv
@h E { G: ` 285 Eb + ` 83 Eb (E ` 368 Eb) +E * < |ii +iH =v E l,
E =n ` 781.59 Eb {SM*
il E vx Ji B ={H {] EB MB V E =v E ` 300 Eb +vEi M, vE E
+xnx E +vx O =v ` 1000 Eb gx E B |i E Vi * xnE b x 29 V< 2011 E
+Vi 230 b È ` 1000 Eb E =v x EB +xnx n l*
E{x E |nk {V + xE +Ii +vE vx =v x EB b E +xi nx E + vE E V
Mi * n vE <E +xnx E i E{x +vx 1956 E v 293 (1) (P) E +vx E *
i B vEh E B E{x E Vx E l, +{E b, +vE Ex +E Zi + <
E{ E { Ex E Ei *
<B b E{ . 3 E +{E +xnx EB Ei *
E{x E E< xnE < E{ S x Ji *
n . 4 +S {{k { vE SV
xnE b x 21 2011 E +Vi 228 b È n0 02.02.2011 E B +< {j Si i
xvx E +x xS nJ< V x< {Vx+ E ME { k Ex EB ]] E + <b ` 57.30
Eb i B Bx + () @h E =`x E xh l*
G
B Bx + ()
i E (` Eb)
6.00
{Vx
1.
x<b E x
2.
3.
]<b B B + +v j
E n-B + +< Exp
4.
ECExc C], B < <Wb < ] b

x + {EM x
4.00
n - V BS B x]E, n
3.30
5.
29.00
15.00
22
57.30
EXPLANATORY STATEMENTS TO FORM PART OF THE NOTICE

(Pursuant to Section 173 (2) of the Companies Act 1956)
Item No. 3 : Borrow in excess of paid-up capital and free reserves
The estimated aggregate of paid-up capital and free reserves as of March 2011 is ` 156 Cr. According to
Section 293 (1) (d) of the Companies Act, 1956 approval of the Shareholders is required to borrow money in
excess of the company's paid-up capital and free reserves. Pursuant to this provision, the company had in
the 43rd annual general meeting held on 18th September 2009 accorded consent to the Company to borrow
up to a limit of ` 300.00 Cr.
The aggregate credit limits sanctioned by State Bank of India and approved by the Board of directors is
` 413.59 Cr. (working capital limit - ` 322.69 Cr. and term loans aggregating to ` 90.90 Cr.) over a period of
time. The projects viz. IVC and MediPark requires ` 285 Cr. and ` 83 Cr. respectively (total ` 368 Cr.)
in the form of long-term debt. With this proposed additional borrowing, the total borrowing would reach
` 781.59 Cr.
In view of the fact that total borrowing as explained above would exceed the ` 300 Cr. limit, it is proposed to
enhance the overall borrowing limit to ` 1000 Cr., subject to approval of shareholders. The Board of directors
had in the 230th Board meeting held on 29th July 2011 given approval to borrow upto ` 1000 Cr.
Sanction of the Shareholders is sought to permit the Board to borrow moneys in excess of the company's
paid-up capital and free reserves. This is permissible under Section 293 (1) (d) of the Companies Act, 1956,
if the Shareholders approve it. With the company's plans for expansion and diversification, your Board thinks
it ncessary to acquire this power and recommends passing of this resolution.
The Board therefore recommends the resolution no. 3 for your approval.
None of the Directors of the Company is interested in this resolution.
Item No. 4 : Mortgage or charge on the immovable properties
The Board of Directors had in its 228th Board meeting held on 21st February 2011, decided to avail FCNR (B)
loan equivalent to ` 57.30 Cr. from State Bank of India as per terms and conditions vide SBI letter dated
02.02.2011 to part-finance the new projects as shown below."
Sl.
No.
FCNR (B) equivalent

to amount (` Cr.)
Project
1.
Office Building at Noida
2.
Sterodial & ARV Drugs Plant
29.00
3.
HINDLAB - MRI Centres in Kerala
15.00
4.
ETD Machines and Packing Machines

at Kakkanad Factory, CSEZ
4.00
HINDLAB - CGHS Network, Delhi
3.30
5.
6.00
Total
57.30
23
B +< E V {j v/+O/422, nxE 02.02.2011 E +x, E{x E +{x xn] +S {{k

{ | Ex SB*
<E +, xnE b x 26 +| 2011 E +Vi +{x 229 b È B +< {j . v/B b
465, nxE 1 S 2011 Si i xvx E +x, ]E E vE {j, Ji @h + E{x E {{k {
vE SV Ex { ]] E + <b, ixi{ ` 322.69 Eb E xv +vi + M-xv +vi v
E =`x E xh l*
={H ni ` 322.69 Eb =v S {V E +, ]] E + <b x ={H =Ji ` 57.30
Eb E n p n @h i ` 90.90 Eb E E n @h E V E l*
(i)
]] E + <b, hVE J, ixi{ |{i ` 413.59 Eb (E S {V + n @h) E

E V @h |{i Ex E B {E |ii E { {V{{ Ex E l 106.447 ] E E{x E
E E vE xx*
(ii)
6 Eb E i B Bx + () n @h |{i Ex E B {E |ii E { {V{{ Ex

E l E{x E 106.447 ] E E vE xx*
(iii) M 15.33 BEc il Ex + ]<b + { + B + xh j vi x {

|l | + ` 29 Eb E i B Bx + () n @h |{i Ex E B {E |ii E {
{V{{ Ex E l E{x E 106.447 ] E E vE xx*
(iv) +{{, E]] + j 3 B + +< Exp { B + +< x { |l | + ` 15 Eb E
i B Bx + () n @h |{i Ex E B {E |ii E { {V{{ Ex E l E{x
E 106.447 ] E E vE xx*
(v)
ECExc C], B < <Wb < ] b x + {EM x { |l | + ` 4 Eb E i B

Bx + () n @h |{i Ex E B {E |ii E { {V{{ Ex E l E{x E 106.447
] E E vE xx*
(vi) n n x]E { x { |l | + ` 3.3 Eb E i B Bx + () n @h |{i

Ex EB {E |ii E { {V{{ Ex E l E{x E 106.447 ] E E vE xx*
E{x +vx 1956 E v 293 (1) (P) + E{x E l E +ix 22 E +x, E{x E +S {{k {
vE/SV xx E vE + i E ]{i E +xnx +E *
<B b +{E +xnx E B E{ . 4 E Ei *
E{x E E< xnE < E{ S x Ji *
b E +nx
.B. vx x
E{x S B ` ={vI ( B B)
24
As per SBI's sanction letter No. Misc. /Adv/422 dated 02.02.2011. the company has to create charge over its
specified fixed assets.
In addition, the Board of Directors has in its 229th Board meeting held on 26th April 2011, decided to avail
fund based and non-fund based facility of ` 322.69 Cr. from State Bank of India, Thiruvananthapuram on
hypothecation of stock, book debts and creation of mortgage of charge on assets of the Company as per
terms and conditions as informed vide SBI letter No. Misc./Adv 465 dated 1st March 2011.
Besides the working capital borrowing of ` 322.69 Cr. referred above, the State Bank of India had sanctioned
term loans aggregating to ` 90.90 Cr. including the foreign currency term loans of ` 57.30 Cr. mentioned
above.
In accordance with SBI sanction letters referred above, the company has to create charges over various
assets as mentioned below.
(i)
Create equitable mortage of 106.447 cents of company's land with building at Poojappura as collateral
security to secure the aggregate credit limits of ` 413.59 Cr. (aggregate of working capital limit and
term loans) availed from State Bank of India, Commercial Br., Thiruvananthapuram.
(ii)
Create equitable mortgage of 106.447 cents of company's land with building at Poojappura as collateral
security to secure FCNR(B) term loan equivalent ` 6 Cr.
(iii)
Create first charge over the 15.33 acres of land and the building and machinery relating to the Steroidal
OCP and ARV manufacturing plant at Belgaum and equitable mortgage of 106.447 cents of company's
land with building at Poojappura as collateral security to secure the FCNR(B) term loan equivalent to
` 29 Cr.
(iv)
Create first charge over the MRI machinery at the 3 MRI Centers at Alleppy, Kottayam & Trichur and
equitable mortgage of 106.447 cents of company's land with building at Poojappura as collateral
security to secure the FCNR(B) term loan equivalent to ` 15 Cr.
(v)
Create first charge over the ETD Machines and Packing Machines at Kakkanad Factory, CSEZ and
equitable mortgage of 106.447 cents of company's land with building at Poojappura as collateral
security to secure the FCNR(B) term loan equivalent to ` 4 Cr.
(vi)
Create first charge over the machinery at the HINDLABS Network, in Delhi and equitable mortgage of
106.447 cents of company's land with building at Poojappura as collateral security to secure FCNR(B)
term loan equivalent to the term loan of ` 3.3 Cr.
Pursuant to Section 293(1) (a) of the Companies Act, 1956 and Article 22 of the Company's Articles of
Association, approval of Shareholders and the President of India is required to create mortgage/charge on
the fixed assets of the Company.
The Board therefore recommends the resolution no. 4 for your approval.
None of the Directors of the Company is interested in this resolution.
By the order of the Board
V. A. SASIDHARAN NAIR
COMPANY SECRETARY & SVP (CAS)
25
I.
|vx E SS + h
1. MEx
1.1. xh Ii
BSBB E z MvE =i{n h E |J xi + Gi * v +{i =i{n, =i{n
+ l I {nM B |nx Ei *
E{x E {Ec C], ixi{ + ExM C], M 1.316 x Eb xh Ex E Ii , V
=i{nx Ii E 10 |ii E Mhx Ei *
l Ij EB P V] x 2004-2005 ` 8,000 Eb 2009-10 ` 21,000 Eb E r nJ * V
E u l I E JS = i E r E M E * BSBB E =i{n + V u |Vi
l I {Vx+ E =iE] { { Ex Ep + V E u < Ij E JS E r E{x E
+{x i Ex E + |nx E M*
1.2 xMi Vx -2020
E{x x 2003 xMi Vx-2010 E +vh E * Vx {U i Exi E l* Vx
S EB V BSBB x <E Ii Wi E + E Ij vEh E n*
BSBB x +{x Eb (1034 nI +nn 1316 nI +nn iE) + b M (5.0 nI +nn 11.5 nI
+nn iE) E xh Ii E i E, =E u <x =i{n E h xii lx x Ji * E{x x n
xh vB, BE ESS l Eb + n <n ]E =i{n ({^ { v) l{i E
l* <E +, +VE E{x <E {Ec C], ixi{ E Eb xh Ii 180 nI +nn iE
gx E |G , < |E BSBB E E Eb xh Ii 1496 nI +nn xx *
E{x x <E x< n Epi xnxE B, |{h B +Sx E |M E v l I Ij
VJ =` *
<|M +{i({) ]b, BE H VJ E{x x E + i+ E =SS Mhk, x Ex M
|i l I nx |l l I |nE x E =q l{i , +{x E Sl | E
*
BSBB x È +xvx E Ub E Wx 2010 niV =Ji ii Ij | E *
+ E{x, MxvE + +{i =i{n V <E J Jhb E Wi Ei |i + +M
E vEh E vx J E 'Wx 2020' E {J xx EB BE {ni E M * BSBB E
10,000 Eb E l I E{x xx Wx 2020 E =q *
1.3 ]]VE x]
E{x E E i/vEh E {h{, BSBB x vEi {] E |vx v
Sxi E x E * < Sxi E x Ex E B, E{x x |Sx E ij ]]VE x]
(B ) E l {x&Sx E l*
26
I. MANAGEMENT DISCUSSION AND ANALYSIS

1.
OVERVIEW
1.1.
Manufacturing capability
HLL is a leading manufacturer and marketer of a range of Contraceptive products around the globe. It also
provides a variety of hospital products, pharma products and healthcare delivery services.
The company has capacity to manufacture 1.316 billion Condoms at Peroorkada Factory, Thiruvananthapuram
and Kanagala Factory, Belgaum which account for nearly 10 percent of the global production capacity.
The union budget for the health sector witnessed a quantum jump from ` 8,000 crore in 2004-05 to ` 21,000
crore in 2009-10. Spending by the State Governments on health care also witnessed a similar increase. As
HLLs products and services predominantly cater to state-sponsored healthcare projects, the increased
spending in this sector by the Central and State Governments have provided huge opportunities for the
company to expand its business.
1.2.
Corporate Plan 2010:
The company conceptualized the Corporate Plan-2010 in year 2003. The Plan was implemented over the
last 7 years. As envisaged in the plan, HLL strengthened its core capabilities and diversified into the services
domain.
HLL expanded its manufacturing capacity for Condoms (from 1034 M.Pcs. to 1316 M.Pcs.) and Blood Bags
(from 5.0 M Pcs to 11.5 MPcs), thereby maintaining its leadership position in these product categories. The
company also established two new manufacturing facilities, one for Female Condoms at Kochi and the
other for Pharmaceutical products (leased facility) at Indore. Besides, the company is currently in the process
of further expanding its Condom manufacturing capacity at Peroorkada Factory, Thiruvananthapuram by 180
M.Pcs, thus taking the total condom production capacity of HLL to 1496 M. Pcs.
The company has ventured into the healthcare services domain through its Diagnostic Services, Procurement
and Infrastructure Development Divisions based in New Delhi.
LifeSpring Hospitals (P) Ltd, a joint venture company established with the mission to be the foremost
healthcare provider - to deliver high-quality, affordable core maternal healthcare to low income mothers, has
entered its fourth year of service.
HLL has commenced business in all broad business verticals mentioned in the Vision 2010 document
except contract research.
Now, the company has engaged a consultant to frame Vision 2020, taking into account recently-commenced
businesses and for further diversification, while strengthening its core segments namely Contraceptives
and Hospital products. The objective of Vision 2020 is to make HLL a ` 10,000 crore healthcare company.
1.3.
Strategic Business Units:
Consequent to the expansion/diversification of the companys business, HLL faced various challenges in
managing a diversified businesses portfolio. To meet this challenge, the company restructured its business
operations into three independent Strategic Business Units (SBUs).
27
+vE Vn,EI + |SxiE iji x E o] B E M`x xx V *

G
1.
2.
3.
]]VE x] (B )
M xvE + ]E B
+{i =i{n B
B
1.3.1. Mxv E + ]E
Mxv E + ]E B Mxv E + ]E =i{n E h E xh + {hx Ei * <
h { Eb, Eb, <x]-]<x ={Eh, JE MxvE M - ]b + xx- ]b
nx, +{iEx MxvE M, ] M + <VC] * B + E B VE,
xE + E ixni E vi Ex l I =i{n E ii h |nx Ei * =i{n
h MxvE, +x <b, +x]]C, E SG xjE, +x]x]C, B ] { M, |Mxx
]] E], |EiE =i{n + Cx *
1.3.2. +{i =i{n
+{i =i{n B H +vx + +Oi V I E Ij l I kE E xVE +{i =i{n
+ + E ii h ni * =i{n h H Sx M, VE S, <b ], ] BC{],
VE + {Ih nix, H +vx ], <x]x ] + H EM ={Eh *
1.3.3
BSBB x n E Ex-Ex iE x + Mhk l I x EB E< {B S E * bE
+Sx E, xnxE Ep + |{h { Ep V Ij E BiE {B |iE xME E M, x Ex
M l I {nM E x Ij =i{z Ex E E{x Ei *
1.4. <Mx E Mi IE EG
l B { Eh j, M x +Wn x Vx
2011 E <n Mv ] H t (<Mx) E Mi
BSBB E x IE EG S E* | EB MB
nl IE EG CxE <Vx + |vx {
xiEk b{ {`G ({ V b B) + CxE
<Vx + |vx { {] b{ {`G ({ b < B)
* < EG E =q l I {nM CxE
<Vx + |vx E Ij E {i +Ei+ E vi
Ex EB kE E VVi Ex *
1.5. =t VJ |vx xi
VxE =t M u Ep VxE =t 2010 E B
E{] +x { V E n-xn E +v { BSBB
l B { Eh P j M x +Vn x 05 Vx 2011 E BSBB E

+Sx E |M u xi ixi{ bE EV E { {] E E
=r]x E* {BBB< E +vx { E M { +{i =zx {Vx *
x BE =t VJ |vx xi E {J i Ex E xh * E{x, <E u +J Ex v VJ

E E Ex E {J i Ex E BE |iì {ni E M *
2. EB k {h
+{E E{x E {U 10 E I{i k {h xS nB Vi *
28
With a view to bring in more accountability, efficiency and operational autonomy, the structuring of SBUs are
as under.
Sl. No.
Strategic Business Units (SBU)
1.
Contraceptives & Pharmaceuticals SBU
2.
Hospital Products SBU
3.
Services SBU
1.3.1. Contraceptives & Pharmaceuticals:

The Contraceptives & Pharmaceuticals SBU manufacture and
market a range of Contraceptive and Pharmaceutical products.
The range includes Male Condoms, Female Condoms, IntraUterine Devices, Oral Contraceptive Pills both Steroidal and
Non-steroidal, Emergency Contraceptive pills, Tubal rings and
Injectables. The SBU also offers a whole range of Healthcare
products for women that address their social, mental and
physical well being. The product basket includes Contraceptives, Ovulation Inducers, Antiemetics, Menstrual cycle
regulators, Antifibrinolytics, MTP pills, Pregnancy test kits, Natural
products and Vaccines.
1.3.2.
Shri. M. Ayyappan, C & MD, HLL laying Foundation stone for

HLLs world class hormonal/steroidal formulation plantUNIPILL Block-with an investment of Rs. 40 Crore at HLLs
Kanagala Factory on 12th September, 2010
Hospital Products:
Hospital products SBU offers a wide range of critical hospital products and services to healthcare professionals
in the field of transfusion services and advanced patient care. The product range includes Blood Collection
Bags, Surgical Sutures, Hydrocephalus shunts, Tissue Expanders, Surgical and Examination Gloves, Blood
Transfusion sets, Intravenous Sets and Blood Banking Equipments.
1.3.3.
Services:
HLL has also launched several initiatives to take reliable and quality healthcare to every nook and corner of
the country. Landmark initiatives in the services sector, namely, medical infrastructure development, diagnostic
centres and Procurement Consultancy, are all conceived to bring about a whole new realm of accessible,
affordable healthcare delivery to every citizen.
1.4.
Academic programme in association with IGNOU
In January 2011, the Union Minister of Health and Family Welfare, Shri Ghulam Nabi Azad launched HLLs
new academic programmes in association with Indira Gandhi National Open University (IGNOU). The distance
education programmes launched include a Post-Graduate Diploma course in Clinical Engineering and
Management (PGDCM) and Post-Diploma course in Clinical Engineering and Management (PDCEM). The
objective of the programme is to mould professionals to address varying needs in healthcare delivery in the
areas of Clinical Engineering and Management.
1.5.
Enterprise Risk Management Policy:
Based on the Guidelines on Corporate Governance for Central Public Sector Enterprises 2010 issued by the
Department of Public Enterprises, HLL had decided to frame an Enterprise Risk Management Policy. The
company has engaged a reputed consultancy firm to build a framework to mitigate various risks faced by it.
2.
FINANCIAL RESULTS FOR 10 YEARS
The summarized financial results of your company for the last 10 years are given below.
29
30
13544.45
2148.08
394.28
207.53
599.00
947.27
12.20
189.45
1553.50
2788.93
4342.43
7676.35
2433.00
10017.05
E +
E { +Vx, V
+ E(< b +< ])
E E n
hV %
JS EB
hV + {V
+Ii + +v
E +S {{k
x +S {{k
E {{k
1915
12598.32
{i
ES E J
2001-02
1837
10530.60
2648.41
8230.40
5283.16
3729.66
1553.50
282.83
18.21
1414.16
827.26
175.85
411.18
2828.45
15785.92
14102.40
2002-03
1850
12056.18
3596.69
9538.97
6738.96
5185.46
1553.50
376.24
24.22
1881.21
1067.25
78.79
455.14
3482.39
17564.20
16253.89
2003-04
1850
15002.34
3743.71
10249.79
8136.8
6583.30
1553.50
361.56
23.27
2010.58
1361.37
115.98
573.90
4061.83
21054.51
19620.49
2004-05
1845
17375.65
3889.58
10944.04
9727.72
8174.22
1553.50
412.80
26.57
1908.54
1206.34
49.25
613.78
3777.91
22545.66
21288.58
2005-06
k <<]
1917
26474.48
4624.37
12313.04
10996.16
9442.66
1553.50
412.80
26.57
1746.78
1004.10
272.50
661.18
3684.56
28906.99
24348.17
2006-07
2008-09
1553.50
155.35
10.00
757.83
896.61
920.64
899.59
3474.66
1880
1927
28795.82 39135.12
6470.55 10831.22
14807.07 19835.30
12242.45 12803.50
10688.95 11249.99
1553.50
155.00
9.98
1427.82
715.13
447.10
733.07
3323.12
35004.89 38188.29
32850.88 36641.86
2007-08
1922
38447.93
12479.05
22652.84
14024.25
12470.75
1553.50
233.03
15.00
1493.39
768.01
756.05
1279.07
4296.52
46548.03
44006.29
2009-10
1939
52662.20
13255.75
23013.02
15557.49
14042.50
1553.50
233.03
15.00
1843.49
905.92
524.37
1439.22
4713.00
54119.85
51564.33
2010-11
(E {B J )
31
4342.43
7676.35
2433.00
Net Worth
Gross Fixed Assets
Net Fixed Assets
Number of Employees
1915
10017.05
2788.93
Reserves and Surplus
Total Assets
1553.50
Equity Share Capital
189.45
947.27
Profit After Tax
Dividend Payout
599.00
Tax
12.20
207.53
Interest
Equity Dividend %
394.28
Depreciation
2148.08
13544.45
Total Income
Earnings Before
Depreciation, Interest
and Tax (EBDIT)
12598.32
2001-02
Turnover
Description
1837
10530.60
2648.41
8230.40
5283.16
3729.66
1553.50
282.83
18.21
1414.16
827.26
175.85
411.18
2828.45
15785.92
14102.40
2002-03
1850
12056.18
3596.69
9538.97
6738.96
5185.46
1553.50
376.24
24.22
1881.21
1067.25
78.79
455.14
3482.39
17564.20
16253.89
2003-04
1850
15002.34
3743.71
10249.79
8136.80
6583.30
1553.50
361.56
23.27
2010.58
1361.37
115.98
573.90
4061.83
21054.51
19620.49
2004-05
1845
17375.65
3889.58
10944.04
9727.72
8174.22
1553.50
412.80
26.57
1908.54
1206.34
49.25
613.78
3777.91
22545.66
21288.58
2005-06
1917
26474.48
4624.37
12313.04
10996.16
9442.66
1553.50
412.80
26.57
1746.78
1004.10
272.50
661.18
3684.56
28906.99
24348.17
2006-07
FINANCIAL HIGHLIGHTS
1880
28795.82
6470.55
14807.07
12242.45
10688.95
1553.50
155.00
9.98
1427.82
715.13
447.10
733.07
3323.12
35004.89
32850.88
2007-08
1927
39135.12
10831.22
19835.30
12803.50
11249.99
1553.50
155.35
10.00
757.83
896.61
920.64
899.59
3474.66
38188.29
36641.86
2008-09
1922
38447.93
12479.05
22652.84
14024.25
12470.75
1553.50
233.03
15.00
1493.39
768.01
756.05
1279.07
4296.52
46548.03
44006.29
2009-10
1939
52662.20
13255.75
23013.02
15557.49
14042.50
1553.50
233.03
15.00
1843.49
905.92
524.37
1439.22
4713.00
54119.85
51564.33
2010-11
(AMOUNT IN RS. LAKH)
3.
BSBB E GE{ E I xS n Vi *
3.1. xh
=i{n *
G
.
x]
l{i Ii
xi {h
(Mi EÈ )
={M Ii
(%)
1316.00
1327.85
(1319.75)
101
Eb
B { B
]<b + { B
nI <E
98.66
586.82
(57.60)
59
xx - ]<b + {
nI M
30.00
26.54
(19.00)
88
b M
B { B
11.50
6.42
(8.21)
56
|Mxx ]] Eb
B { B
26.00
23.58
(25.11)
91
BSBB E |J =i{n
BSBB x +{x Eb =i{nx x] 100 % ={M Ii |{i E * +x =i{n E B k ={M Ii |{i

Ex EB | E V *
3.2. {hx
v {hx |Sx x {U E +v E ` 200 Eb E ix ` 219 Eb {i =i{z E *
{hx |Sx +i] |M, ={H |M, <-E |M + l I |M E
VB Exi EB MB * <x |M E x{nx <] xS nB Vi *
3.2.1. +i] |M (+< b)
E{x E +i] |M (+< b) i E 90 n =i{n E ih Ei * Eb E }M{
={H b b 42 n + BS B-{E b M 20 n {hx E Vi * b + x<]b +
B] ]{ S Eb b BE *
<E | +i] |M E B xn + lMi G |J V ji * +i] b
r |{i Ex E + E{x E Eb + b M { W nE bb { +vE vx nx E Vx *
BSBB E +xi] |Sx E |J Ij - nIh +E, nIh { B, v { + +E, {x
xx + ]b ij V * BSBB x <x n +{x b E {VEi Ex EB x E *
2011-12 , E{x E <x n E Ij x W | Ex E Vx *
BSBB x M Ei {n n (V ), W, Ex + Mn V VIj E{x E =i{n E
{hx E f nx EB {hx E{E E ixi E *
32
3.
BUSINESS REVIEW
A review of HLLs business activities is given below:

3.1.
Manufacturing
Sl. No.
Product *
Unit
Installed
Quantity
Capacity
capacity
manufactured
utilization (%)
(Previous year
in bracket)
1
Condoms
MPcs
1,316.00
1,327.85
(1319.75)
101
Steroidal OCPs
Million Cycles
98.66
58.68
(57.60)
59
Non-Steroidal OCPs
Million Tablets
30.00
26.54
(19.00)
88
Blood Bag
MPcs
11.50
6.42
(8.21)
56
Pregnancy Test Cards
MPcs
26.00
23.58
(25.11)
91
* HLLs major products

HLL has achieved 100% capacity utilization at its Condom production units. Efforts are being made to
achieve better capacity utilization for other products.
3.2.
Marketing
The direct marketing operations generated a turnover of ` 219 crore as compared to ` 200 crore during the
previous year.
The marketing operations are carried out through International Business Division, Consumer Business
Division, Hi-care Business Division and Womens Healthcare Division. The performance highlights of these
divisions are outlined below.
3.2.1. International Business Division (IBD)
The companys International Business Division (IBD) distributes products to over 90 countries worldwide.
MOODS, the flagship consumer brand of condoms is marketed in 42 countries and HL- Haemopack Blood
Bags in 20 countries. MOODS is now one among the top four Condom brands in UAE.
Since inception, tenders and institutional sales have been the major sources of revenue for the International
Business Division. To achieve a quantum leap in international business, the company plans to focus more
on branded business with special emphasis on Condoms and Blood Bags. The thrust areas of HLLs
international business operations are South America, South East Asia, Middle East & Africa, European Union
and Commonwealth Independent States & Russia. HLL has invested in registering its brands in these
countries. In 2011-12, the company plans to tap new markets in countries in these regions.
HLL has in place its marketing executives in the Gulf Co-operation Council (GCC) countries, Brazil, Kenya
and Bangladesh to ramp up marketing of companys products in these territories.
33
E{x x 2009-10 E B +< + +< B ']C xi {E' + 2009-10 EB E{C xi

{E E *
3.2.2. < E |M (BS b)
Ivx E nx < E |M (BS b) x 31 +H 2010 E < bx] b x E +vx BE x b
M {n S E * bx] E +l "< E ={"* bx] n Ei H +vx +{I+ E
+Ei+ E { Ex EB +E{i (xb <xV |]C], ]b ]M,<x<x {M,CE]<x {], B
b ]) BE Ih r b M * <x] i ={MEi+ B bE kE nx E ={M Ex
+x + v VbM*
E nx, |M x xE + Bx + BS B E nxn E { Ex E + E E 14 V+ 32 b Sx
Ep E l{i E l* |M E E b P]E {lCEh x] + xx] I x] E l{i Ex E
È |{i + *
3.2.3. l I |M (b BS b)
E{x E b BS b {x <b E l 30 =i{n E |ii Ei * b BS b E +Oh b - xC b B,
V]x + *
b BS b <bx W E M<xE Jhb |Si Ei VE 15% E r E l ` 2685 Eb
* |M E Jhb 60% EV V =SS |lEi =i{n M b Mx ]x bM (b ), +x,
E +b, <] ]x b< (+< b) + MC]MM E M*
3.2.4. ={H |M ( b)
E{x u i E Eb E b b 19 {n ={v + { b E { Sx M +
|iì "{ b {n" |{i < * x |nk EB Vx BEj Eb b , b*
3.3.
|M
BSBB E ix |M ;
3.3.1. |{h B { |M ({ b)
|{h + { |M 1998 l{i V n |{h EB l B { Eh j E +vx
] |{h lx +Eh (Bx { B B) BE E { xEi *
{ b E n n E bE ={Eh E |{h + +{i EB E S E Exx Mn *
3.3.2. +Sx E |M (+< b b)
E{x x |vx j l I Vx E +vx M bE EV + bE EV {Vx+ E =zx
G& |l Sh V< 2010 + +Mi 2010 E { E *
34
The company won AIRIA latex export award for 2009-10 and CAPEXIL special export award for the year
2009-10.
3.2.2 HI-Care Division (HCD)
During the year under review, HI-Care Division (HCD) launched a new blood bag variant under the brand
name Donato (signifies Gift of God) at Mumbai on October 31, 2010. Donato Blood Bags are feature-rich
with Needle injury protector, frosted tubings, inline sampling, vaccutainer port, LD filter and designed to
meet the needs of advanced transfusion service requirements in the country. These in built features will
enable ease of use and convenience to end users - both donors as well as medical professionals.
During the year, the division had set up 32 blood storage centers in 14 districts in Kerala, meeting the
guidelines of NACO and NRHM. The division also received contracts to set up blood component separation
units and neonatal care units in Kerala.
3.2.3. Women's Healthcare Division (WHD)
The companys WHD now offers 30 products with a pan-India presence. The leading brands of WHD are
Novex DS, Hilgestrone and Hilrab.
WHD operates in the Gynecology segment of Indian Pharma Market - valued at ` 2,685 crore, with an annual
growth of 15%. The division has 60% coverage in the segment, of which high priority product groups would
be Dysfunctional Uterine Bleeding (DUB), Iron and Folic acid, Intra Uterine Contraceptive Devices (IUCD)s
and Galactagogue.
3.2.4. Consumer Business Division (CBD)
Moods brand of condoms owned by the company is available in 19 variants
and was selected as a Super Brand. The brand also obtained the coveted
Power Brand status. Moods is the only condom brand to be conferred
this honour..
3.3.
Service Divisions
HLL has three service divisions; these are:

3.3.1.
Procurement & Consultancy Division (PCD)
Procurement & Consultancy Services Division set up in 1998, is one of

the designated National Procurement Support Agencies (NPSA) under
the Ministry of Health & Family Welfare for domestic procurement.
PCD is the implementation partner of SAARC Secretariat for procurement
and supply of Medical Equipments to SAARC member countries.
3.3.2.
Infrastructure Development Division (IDD)
The company completed upgradation of Bangalore Medical College and
Shri. K. K. Suresh Kumar, Director

(Marketing) receives the prestigious Power
Brand status for MOODS brand recognizing
it as one of the top 200 brands in India, on
01 October 2010.
Salem Medical College Project under PMSSY 1st Phase in July 2010 and
August 2010 respectively.
35
E nx, ixi{ bE EV (] B ) E =zx {Vx, xx l B { Eh j u

5 Vx 2011 E =nP]x E M* bE EV E =zx {Vx E =nP]x 20 +Mi 2010 E
ixb J j u EB MB* BSBB x M bE EV E =zx { E *
l B { Eh j x xx <]]] + {-bE <x (Bx +< { B) + Ij {bE <x l (+ +< { B) E xh E + ix +vE bE EV E =zx E E BSBB
E { *
E{x S, E { xh x] l{i Ex EB E V |vE E l Zi E *
3.3.3. xnxE |M
BSBB u l{i "xn", ES V xM (< B +< ) E l Mi +v (<), < +
VV xM, M E < B +< b +{i E ] /B + +< Ep E |vx + |Sx EB v
|vx |nx E * 64 < ] Ex x + 1.5 ] B + +< Ex x E +xIh +
=zx BSBB ] u xi E Vi *
|M V BS B + +x Exp l+ EB Sx Ep + x |M x]E E l{x E v
"n" J+ E i E * x E{x +{i E B + v Ep E { Ei E V
*
3.3.3.1. <E Ep
|M E E E Mi E l ixi{ bE EV <E Exp xE BE ]E Ep
l{i E * <E Ep VE <{x], ={V + Vx I +v E |nx Ex { vx nM* <x
=i{n E W x Ex M Ei { |nx Ex Ep E I * M V E +vE +E i
xSi EM*
<E Exp E {Vx E E E +x S bE EV + +{iV E Ij lx, ixi{ iE
i Ex E Vx *
4.
4.1. v |vx
{S Vx 550 bE EV EB l I +Sx v+ E =zx E |i ni + =x
{S E E Ij ] l+ E { |ii EB MB * xi: E lB <E B lMi
l E + <x v+ E +xIh Ex E`x< Ei * E{x +Sx + ={Eh +xIh {
Epi * E{x { ixi{ + V{ {iSS E { {] +{i E v |vx E Sx E
*
5.Sxi,VJ + =rMxi
BSBB x Vx E l x Ex |J Sxi, VJ + =rMxi+ E xS Si E M *
{V /{Vx Mi + xv E Mi +xE xx E xv E ={vi* +E +xnx |{i
Ex E +x BSBB Vxi + hb E { {V fx E Vx *
+|H xh Ii
BSBB +iH xh Ii E ={M EB { ]<b + xx-]<b JE M xvE
M E v BE {J xi xBM*
36
During the year, the Thiruvananthapuram Medical College (TMC) Upgradation Project was inaugurated on
January 5, 2011 by the Honourable Union Minister for Health & Family Welfare. The Salem Medical College
Upgradation Project was inaugurated on August 20, 2010 by the Chief Minister of Tamil Nadu. HLL has also
completed the upgradation of the Bangalore Medical College.
MoHFW has entrusted HLL the task of upgrading three more medical colleges, apart from construction of
National Institute of Para-medical Sciences (NIPS) and Regional Institute of Para-medical Sciences (RIPS).
The company entered into an agreement with Kerala Water authority for setting up a PVC manufacturing unit
at Chavara, Kollam.
3.3. 3. Diagnostic Services Division:
Hindlabs set up by HLL, in partnership with Employees State Insurance Corporation (ESIC), is providing
facility management services for management and operations of CT / MRI centres at ESIC Model Hospitals
at Andheri (E), Mumbai and Rajajinagar, Bengaluru. The maintenance and upkeep of the 64 Slice CT scan
machine and 1.5 Tesla MRI scan machine are coordinated by HLL team.
The division is expanding the Hindlabs chain by setting up collection centres and new laboratory networks
for CGHS and other central institutions.
3.3. 3.1. Lifecare Centre:
This division, in partnership with Government of Kerala, is setting up a specialty retail centre called Lifecare
Centre at Medical College, Thiruvananthapuram. Lifecare centre will focus on providing surgical implants,
consumables and life-saving drugs. The mission of the centre is to provide these products at an affordable
price than the market price. This is to ensure much-needed relief to poor patients.
Lifecare Centre project is planned to be extended to other four medical colleges in Kerala and to the
Regional Institute of Ophthalmology, Thiruvananthapuram.
4.
OPPORTUNITIES
4.1
Facilities Management business:
The twelfth five-year plan proposes upgradation of Healthcare Infrastructure Facilities for 550 Medical Colleges
and of these, fifty of them have been proposed as national institutions in the Government sector. Generally,
Government institutions find it difficult to maintain and manage these facilities, in the absence of an institutional
arrangement for the same. The company foresees a business opportunity in Facility Management Services,
focusing on infrastructure and equipment maintenance. The company is already handling facility management
at super specialty hospital at Trivandrum and Jipmer, Pondichery.
5.
CHALLENGES, RISKS AND CONCERNS
The major challenges, risks and concerns faced by HLL together with the mitigation plan are listed below:
Availability of funds to finance capital expenditure / project costs and optimizing cost of funds.
Subject to obtaining necessary approvals, HLL plans to raise capital in the form of shares and
bonds from the public.
Idle manufacturing capacity
HLL will put in place a framework policy for utilization of spare manufacturing capacity particularly with
regard to Steroidal and Non-steroidal Oral Contraceptive pills.
37
6.+xvx B E
E{x E E{] +xvx B E Ep E{x + v ] l V +< +< ] Ex{, +< +< ] <,
Sj ix <x]]] bE <x +hb iExV, ixi{, Ij E Ep, ixi{ E M E
l +xvx B E {VxB Exi E *
BSBB 02 +Mi 2011 E x +vi

|Vxx {Ih E] E xh E B <bx
E= + bE S (+<B+)
E l BE |tME iih Zi
Ei *
E nx, BSBB + & b Ep E =SS Sxi xh E +vx E]b E{-] EB bOb {

E]M {Vx E B & xn M] xbx B $ 100,000 E xv |{i E * b ] u
|Vi |V]x Vx M E xnxE {Ih EB +< B +-{ + { {n-BSBB {Vx E
nx | < * <x] ]<x ] E { xnxE Ex { E M* E<] b{x ] E E
EB +< +< ] Ex{ E l n M {Vx {i E +i Sh * Ei +xvx B E
+Sx E l{x |Mi { + v 2011 E +i iE i E VBM*
+xvx B E {
{V
- ` 352.22 J (` 108.91 J)
+i
- ` 182.94 J (` 114.28 J)
{U vi +Eb*
7.
M`vx / |tME =zx
7.1. b M xh v E i
l B { Eh P Ex] j Mx +Wn x 2011 Vx E ixi{ n b M xh
v E =nP]x E* x 20,000 E ] v, bx^ b x E +vx x h E H O M E
=i{nx Ei * < E l, l{i H M E xh Ii 5.0 nI +nn 11.5 nI +nn iE f M *
7.2. |tME =zx
b M xh C] b M ={M Ex < E xEx E Ex EB BE Si < Vbx x
E {xVx Ei + < OE Ei v +i + G f Vi * |iI E Vi E
BE Si < Vb < E xE E xEx E EM, +xl Hni+ EB {x E Eh
M *
38
6.
RESEARCH & DEVELOPMENT
The company's corporate research and development centre is implementing R&D projects, both in-house
and in collaboration with different national institutions namely, IIT Kanpur, IIT Mumbai, Sree Chitra Thirunal
Institute for Medical Science & Technology, Thiruvananthapuram, Regional Cancer Centre,
Thiruvananthapuram.
During the year, HLL R&D Centre received an external funding of US $ 1,00,000 from the Bill & Melinda Gates
Foundation for the project 'Biodegradable polymer coating for Coated Copper-T' under the Grand Challenges
Explorations. ICMR-POP council HLL project for the clinical trial of Progesterone Vaginal Ring sponsored by
DBT was started during the year. The preclinical evaluation of Intra Uterine System was completed. Another
collaborative project with IIT-Kanpur, for the development of leucocyte depletion filters is in the final stages of
completion. The setting up of a state-of-the-art R&D infrastructure is in progress and the facility will be ready
by end of 2011.
Expenditure on R & D
Capital Expenditure
Recurring Expenditure
` 352.22 lakh (` 108.91 lakh)*

` 182.94 lakh (`114.28 lakh)*
* Figures pertaining to previous year.
Shri. Ghulam Nabi Azad,

Union Cabinet Minister for
Health and Family Welfare
inaugurated the second Blood
Bag Plant DONATO BLOCKat Akkulam Factory, on 05
January 2011.
7.
TIE UPS /TECHNOLOGY UPGRADATION
7.1.
Expansion of blood bag manufacturing facility
In January 2011, the Union Cabinet Minister for Health and Family Welfare, Shri Ghulam Nabi Azad inaugurated
the second Blood Bag manufacturing facility at Thiruvananthapuram. The new 20,000 sq. ft. facility produces
a new range of blood collection bags under the brand name Donato. With this the installed blood bag
manufacturing capacity has increased from 5.0 M Pcs to 11.5 MPcs.
7.2.
Technology upgradation
The blood bag manufacturing factory is deploying an automatic needle assembly machine to prevent damages
to needles used in blood bags and thereby improve customer acceptance and improved sales. It is expected
that automatic needle assembly would prevent even minor damage to the tip of needle, which could cause
discomfort to blood donors.
39
7.3. {]x] B Bx V E l Zi
E{x x V<, 2011 E +{x C] E tiH EB CV E E
E x Ex E{x E | E =VM Ex E E *
8.
+ix xjh |h
E{x x xMi J {I M ( B B) E +vx +ix J {I +Vi E * E{x, +ix J

{I xn E Vx EB E E xH Ei * B B, J {I E EIj E { ni +
E J {I E Mnx ni * +M, B B J{I u S M +ix J{I xn
E xIh Ei * M E Vx + ] xn E +v { |SiE + J{I xn E
Vi *
BSBB x +ix J {I ]{{h E vi Ex EB {{i +x{x ij l{i E * J J {I
+Ex E =E +x{x xSi Ex E o] J {I i SS E Vi *
E{x E{] +x E M E { BE =t VJ |vx {J i Ex E Y M`x E M *
< =q EB +M k E nx { Vx xnx EB { x J *
9.
+v E ri
+{x =i{n Mhk, b, ih x]E + W v E WB r + ri |ni E |i |iri E l

BSBB x <E |iM W E i {E h Ex E Ii l{i E * , E{x E E Mi
vi - E l Vb n V +v E {k E r E B E *
E{x xij E =SS xnhb + {] k |vx EB |ir * +x nx GMi x
vE E fM*
40
7.3.
Pact with Petronet LNG
In July 2011, the company signed an agreement with Petronet LNG Ltd. (PLL) for long-term procurement of
Liquefied Natural Gas (LNG) to power its factories at Peroorkada and Akkulam in Thiruvananthapuram. The
companys tie-up with PLL is an attempt to highlight its efforts to counter the massive energy shortage in the
country.
8.
INTERNAL CONTROL SYSTEMS
The company has organized Internal Audit under Corporate Audit Services (CAS) department. The company
engages external firms to carry out internal audit assignments. CAS defines the scope of audit and provides
guidelines to external audit firms. Further, CAS supervises the internal audit assignments carried out by
audit firms. The department also undertakes operational and special audit assignments based on annual
plans and specific assignments.
HLL has installed adequate compliance mechanisms to address internal audit observations. A summary of
major audit observations is discussed in the audit committee with a view to ensure its compliance.
The company has also engaged an expert consulting firm to formulate an enterprise risk management
framework as part of corporate governance. The assignment would be completed during the next financial
year.
9.
ENHANCED VALUE TO THE SHAREHOLDERS
With its commitment to growth and enhanced profitability through its product quality, brands, distribution
network and market relationships, HLL has proven ability to successfully exploit the markets it competes in.
This, coupled with consistently increasing book value for the companys share, has led to accretion of
shareholders wealth.
The company remains committed to the highest standards of ethics and transparent financial management.
Continuing business investments will enhance shareholder value in the days to come.
41
II. n
E B xnE E {] 2010-11
n
BSBB <E ]b
({ nix ]C ]b)
xnE b E 31 S 2011 E {i E 45 E {] + J {I {] i J{Ii Ji +
= { i E xjE J {IE E {] |ii Ex i J *
1.
k x{nx
E{x x {U E ` 442.00 Ec E {i E ix 17% r {VEi EE ` 517.00 Ec E {i

E * E{x x {U E ` 14.93 Ec E ix E nx `18.43 Ec E x ={Vi
E *
|{h B {ni |M + +Sx |M u xnx E E S EE E{x x {U E
` 1294.00 Eb E ix E nx ` 1131.00 Eb E *
2.
Zi Y{x
VxE =t M 2009-10 E B +{E E{x E x{nx E '`' E { xvi E M +

2010-11 '`' Ex E |iI E Vi *
3.
vEh/ih
3.1. x] x{Ex xh x]:

n E E cE E lEi Wi E vi Ex E B E |{i n { x] x{Ex E
+{i E B i E BE EG | E * < v l B { Eh j x ] E +{ E i { 193 nI +nn x] x{Ex E +{i EB BE +n n * x] x{Ex E xb x
"b " * E{x x +Ei+ E { Ex E B xi+ E {Sx E * <ix E{x, |i 200 nI
+nn Ii E l ExM, M BE xh v l{i E *
v +| 2012 hVE =i{nx Ex E |i E Vi *
3.2. ES C] i {Vx
ESx { <ExE Wx, ES li E{x E C], {EM + VS v i EE ` 80 Eb E
{i Ex E Vx * =E i Vx E M E { , ` 5 Eb E +xxi Mi { 36000
C ] Ij E l Ex E xh + *
42
II. DIRECTORS REPORT (2010-11) TO THE MEMBERS

The Members
HLL Lifecare Ltd.
(Formerly Hindustan Latex Ltd.)
The Board of Directors have pleasure in presenting the 45th Annual Report and Audited Accounts with Audit
Report and the Report thereon by Comptroller and Auditor General of India, for the year ended March 31,
2011.
1. FINANCIAL PERFORMANCE
The company has achieved a turnover of ` 517.00 Cr, a growth of 17 % compared to the previous years
turnover of ` 442.00 Cr. The company has earned a net profit of ` 18.43 Cr compared to ` 14.93 Cr during the
previous year.
Considering the value of transactions handled by the Procurement & Consultancy Division and Infrastructure
Division, the company handled a business of ` 1131.00 Cr compared to `1294.00 Cr during the previous
year.
2. MEMORANDUM OF UNDERSTANDING
Department of Public Enterprises rated the performance of your company as Excellent for the year 2009-10.
The company is expected to achieve the same rating in 2010-11.
3. DIVERSIFICATION /EXPANSION
3.1. Sanitary napkins manufacturing unit:
To address the menstrual hygiene needs of adolescent girls
in the country, the Government of India (GOI) is launching a
programme to supply sanitary napkins at subsidized rates. In
this regard, the Ministry of Health & Family Welfare has placed
an order with HLL to supply 193 million pieces of sanitary
napkins at block level across the country. The brand name for
sanitary napkins is Freedays. The company has identified
manufacturers to meet the requirement. Meanwhile, the
company is setting up a manufacturing facility at Kanagala,
Belgaum with a capacity of 200 million pieces per annum.
The facility is expected to commence commercial production
in April, 2012.
3.2. Expansion project at Kochi factory:
The companys factory situated at Cochin Special Economic
Zone, Kochi plans to achieve a turnover of ` 80 Cr by expanding
into a packing and testing facility. As part of its expansion plans,
it has started construction of a building with an area of 36,000
M at an estimated cost of ` 5 Cr.
2
Foundation stone laid for the multi storey building

at Kakkanad Factory, Cochin (KFC) as part of the
Capacity Expansion Project on 09 May 2011.
43
3.3. E M Cx x] (Exp +xvx l, E, S |n + V Cx |M,

Mxb + {S <]]] + <b,Ex E {x&|ix
i E x Exp +xvx l, E b { ] Cx xh v E {xrh E B {Vx |vx
{ni E { BSBB E { ({Vx E Mi ` 50 Eb *) + { x E =SS Sh * +i
ExM + vxi EE{ Q | M * l B { Eh j x E{x E V Cx,
Sz + {S <]]] + <b, Ex E {x&|ix EB {Vx |vx {ni E { xH E *
4.
xnE x k 2010-11 EB ` 233.03 J E +i E E * E{x E |nk

{V E 15% iE +xxi *
5. |vx |h
E{x E xh x]/|M, xS =Ji |hx |{i Ex V J *
+< B + 9001:2008 : +CE, {Ec, M, x, ESS E xh x] + x<b E |{h B

{ |M E B |hx*
+< B + 13485 : +CE, {Ec, ExM + ESS xh x] E B |hx*

+< B + 14001 : +CE, {Ec + ExM E xh x] E | {h |vx |h E B
|hx*
+ BS B B B 18001 : +CE, {Ec + ExM x] E E l B I E B

|hx*
+< B + 17025 E +x {Ec C], ixi{ i =i{n {Ih |M E B Bx B

B |ix*
{Ec + ES x] xi { Eb + +CE C] xi b M, E{-], VE

S + <b h] E B < E *
{Ec C] b BS + 2003, +< B + 4074 - 2002, B B Bx B +< B + 4074, B B ]

B b 3492 + V + B ] -4645- 61 V +i] Mhk xn + xE E {E h { Ex
E + E +< ] <, B B B, Bx B E V =i{n |hx |{i Ex V J *
E nx E{x E xh x]/ |M x xB |hx E *
+< B + 15189 E +x n E Bx B B |ix*

ES x] E B +< B + 14001 + + BS B B B 18001 |hx
44
3.3. Revival of Government Departmental Vaccine Unit (Central Research Institute, Kasauli, Himachal
Pradesh and BCG Vaccine Laboratory, Guindy and Pasteur Institute of India, Coonoor):
The Government of India has entrusted HLL as Project Management Consultant for the revival of the DPT
Vaccine Manufacturing Facility at Central Research Institute, Kasauli (the cost of the project is ` 50 Cr) and
is in advanced stages of completion. Final commissioning and validation activities will start soon. The
Ministry of Health & Family Welfare has also appointed the company as the Project Management Consultants
for revival of BCG Vaccine Laboratory, Guindy, Tamil Nadu and Pasteur Institute of India, Coonoor.
4. DIVIDEND
The directors have recommended a final dividend of ` 233.03 lakh for the financial year 2010-11. This works
out to 15% of the paid-up equity share capital of the company.
5. MANAGEMENT SYSTEMS
The companys manufacturing units/divisions continue to possess the certifications mentioned below:
ISO 9001:2008 certification for manufacturing units at Akkulam, Peroorkada, Belgaum, Manesar,
Kochi and Procurement & Consultancy Division at Noida.
ISO 13485: certification for manufacturing units at Akkulam, Peroorkada, Kanagala and Kochi.
ISO 14001: certification for manufacturing units at Akkulam, Peroorkada and Kanagala for efficient
environment management systems.
OHSAS 18001: certification for units at Akkulam, Peroorkada and Kanagala for Occupational Health
and Safety.
NABL accreditation for finished products testing laboratory at Peroorkada factory,

Thiruvananthapuram in accordance with ISO 17025.
CE mark for male condoms produced at Peroorkada and Kochi Units and Blood bag, Copper T,
Surgical Sutures and Hydrocephalus shunt produced at Akkulam Factory.
Peroorkada Factory continues to possess product certifications KITE, SABS, NF mark besides
meeting a wide range of international quality specifications and standards such as WHO 2003,
ISO 4074-2002, SANS ISO 4074, ASTM D 3492, and GOST 4645-61.
During the year, the companys manufacturing units/service divisions have obtained the following new
certifications.
NABL accreditation for HINDLABS in accordance with ISO 15189

ISO 14001 and OHSAS 18001 certification for Kochi Unit.
45
6. Sx |tME
=t vx Vx - i {Vx E +SU
BSBB M`x E +-{ B B { {h E +v { =t vx Vx (< + {) E Exx E +{x =SS
+l * < =q E B b] Exp l{i E M V ] E +-{ M`x E E E B < + {
i |{i |Sx E B BE x Exp E { E EM* BE |E {Vx E { x, MbM BSBB
E {b VS E] xh v x 1 Vx 2011 BE +M b {h B B { {h |G
E Exx | E *
7. x vx
7.1 x vx E
+{E E{x, =xE u xH x vx E E E B =SS |lEi ni * Ivx E nx, E{x x
E{E E B 1624 E n + EM E 1799 E E n i EE v |Ih EG
+Vi E l*
7.2 +tME {E
{U E V 2010-11 E{x n{h +tME {E E I x *
7.3 +xSi Vi/+xSi VxVi/+x {Ub M/E i { EM H E B +Ih*
E{x +xSi Vi/+xSi Vx Vi +x {Ub M n E +Ih E v ]{i E xn E {x V
i + i B {nzi xn E {x Ex E B | =`B * i +x E B M B Epi
| M*
E ES E H 01.04.2011 iE E +xSi Vi/+xSi VxVi/+x {Uc M/E i { EM
H E |ixvi xS n Vi *
h
|ixvi
ES E J
: +xSi Vi
+xSi VxVi
+x {Uc M
E { EM
+x M
ES E E J
308
85
473
45
1028
1939
7.4 ES E h :
E n x, BSBB E E M |i ` 60 J |i ` 5 J E {E |{i Ex
E< ES x * <B E{x +vx 1956 E v 217 (2 B) E +vx +x ES E h
"x' E { x V*
46
6. INFORMATION TECHNOLOGY
Enterprise Resource Planning - Good to Great Project
HLL is in its advanced stage of implementing Enterprise Resource Planning (ERP) based on the SAP
environment across the organization. A state-of-the-art data centre has been set up for this purpose which
will function as the nerve center for the ERP-assisted operation for all functions of the organization across
the country. As a pilot project, HLLs Rapid Test Kit Manufacturing facility at Manesar, Gurgaon has commenced
implementation of business processes in the SAP environment since January 1, 2011, in a separate hardware
environment.
7. HUMAN RESOURCES
7.1. Human Resources Development
Your company gives high priority for development of human resources employed by them. During the year
under review, the company had organized various training programmes involving 1624 man days for executives
and 1799 man days for workmen.
7.2. Industrial Relations
The year 2010-11 witnessed harmonious industrial relations in the company as in the previous years.
7.3. Reservation for SC /ST/OBC and physically challenged
The company continues to follow the presidential directives in respect of reservation to SC/ST/OBC
Communities and efforts are taken to fulfill the directives in Recruitment and Promotion. Serious and focused
effort was also taken for Special Recruitment Drives.
The representation of SC/ST/OBC/Physically Challenged categories in the total employee strength as on
01.04.2011 is given below:
Description
Representation of
No. of employees
:
SC
308
ST
85
OBC
473
Physically challenged
45
Other categories
1028
Total strength of Employees
1939
7.4. Particulars of Employees:

During the year, HLL did not have any employee for the whole or part of the year, receiving, in aggregate, a
remuneration of ` 60 lakh per annum or ` 5 lakh per month. Therefore, the particulars of the employees
under Section 217(2A) of the Companies Act, 1956, may be treated as Nil.
47
8. H =t E{x
<|M +{i |<] ]b - BSBB + +Ex b <x E{x, B B u x< 50: 50 H =t
E{x x nn EE{, +{], +, S{], {x{ + iSE U& (6) + +{i Vb l* +{i
E {vx E{x E nn + =E S + 12 +{i * E{x x Vb, x + Vxb E i]
V +{i E |Sx n E n l* +{i xir Eh E B n E nB l E <|M
+{i E B |Eh {S Vn C] {S +SU i E EM* E{x ] Vvx Ij, x< n
+{i E n C] l{i E *
E nx, H =t E{x x {U E ` 3.45 Eb E ix ` 5.30 Eb E E + +Ei E *
Ivx E nx E{x E + 2009-10 E ix 74% g M l * EIi gx E E{x u
B MB ={ x {{i {h |{i E * Mi E nx (` 4.67 Ec) E +Ec E ix 40% E g nE
E{x E E E { x (` 2.80 Ec) iE P] M *
H =t E{x E {J +VxE + +i& +M {S E B fx E Vx Ei *
E{x ih {nb x +EE W + Ex E Ii E +v { {x <b <E i Ex E
Vx Ei * Vx 2011-15 tx 12 +{i i 100 +{i l{i Ex EB S Ei *
9. V Exx
E{x { x` E l i E E V xi Exi E M * E nx 330 ES E < E
|M EE E xx E Ii gx E + n |Ii E M* ES E n +{x E Ex E B
|ix n M*
BSBB 14 i, 2010 ={]{i

"M' Ij (xni V) E S =iE] <n Mv
V {E (|l lx) Ei *
E{x E n {Jc i E E xx V j (M), u =nP]x EB MB + ixi{ E +v

{ u {x EB MB*
E{x |i +{x M {jE 'x' + E n xW ] 'E{] xW' |Ei Ex V J * < x
]E, ixi{ ` {jE {E E *
BSBB x < V Exx E{x u ={v EB O x{nx E + i E xx ={ ]{i
E EE <n Mv ] Bb E *
48
8. JOINT VENTURE COMPANY

LifeSpring Hospitals Private Limited the 50:50 joint venture company formed by HLL and Acumen Fund Inc.,
USA added six more hospitals at Kukatpally, Amberpet, Alwal, Champapet, Puranapool and ToliChowki in
Hyderabad. With this addition of hospitals, the company has 12 hospitals in and around Hyderabad. The
company had closed down business operations of hospitals in coastal districts of Vijayawada, Nellore and
Rajahmundry. These hospitals were closed down for the strategic reason that for LifeSpring Hospitals,
cluster approach would work better than dispersed approach. The company is establishing another cluster
of hospitals in National Capital Region New Delhi.
During the year, the joint venture company posted a gross income of ` 5.30 Cr. compared to ` 3.45 Cr during
the previous year. During the year under review, the business income of the company had grown by 74% as
compared to business income for year 2009-10. The measures taken by the company to drive efficiency has
yielded considerable results. The companys loss before tax (` 4.67 Cr.) has decreased by a heartening
40% as compared to corresponding figure (` 2.80 Cr.) during the previous year.
Future outlook of the joint venture company is promising and hence it plans to scale-up business in the next
five years. The company plans to expand to urban localities pan-India, based on expansion criteria namely
attractive market and ability to serve. The business plan 2011-15 envisages setting up 100 hospitals including
existing 12 hospitals.
9.
IMPLEMENTATION OF OFFICIAL LANGUAGE
The company implemented the Official Language Policy of Government of India with utmost devotion. During
the year, 330 employees were trained in Hindi to enhance their ability to discharge their functions using the
language. Employees were given incentives for their work in Hindi.
Hindi Fortnight Celebration of the company was inaugurated by Honourable Minister for State (Home),
Government of India and concluded by the Worshipful Mayor of Thiruvananthapuram.
The company continued to publish its in-house magazine Samanvaya annually and a monthly Hindi
newsletter Corporate News. It bagged the best magazine prize from TOLIC, Thiruvananthapuram.
HLL also bagged the coveted Indira Gandhi National Award this year from the Honourable Vice President of
India for overall performance achieved by the company in official language implementation.
49
10. nE {
10.1 BS +< /Bb { El xi
Ivx E nx, BSBB x BS +< /Bb { ] xi xn] Mnx E +v { ' BS +< / Bb
{ El xi ' +Ei E * BS +< /Bb vi +, V El , v {I {
E{x E E E Ii Ex E =q E l xi Ei E l*
10..2 +i {n Ex +x - ' x*'
E Ih E +x, ix BE i + +x nEx Eb Jnx EB + V {
Eh E |Mi { | bi + +Ii C E B Vi * < P]E E v vi Ex EB
BSBB x 11 V< 2011 VxJ n { M xv E Jn { { ] { +i {n Ex
+x, ' x', E S E * BSBB VE x]EM <] + 'iam not shy.com' <] E
WB +x E |zx EM*
+x E E { BSBB E E ]x + ]xb V VxE lx VBM +
VMEi i E gx EB =S E l xE Eb + M xvE E ih EM*
BSBB x BBxB E Mi
14 Vx 2011 E E Hnx {
c BBB +x S E*
10.3 V B B B VMEi +x
H ni nx E h Ex + H nx E VMEi {n Ex E +, BSBB x B Bx B E
lx E l 14 Vx 2011 E E E b V B B B +x S E l* E E l
j x B Bx B E ` 54 J ={H+ E B B B VE +xx +x E =nP]x E *
50
10.
COMMUNITY INITIATIVES
10.1. Workplace policy on HIV /AIDS:

During the year under review, HLL adopted the Workplace Policy on HIV/AIDS based on the guidelines laid
down in the National Policy on HIV /AIDS. The policy was developed with the objective to protect the companys
workforce directly or indirectly from HIV/AIDS-related problems, which is a workplace issue.
Shri. Adoor Prakash, Minister for Health

& Family Welfare, Govt. of Kerala,
launching Im not shy, a nation-wide
confidence building campaign of HLL on
condom purchase on the World Population
Day on 11 July 2011.
10.2. Confidence building campaign I am not shy

According to a recent survey, one out of three Indians is still shy to buy condoms from pharmacies and other
shops, thereby affecting the progress of family planning and leading to unprotected sex. In order to address
this factor directly, HLL launched a year-long nationwide confidence-building campaign on contraceptive
purchase called I am not shy on World Population Day, July 11, 2011. HLL will promote the campaign
through social networking websites and through the website www.iamnotshy.com.
As part of the campaign, HLL volunteers will also go to public places like railway stations and bus stands,
and distribute condoms and other contraceptives free-of-cost along with brochures to raise awareness
levels.
10.3. State-wide SMS awareness campaign:
To commemorate World Blood Donor Day and create awareness about blood donation, HLL launched
Keralas largest ever state-wide mobile SMS campaign on June 14, 2011, with the support of BSNL. Keralas
health minister inaugurated this unique campaign by sending SMS to 54 lakh BSNL mobile customers.
51
10.4 { { CxE
BSBB x v E VMEi {n Ex E + i E E ] i EG E M E { ] - M
]]M +hb E S E * + EG ixi{ | E * ]]M x, ME
i E VS + v E VMEi gx E B {{l Ei *
BSBB x 01 Vx 2011 E v E
VMEi x + M E b MEW VS
Ex E i nx EB BE SE-+{
x "]' (M ]]M + I) S E*
10.5 Eb {
BSBB x ]Ex{E, ixi{ Eb { l{i E + +x +< ] {E Eb bM x
+ B { xx E Vx *
11. iEi
BSBB iEi M E i xE iEi { + <E xSi Ex E + EE{ MB Vi * M
+xh, {UiU + +vE +EE VS +Vi Ei * iEi M E xE =Si E< EB I
|vE E +vE i { {] E Vi *
M, Exp iEi Ex + l B { Eh j E iEi Ev E l iEi vi xn E
Exx E B iSi Ei * Ep VS E l VxE ]E iSi Ei + =xE VS {bi
i Ei * BSBB E iEi M BSBB E ES E S iEi { +ii VMEi {n
Ex EB E{x E v x]/E iEi vi EE{ E xx Ei *
12. xnE E ni h
E{x +vx 1956 E v 217(2B B) E +vx +{I+ E +x, xnE E ni h E v Binu {]
n Vi
S 31, 2011 E {i k E J E i Sx E v {]Eh E l ={H

J xE E {x E M *
xnE x B J xi E Sx E il Mi { =xE |H E il E B Zn xh
B +Ex xB MB iE k E +i il {xIvx EB E{x E x { E{x E E
{ B h nx *
52
10.4. Clinic on wheels initiative:

HLL launched STAR Sugar Testing and Review as part of Govt. of Indias nation-wide programme to
create awareness about diabetes. At present, the program is piloted in Thiruvananthapuram city. The mobile
testing van circuits the city, checking glucose levels and raising awareness about diabetes.
10.5. Condom shops:
HLL recently set up a condom shop in Technopark, Thiruvananthapuram and plans to put up condomvending machines and similar shops in other IT parks.
HLLs second contraceptive outlet

Moods Planet opened at
Technopark, Thiruvananthapuram on
9th February 2011.
11.
VIGILANCE
The thrust of HLL Vigilance Department is on preventive vigilance and activities are geared towards ensuring
this. The department conducts investigations, enquiries and periodic surprise checks. Findings of the
vigilance department are periodically reported to the competent authority for appropriate action.
The department interacts with the Central Vigilance Commission and the vigilance wing of the Ministry of
Health and Family Welfare to implement vigilance-related directives. It also interacts with the Central Bureau
of Investigation by sharing information and providing assistance in their investigations. HLL Vigilance
coordinates vigilance-related activities in different units/offices of the company for generating greater
awareness on vigilance matters among employees of HLL.
12.
STATEMENT OF DIRECTORS RESPONSIBILITY
Pursuant to the requirement under Sec.217 (2AA) of the Companies Act, 1956, with respect to the directors
responsibility statement, it is hereby confirmed:
That in the preparation of the accounts for the financial year ended March 31, 2011, the applicable
accounting standards have been followed along with proper explanation relating to material
departures;
That the directors have selected such accounting policies and applied them consistently and
made judgments and estimates that were reasonable and prudent so as to give a true and fair
view of the state of affairs of the company at the end of the financial year and of the profit or loss of
the company for the year under review;
53
xnE x E{x E {{k Ii Jx + E{] il +x +xii+ E Ex B {i Mx EB

E{x +vx, 1956 E |vx E +x {{i J E +J E +xIh EB =Si + {{i vx
n *
xnE x S 31, 2011 E {i k EB 'E E' E +v { J i E *

13. Ei k h
BEE H =t E{x |{i =E xnE b u +xni k h { +vi J {Ii Ei k
h J xE 27 (B B - 27) - E{x (J xE) x, 2006 E l {fi E{x +vx 1956 E v 211
(3 ) E +vx +vSi 'H =t' k {]M +vx - E +x i E M *
14. J{IE
E nx +xi & n, xn JE, ixi{ E E{x E vE J{IE E { xH E
l* 2011-12 E B vE J{IE E xjE B J{IE ( & B V) u E{x +vx 1956 E
v 619 E +vx xH EB VBM*
15. Sx +vE +vx 2005
+{E E{x Sx +vE +vx 2005 (+ ] +<) 2005-06 Exi E M* +vx E +x
E{x x Vx Sx +vE, E VxSx +vE + +{ |vE E x E{x E <] |Ei E *
+ ] +< +nx |{i, x{]x EB, +Ei En +n E J*
1 +| 2010 iE i + ] +< +nx E J
2010-11 E nx |{i + ] +< +nx E J
41
2010-11 E nx x{]x EB + ] +< +nx E J
42
31 S 2011 iE i + ] +< +nx E J
16. Bb x
+{E E{x x xxJi Bb x E l*
16.1. {Ec C], ixi{
Exp E j b V B B B B +< Bb 2008 EB =iE] I x{nx E B { B ] E

|l {E* (2010
)
V xi E =iE] x{nx E B <n Mv

V {E* (2009-10)
=k {h x{nx E B Ox]E Bb 2009 +

{h |vx |h | =iE]i E B 2010
Mb ] h*
54
14 i 2011 E ]{i nIh Ij V E =iE] Exx EB

] V {E (ui {E) Ei *
That the directors have taken proper and sufficient care for the maintenance of adequate accounting
records in accordance with the provisions of the Companies Act, 1956 for safeguarding the assets
of the company and for preventing and detecting fraud and other irregularities;
That the directors have prepared the accounts for the financial year ended March 31, 2011 on a
going concern basis.
13.
CONSOLIDATED FINANCIAL STATEMENTS
The Audited Consolidated Financial Statements based on the financial statements received from the lone
joint venture company as approved by its board of directors has been prepared in accordance with Accounting
Standard 27 (AS-27) Financial Reporting of Interests in Joint Ventures, notified under Section 211(3C) of
the Companies Act, 1956 read with Companies (Accounting Standards) Rules, 2006 as applicable.
14.
AUDITORS
M/s. Ananthan & Sundaram, Chartered Accountants, Thiruvananthapuram was appointed as statutory auditors
of the company for the year. Statutory auditors for the year 2011-12 will be appointed by Comptroller & Auditor
General (C&AG) under Section 619 of the Companies Act, 1956.
15.
RIGHT TO INFORMATION ACT, 2005
The Right to Information Act, 2005 (RTI)was implemented in HLL in 2005-06. In accordance with the Act, the
company has published the names of the Public Information Officer, Asst. Public Information Officers and
Appellate Authority in the companys website.
Number of RTI applications received, disposed off, denial of cases etc.
16.
No. of RTI applications pending as of 1st April 2010
No. of RTI applications received during year 2010-11
41
No. of RTI applications disposed off during year 2010-11
42
No. of RTI applications pending as on 31st March, 2011
AWARDS AND RECOGNITIONS
Your company received the following awards and recognitions.

16.1. Peroorkada Factory, Thiruvananthapuram
Central Ministry of Labour DGFASLI Award - 1st Prize to PFT for best safety performance for 2008
(declared in 2010)
Indira Gandhi Raja Bhasha Award for best performance of Official Language Policy
(2009-10)
GREENTECH Award 2009 for best Environmental Performance & 2010 in Gold Star category for
effective excellence in Environment Management System.
55
E V C]W + 2010 Bb
o
=iE] I i
o ui =iE] I x{nx
] I {n (E S{]) 2010 Bb
o =iE] I x{nx
o =iE] I +vE
o =iE] I Ex
i C] E V |nh xjh b =iE]i Bb - 2011
16.2. +CE C], ixi{
E V |nh xjh b 2011 {{i B xi |nh xjh E B P =tM E S ii

{E + ` 25,000/- E xEn {E |{i + *
+< < < <-E S{] S 2011 'Bxx + b ]V + +< b E{ ] b 380 B',
E ]b E B ii {E E *
16.3. xi Bb
E{x x 2009-10 E B B +< + +< B ]C xi Bb + E{C xi Bb

Vi *
B. +{{x, +vI B |v xnE, BSBB

24 S 2011 E E{C xi {E
2009-2010 Ei *
56
Awards from Kerala State Factories and Boilers 2010

o
Best safety committee.
Second best safety performance.
HLLs Peroorkada Factory won first

prize for Industrial safety in the
large size industries by National
Safety Council (Kerala Chapter) on
05 March 2011.
Awards from National Safety Council (Kerala Chapter) 2010

o
Best safety performance.
Best safety officer
Best safety story
Kerala State Pollution Control Board Excellence Award 2011 in large scale sector
HLL bagged Kerala State

Pollution Control Board Award
for 2010-2011 on 06 June 2011.
16.2. Akkulam Factory, Thiruvananthapuram
Received the Kerala State Pollution Control Board Award for Substantial and Sustained Pollution
Control, securing third prize among small scale industries and also received a cash award of
` 25,000 in the year 2011.
Secured third prize for case study presentation on elimination of feed wastage of IUD Copper T
model 380-A., from IEEE - Kerala chapter in March 2011.
16.3. Export Awards:
The Company won AIRIA Latex Export Award for 2009-10 and Capexil Special Export Award for
2009-10.
57
17. >V Ih, iExE +x, n p +Vx/

E{x +vx 1956 E v 217 (1) (<) E +x E{x x 1988 E +vx (xnE b E {] h E
|E]Eh) 31.03.2011 E {i E B >V Ih, iExE +x, n p +Vx/ vi +{Ii
Sx +xv - E E { n Vi V < {] E M *
18. VE =kni { {]
E nx E{x E E VE =kni EE{ vi {] +xv -J E { n Vi *
19. EiYi
BSBB E xnE, i E E l B { Eh j E nE vxn |E] Ex Si *
xnE OE, ]] E + <b + +x M u nB MB x lx E |i + |E] Ei *
xnE E{x E ES u nB MB E`x xi + |ix + E{x E |Mi E + =xE Mnx {Sxi
+ | Ei *
b E i
B.+{{x
+vI B |v xnE
ixi{
10 +Mi 2011
58
17. CONSERVATION OF ENERGY, TECHNICAL ABSORPTION, FOREIGN EXCHANGE EARNINGS / OUTGO

In terms of Section 217(1)(e) of the Companies Act, 1956, the information regarding Conservation of Energy,
Technology Absorption, and Foreign Exchange Earnings and Outgo, required under the Companies
(Disclosure of particulars in the Board of Directors. Report) Rule 1988, for the year ended 31.03.2011 is
given as Annexure-A, forming part of this report.
18. REPORT ON CORPORATE SOCIAL RESPONSIBILITY
A report relating to Corporate Social Responsibility activities of the company during the year is given as
Annexure B.
19. ACKNOWLEDGEMENTS
HLLs directors wish to place on record their sincere thanks to Government of India, particularly the Ministry
of Health & Family Welfare. The directors acknowledge with thanks the valuable support given by customers,
State Bank of India and other business associates. The directors recognize and appreciate the hard work
and efforts put in by all the employees of the company and their contribution to the progress of the company.
For and on behalf of the Board
M. AYYAPPAN
Thiruvananthapuram
10th August 2011
59
+xv E
xnE E {] E +xv
31 S 2011 E {i EB E{x (xnE b E {] h E |E]x) x 1988 E +vx +E *
h
E) V + <vx
1. V
(E) Jn M (x])E b BS
(`)
n /x] (`)
(J) xV =i{nx
(i) =i{ni x] (E b BS)
BS B b i E ={M (])
=i{ni x]/] (E b BS/])
Mi/x] (`)
(ii) { ]<x Vx] u
2. E
3. x i
{h (])
(`)
n/x] (`)
(J) =i{nx E |i x] E ={M
(i) Ehb
x] (nI +nn) =i{nx (Mgx)
V (E b BS) |i nI +nn (xE 8418)
x i (E ]) |i nI +nn (xE 6.19)
E
(ii) E{-]
=i{ni E {h (nI +nn)
V |i nI +nn (E b BS)
(iii) -b/Bx, , xC B |]
=i{ni E {h (nI +nn)
-b/Bx (nI <E)
, xC B |] B xB =i{n
J{i E M< V (nx =i{n) E b BS
(iv) b M
=i{ni E {h (nI +nn)
|i M V (E b BS)
(v) S
=i{ni E {h (J nVx)
V |i nVx (E b BS)
(vi) E bM - ]Gx
=i{ni x] (EO)V (E b BS)|i E
x i |i EO (E ])
60
2009-10
2010-11
1,45,92,943.00
5,97,61,704.00
4.10
1,41,55,902.00
5,84,31,522.20
4.13
12,18,026.00
2,90,319.00
4.20
8.34
M x
M x
9,34,317.00
1,88,911.00
4.95
10.54
M x
M x
45,85,240.50
11,94,86,670.00
26.06
47,76,083.00
14,43,37,922.13
30.22
1,410.89
7,115.67
3.07
M x
1,407.65
6,709.80
2.95
M x
4.25
73,229.00
4.29
64,920.00
51.20
26.91
23,42,170.00
56.20
29.72
23,85,260.00
8.21
0.27
6.41
0.30
0.70
6.60
0.82
5.09
991.00
400.16
101.82
1,001.03
481.34
116.15
ANNEXURE A
ANNEXURE TO DIRECTORS REPORT

Details required under the Companies (Disclosure of particulars in the Report of Board of Directors) Rules
1988 for the year ended 31st March 2011
Particulars
(A)
2009-10
2010-11
Power & Fuel
1.
Electricity
(a) Purchased (Units)KWH
Amount (`)
Rate /Unit (`)
(b) Own generation
(i) Units generated (KWH)
HSD Oil consumption (Ltr)
Units generated/ Ltr (KWH/Ltr)
Cost /Unit (`)
(ii) Through Steam Turbine Generator
2. Coal
3. Furnace Oil
Quantity (Ltr.)
Amount (`)
Rate /Unit (`)
(B) Consumption per unit of production
(i) Condoms
Unit (M. Pcs) Production (Moulded)
Electricity (KWH) per M. Pcs (Standard 8418)
Furnace Oil (KL) per M. Pcs (Standard 6.19)
Coal
(ii) Copper T
Total Quantity Produced (M. Pcs)
Electricity per M. Pcs (KWH)
(iii) Mala-D/N, Saheli, Novex & Preventol
Mala-D/N (M. Cycles)
Saheli, Novex & Preventol and new products
Electricity consumed (both products)-KWH
(iv) Blood Bags
Electricity per bag (KWH)
(v) Sutures
Total Quantity Produced ( Lacs Dozen)
Electricity per Dozen (KWH)
(vi) Bulk Drug Centchroman
Unit (Kg) produced
Electricity per Kg (KWH)
Furnace Oil per Kg (KL)
1,45,92,943.00
5,97,61,704.00
4.10
1,41,55,902.00
5,84,31,522.20
4.13
12,18,026.00
2,90,319.00
4.20
8.34
NA
NA
9,34,317.00
1,88,911.00
4.95
10.54
NA
NA
45,85,240.50
11,94,86,670.00
26.06
47,76,083.20
14,43,37,922.13
30.22
1,410.89
7,115.67
3.07
NA
1,407.65
6,709.80
2.95
NA
4.25
73,229.00
4.29
64,920.00
51.20
26.91
23,42,170.00
56.20
29.72
23,85,260.00
8.21
0.27
6.41
0.30
0.70
6.60
0.82
5.09
991.00
400.16
101.82
1,001.03
481.34
116.15
61
(vii) M {Ih E]
=i{ni E {h (nI E])
V |i nI E] (E b BS)
BS B b i |i nI E] (E b BS)
(viii) Ehb
=i{ni E {h (+nn)
V |i +nn (E b BS)
25.21
504.80
2,856.00
23.58
652.56
2,650.00
10,03,612.00
0.0085
8,99,803.00
0.02
E) {Ec C], ixi{ B MB >V Ih ={

<] b E B 200 E B <] >V S l{i EE Ex E M*
25 x 12 ] +vi B V nI C V Ih ={*
]] <] {xih - >V nI ] E ={M EE 25 x |iE { EB 50 ] >V E Si E
M*
j <]M EB 400 E B ]x Mx - +{Ii ]V E xjh Ex EB +]]E ]V
M] E l E j <]M EB 400 E B ]x l{i E M*
]V Ih ={*
=txE EB ]]b < ] { V E {x& ={M, =E u 30 E/nx E Si Ex, V ` 2200
/ nx *
+{V ={S j E ExM*
>V | + B ] 630 E B ]x l{i EE Ex E M*
P) ECExc C], ESx B MB >V Ih ={*
E B xi |ii i Ex { <]M B B/B < b E l M V <C]]
={M E MM 40% Si E V Ei *
R) |tME +x, +Oh B xS
Ivx E nx +{E E{x E {Ec C], ixi{ xxJi |tME E Ei/+i/
+Oi EB MB*
j '' & '' ih |h l{i E M*
16 B + ]<{ {EM x <] b l{i E M *
j E ExEh +xM n nE + & j +xpEh | EB MB*
< ] b +xM 40 ]x =SS ]V ]]M E B { B +vi x] + EpEi
x]M ]x l{i E M*
B 4 x B B b B ({IE xjh B b] +vOh) |h E Exx*
62
(vii) Pregnancy Test Kits

Total Quantity Produced (M. Kit)
Electricity per Million Kit (KWH)
HSD Oil per Million Kit (LTR)
(viii) Female Condoms
Total Quantity Produced (Pcs)
25.21
504.80
2,856.00
23.58
652.56
2,650.00
10,03,612.00
8,99,803.00
0.0085
0.02
Electricity per Pc (KWH)
a) Energy conservation measures taken at the Peroorkada factory, Thiruvananthapuram:
Installed and commissioned 200 KVA Light energy saver for Lighting feeder.
Replaced old rewound induction motors by energy efficient class eff2 induction motors.
Installed and commissioned 25 Nos of 12W solar based LED street lights.
Replaced / Modified 6 Nos of electrically heated dehumidifiers with steam heated dehumidifiers
in plant B,C & in M1 & M2 M/cs.
Received power factor incentive of ` 3.36 Lakhs from KSEB.
b) Energy conservation measures taken at the Kanagala factory, Belgaum:
Modification in streetlight - Saving of 50W of energy for each pole 25 Nos. by using energy efficient
tube
Fixing of 400 KVA Transformer for plant lighting - Installed 400 KVA Transformer exclusively for
Plant Lighting with Automatic Voltage Regulator for regulating the required voltage.
APFC Panel fixed for Steroidal HVAC DB - Fixed separate APFC panel for Steroidal HVAC panel for
power factor improvement.
c) Energy conservation measures taken at Akkulam factory, Thiruvananthapuram:
Reuse of treated ETP water for gardening thereby achieving a savings of 30kL/day, which amounts
to ` 2200/day.
Commissioning of waste water treatment plant.

Installed and commissioned energy efficient OLTC 630 KVA Transformer.
d) Energy conservation measures taken at Kakkanad factory, Cochin.
With the proposed multistorey building constructed at KFC, complete lighting will be with CFL/
LED which could save about 40% of electricity usage.
e) Technology absorption, adoption & innovation

During the year under review, your companys factory at Peroorkada, Thiruvananthapuram developed
absorbed / adopted the following technologies.
Slurry dispensing system installed in Plant B &C.

Installed vibratory feeder in 16 SR type packing machines
Introduced pressure reducing valves in vulcanizing section of Plant B & dehumidifiers in
Plant B & C.
Installed PLC based units and centralized monitoring station for all High voltage testing in 40
stations in ETD section.
Implementation of SCADA (Supervisory Control and Data Acquisition) system in M4 machine.
63
Ivx E nx +{E E{x E +CE C], ixi{ xxJi |tME E Ei/+i/

+Oi EB MB*
} E] M E E
|Vx M E B CE M x E E *
x +< b E B ] < E E *
+< b E B E{ ] B E 375 ]b x] E E*
n xx ] vE +E{x E E *
Ivx E n x +{E E{x E ECExc C], ESx xxJi |tME E Ei/+i/+Oi
EB MB*
E B x] { Eb E VS Ex E B B B +ii Si <C] xE VS x E ={M
E * | x] x +{iEi {V + ={V E +i E l* E B x 75%
{V + ={V E nEi E + 25% + < B +{iEi |{h E Vi *
S) +xvx B E EE{
{ B ]
BC BC BC Eb E Ex xh EB fS Ei E M *
xB +x{ +E{x (+v {v & b]) E l xB Eb +E{i EE Ei E M *
56 B B Sc< E l Eb Ei E M *
Eb =i{nx E B ={S l ]C jEh Ei E M *
=i{nx <x ={M Ex EB i +C{x E |M l{i E M *
^ ES, {x ] +n V xB Mxv E l Eb Ei E M - xb x xB =i{n {n*
xi]E +<|x ]C Eb E =i{nx E B jEh Ei E M*
B B ]
b M E B v < { E E *
E B
E B Eb |Sx, < l E{x, E E iExE M E l * Eb
x<] c +vi * P]E Mi =SS x E Eh =i{n Mi =SS * + & b ] E i
]C +vi Eb Ei EB V * EiEi + Ei +vx +Vi EB V
*
U. n x +Vx B JS
64
(2010-2011)
S
(` J )
(2009-2010)
Mi
(` J )
1. +Vx
5126
5291
2. JS
6263
6029
During the year under review, your companys factory at Akkulam, Thiruvananthapuram developed /absorbed/
adopted the following technologies.
Development of Buffy coat bag.

Development of Vacuum Sealing Machine for special purpose bags.
Development of T frames for Hormone IUD.
Development of Copper T Mcare Cu 375 Multiload variant for IUD.
Development of indigenous sampling tube holder design
During the year under review, your companys factory at Kakkanad, Cochin developed /absorbed / adopted
the following technologies.
KFC unit is utilizing automated electronic testing m/c imported from USA for testing male condoms.
Initially the unit was importing all the spares and consumables from the machine supplier. KFC
has indigenized 75% spares and consumables and the balance 25% is procured from OEM
suppliers.
f) R&D Activities
PFT
Developed moulds for in house manufacture of XXX condoms.
Developed condoms with 56mm width.
Development of improved PVC composition for Blood Bag film.
The female condom operations at KFC is with technical collaboration from Female Health
Company, UK. The female condoms are nitrile rubber based. As the component costs are higher,
the product costs are high. With the assistance of the R&D team, latex based female condoms
Designed and developed new condoms with new unique design (Half circumferential ribs &
dots).
Developed cure stabilized latex formulation for condom production.

Established the use of ready to use aquaspersion in production line.
Developed condoms with new flavors like butter scotch, passion fruit etc.
Developed formulation for production of condoms from synthetic isoprene latex.
AFT
KFC
are being developed. The functionality and acceptability studies are being conducted.
g) Foreign exchange earnings & outgo
(2010-2011)
(2009-2010)
Current year
Previous year
(Ìn lakh)
(` In lakh)
1.
Earnings
5126
5291
2.
Outgo
6263
6029
65
xnE E {] E +x
G.
.
J{IE E ]{{h/i
1.
nxn + xn
{]Eh |{i x E M * E +O,
|{i +O, |ii V + x {IE
u iiE {] E +vx *
k h E +xS 26 (3) (iii) E +vx

Ji { ]{{h {{i { |E] E M *
{ E i (E M + +i ] OE
E UbE) E{x nxn E {jS Ei
+ = xMh |iG * xn, +O +
V E E x E + x
{ {x E xE E +x *
2.
` 74.37 J
{ E V vx i
{Vx+ E E E { *
< n 26 (3) (vi) E ii JiE/{]EhiE

]{{h E +vx {{i { |E] E M *
3.
i E xn JE lx E Y
E i E E +x E{x u
+ {I ni E +vx J xEn
ix {j {i n E { |E] E
Vi *
i E xn JE lx E Y E
i E E +x |E]x E |i E
M *
|v E =k
B. +{{x
+vI B |v xnE
66
ADDENDUM TO DIRECTORS REPORT
Sl.
Auditor's
No.
Comments / Qualifications
Management Reply
1.
Balance Confirmation from Debtors

and Creditors are not received in all
the cases. Balances Advance
outstanding, Advance received,
Security Deposits and Earnest
Money Deposits are subject to
confirmation by parties
This has been adequately disclosed in the

Notes on Account under Schedule 26 (3) (iii) of
the financial statements. The Company has
been sending communication to trade debtors
(other than Govt. Departments and International
Customers) as in the earlier years and the
response from them is neglible. In the matter
of creditors, advances and deposits, the
outstandings are routine in nature and as per
the norms generally followed.
2.
Credit balances of ` 74.37 lakhs

remain as outstanding of the
projects pending reconciliation.
This has been adequately disclosed vide

explanatory / clarificatory notes vide item 26 (3)
(vi)
3.
The cash and bank balances held

by the Company under trust and the
relative liabilities are disclosed as
contra items in the Balance Sheet
in accordance with the option of the
Expert Advisory Committee of the
Institute of Chartered Accountsants
of India.
The disclosure has been affected as per the

opinion of Expert Advisory Committee of Institute
of Chartered Accountants of India.
M. AYYAPPAN
67
+xv J
E{] VE =kni { {]
BE Vn xME E { , E{x +{x E{] VE Vn EG E +vx +xE Miv V *
E nx E{x E v B + Miv E + ` 17.13 J JS + *
+{E E{x u l{i nix ]C { xVx |zx x (BS B B { { ]), BE i kE
l M`x x E nx +{x E V J * =xE E Ji& xxJi Ij li E M *
E)
|nE E x]E u i- l I |nx Ex*
J)
BS +< E xh, SEi + I*
M)
MxvE E ={M E f nx EB VE {hx *
P)
E l EG EB iExE i*
={H Ij E |J E xx V *
E nx, =k |n (.{) E 63 Mb +{i, 367 CxE E x]E + 10,880 iM x]E
+]i V /j E | I |nx E M *
x x M + +iM M nx EB +v (+O) E |Sx E EM x n * BS +< E
xh, SEi + I E +vx, x +xw |n E S V E C EM (B B b) + x E
l C Ex x (B B B) EB Mi BS +< Bb xh EG E l M n M *
=k |n V MxvE E VE {hx E i + Wi Ex EB ] Bb xjh M`x (xE)
E l E E V * 6 V v VE {hx b E |{, i + xx EB E 7000
Eb bM x E |Sx E * {S M + +w |n nE P]x+ E +Vx + S O
E v Eb E ={M * x x ] Bb xjh Vx-III E I E E Ex
EBE E Vx Exi Ex E B v V Bb xjh i E iExE i |nx E *
68
ANNEXURE B
REPORT ON CORPORATE SOCIAL RESPONSIBILITY

As a responsible corporate citizen, the company has been undertaking number of activities under its Corporate
Social Responsibility programme. During the year, the company incurred ` 17.13 lakh towards various CSR
activities.
HINDUSTAN LATEX FAMILY PLANNING PROMOTION TRUST (HLFPPT), a not-for profit professional Health
Service Organisation set up by your company continued its work during the year. Their work is primarily
organized on the following strategic areas.
a)
Providing maternal and child health care

through a net work of service providers.
b)
Prevention, treatment and care for HIV
c)
Social marketing for promoting use of

contraceptives
d)
Technical assistance for public health

programmes.
The major works in the above areas are as

follows:
During the year, maternity care has been
provided to mothers / women through a net work
of 63 Merry Gold Hospitals, 367 Merry Silver
Smt. Sonia Gandhi, UPA Chairperson inaugurates the HLLHLFPPT Health Mela at Raebareilly on 05 February 2011.
Clinics and net work of 10,880 Merry Tharang

covering districts in Uttar Pradesh (U.P.)
The Trust has also streamlined the operations of Aushadhy Pharmacy (Agra) both for Out patients and In
patients. Under the prevention, treatment and care of HIV, the Trust has been associated with Swagathi HIV
/ AIDS prevention programme for Female Sex Workers (FSW) and Men who have sex with men (MSM)
community in 4 districts of Andhra Pradesh.
The Trust has also been working closely with National AIDS Control Organisation (NACO) in expanding and
strengthening of Social Marketing of contraceptives in state of Uttar Pradesh. Around 7000 Condom Vending
Machines are operating in 6 States making various social marketing brands, available, affordable and
accessible. It has also propagated use of Female Condom in West Bengal and Andhra Pradesh though
organizing community events and providing communication materials. The Trust also provided technical
assistance to various State Aids Control Societies for implementing their annual action plans for realizing
the goals of National Aids Control Plan-III.
69
III.
E{] +x { {]
E{] +x, +iE |GB + E x + ]Eb E M i E{x u {x EB

x + v E n Ji Ei * E nxE E {]M E +Ei, J{I VxE +
nPEx I E l v, |h + |G+ E vx Ji *
BSBB x VxE =t M u V EB MB Exp VxE Ij =t 2010 EB E{] +x {
nxn E +{x + |M M * +{ E E{x Exi x |G E I{i h xS n
Vi *
1. xnE b
1.1.b E x]
+{E E{x E V E M< xnE b E H 9 V l B { Eh j, i E E
|ixvi Ex n (2) E xnE n (2) ij xnE + S (4) EiE xnE - x xnE ({hx),
xnE (iExE B |Sx), xnE (k) + +vI B |vE xnE* + ij xnE E BE {n H *
BSBB x H x E E< E *
1.2. xB xnE
xH xnE E I{i k, EiE Ij =xE Yi + xnE {n E B +x E{x E x xS
n Vi *
G
1
x
V E{
I{i k + Yi E |Ei
B.E. E{{ & E{x,
xn JE, Ex{ E Mn
+x E{x b<C]{
1) p <{<
b{ ]b
2) p b]
b{ ]b
3) p Vx ]
E{x ]b
4) <b bE
<]]] ]b
5) .{ ]E BCSV
]b
b +i V
E |, +Mx ]
EM M`x, B +< +< B B,
x< n
1.3.xnE E V
Ivx E nx, E{x E xnE b {S (5) È +Vi E, x Vx 24, 2010, +Mi 17, 2010,
i 27, 2010, n 14, 2011 + 21, 2011. E n È E S E +vEi +i 116 nx
+vE x l*
b È + {U E x È E W Sx xS n Vi *
70
III. REPORT ON CORPORATE GOVERNANCE

Corporate governance primarily refers to the framework of all rules and relationships by which a corporation
must abide, including internal processes as well as governmental regulations and the demands of
stakeholders. It also takes into account systems and processes which deal with the daily working of the
business, reporting requirements, audit information and long-term goal.
HLL adopted and put into practice, the Guidelines on Corporate Governance for Central Public Sector
Enterprises 2010 issued by the Department of Public Enterprises. A brief description of governing process
practiced in your company is given below.
1.
BOARD OF DIRECTORS:
1.1. Composition of Board of directors:

The sanctioned strength of the Board of Directors of your company is nine (9) comprising two (2) official
directors representing the Ministry of Health & Family Welfare, Government of India, two (2) independent
directors and four (4) functional directors namely, Director (Marketing), Director (T&O), Director(F) and
Chairman & Managing Director. One post of independent director is vacant at present. HLL has initiated
action to fill up the vacancy.
1.2. New Directors
Brief resume of newly-appointed directors, their expertise in specific functional areas and names of other
companies in which directorship is held is given below.
Sl. No.
1.
Name
Shri Sanjiv Kapoor
Brief resume and
Directorship in
nature of expertise
other companies
Partner of
i)
M/s. S.K. Kapoor & Co.,
Mahindra Lifespace
Chartered Accountants,
Developers Ltd.
ii) Mahindra World City
Kanpur
Developers Ltd.
iii) Mahindra Ugine Steel
Co. Ltd.
iv) Sahara India Medical
Institute Ltd.
v) U.P. Stock Exchange Ltd.
2.
Dr. Aarti Vij
Faculty in-charge,
Organ Retrieval
Banking Organization,
AIIMS, New Delhi
NIL
1.3. Directors attendance:

During the year under review, the Board of Directors of the company met five times, i.e. on June 24, 2010,
August 17, 2010, September 27, 2010, December 14, 2010 and February 21, 2011. The maximum interval
between any two meetings was not more than 116 days.
Information of attendance at the board meetings and the last annual general meeting is given below.
71
xnE E x
E nx
+Vi b
È
È E V
2010 - 11 E
n x
+x
+x E{x
xnE{ b i E
E J
ni/+vIi
E J
b Mi B V B
È
B.+{{x
xn n
.E.|n
b.B.E.{hb
b. E.xn
V E{
+i V
E.E. E
B.b.E
+.{. Jhb
1.4.+< B +< u V EB MB xE
E{x, E{x G] + <b E l u V EB MB G] ]bb 1 (B B-1) xn] V
Sx i b È {{i { +x{x *
2.b E i
2.1.J{I i
{ J{I i E +v 26.06.2010 E {i x E Eh xxJi xnE E l J{I i E
{xM`x E M*
1. V E{
- +vI E { M E +EE xnE
2. b.+i V
- n E { M E +EE xnE
3. E.E. E
- xnE ({hx) - n
2010-11 E nx J{I i x x 10 <, 2010 + 16 S, 2011 E n È +Vi E l*

b u +xni V i E E Ex E B nxn il i xi +vE xS nB Vi *
72
Name of the Director
Board
meetings
Attendance of
meeting during
2010-11
held
during
the
year
Board
Meetings
No. of other
Directorships
Last
AGM
No. of
membership /
Chairmanship of
Board
Committee
in other
companies.
Shri M. Ayyappan
Yes
Shri Naved Masood
Yes
Shri B.K. Prasad
Yes
Dr. A.K. Panda
No
Dr. K. Mohandas
No
Shri Sanjeevi
No
Shri Sanjiv Kapoor
No
Dr. Aarthi Vij
No
Yes
Shri M.D. Sreekumar
Yes
Shri R.P. Khandelwal
Yes
1.4. Standards issued by ICSI

The company is in substantial compliance with the secretarial standard governing board meetings as set
out in Secretarial Standard 1 (SS-1) issued by the Institute of Company Secretaries of India.
2. COMMITTEES OF THE BOARD
2.1. Audit Committee
As the term of the previous Audit Committee ended on 26th June 2010, the Audit Committee was reconstituted
with the following directors.
1.
Shri Sanjiv Kapoor
Non-official part-time director as Chairman
2.
Dr. Aarti Vij
- Non-official part-time director as Member
3.
Director (Mktg.) - Member
The Audit Committee had two meetings during the year 2010-11, i.e. on May 10, 2010 and March 16, 2011.
The guidelines for the working of the Committee as approved by the Board and the powers vested with the
Committee are given below.
73
2.1.1.nxn
E)
E{x E k h , {{i + M xSi Ex E E{x E k {]M |G E xIh

Ex + <E k h E |E]Eh Ex *
J)
J{I E xH + J{I E xvh + E +x E Mix E +xnx E B

Ex*
M)
J xi + {ri E {ix { J { vx Epi EE E k h

b E |ii Ex E { |vx E l I Ex *
|vx u xh E |M E +v { J J |] *
J{I {] E n E *
J{I =i{z i{h Vx *
Si E{x *
J xE E l +x{x *
k h v Exx +{I+ E +x{x*
E vi {] xnx x vE |vx, =xE E in +n E l E{x E iE |Ei E
xnx VE E{x E i E l H P Ei *
74
P)
|vx, + +iE J{IE, +iE xjh |h E |{ii E I Ex*
b)
+iE J{I M E Sx, ]M + M |vx E +vE E ì, {]M Sx i

+ +iE J{I E +k i +iE J{I EE{ E {{ii E I Ex *
S)
E i{h {h { +iE J{IE E l SS + ={ +xix Ex*
U)
+iE J{IE u E +iE VS-{bi E {h E I Ex V E ni vJW,

+xi iE |Ei E +iE xjh |h E +i , b E {] Ex*
V)
J{I x E { E J{I E l J{I E i E +iH =k J{I E |Ei E

SS Ex E =rMxi E Ij E {i M E*
Z)
E{x E k + VJ |vx xi E I Ex*
\)
VEi+ E @h{j E Mix {{i SE E Eh VS-{bi Ex*
])
i i E E BE È M/M*
`)
J{I i È E {] b u E Ex + +E E< EB b E È |ii E

VBM*
b)
n J{I i {] b u Ei x i, = b Eh i +Ji EM*
2.1.1.
a)
Guidelines
Oversight of the companys financial reporting process and the disclosure of its financial information
to ensure that the financial statement is correct, sufficient and credible.
b)
Recommending the appointment and removal of external audit, fixation of audit fee and also approval
of payment for any other services.
c)
Reviewing with management the annual financial statements before submission to the Board, focusing
primarily on any changes in accounting policies and practices;
Major accounting entries based on exercise of judgment by management;

Qualifications in draft audit report;
Significant adjustments arising out of audit;
The going concern concept;
Compliance with accounting standards;
Compliance with legal requirements concerning financial statements;
Any related party transactions i.e., transactions of the company of material nature with promoters
or the management, their subsidiaries or relatives etc. that may have potential conflict with the
interest of company at large.
d)
Reviewing the management, external and internal auditors, the adequacy of internal control systems.
e)
Reviewing the adequacy of internal audit function, including the structure of the internal audit department,
staffing and the seniority of official heading the department, reporting structure coverage and frequency
of internal audit.
f)
g)
Discussion with internal auditors, any significant findings and follow up thereon.
Reviewing the findings of any internal investigations by the internal auditors into matters where there is
a suspected fraud or irregularity or a failure of internal control systems of a material nature and reporting
the matter to the Board.
h)
Discussions with external auditors before the audit commences, nature and scope of audit as well as
post-audit discussion to ascertain any area of concern.
i)
Reviewing the companys financial and risk management policies.
j)
To look into the reasons for substantial defaults in the payment to the depositors debenture.
k)
The Committee shall meet at least once every quarter.
l)
The Audit Committee meeting reports shall be presented in the Board meeting for adoption and
necessary action by the Board.
m)
If the Audit Committee Reports are not accepted by the Board, the same shall be recorded with reasons
in the Board.
75
2.1.2. +vE
(i)
E Miv E <E Sl E +n VS {bi Ex*
(ii)
E ES { + ES =xE VxE ffx*
(iii) b E xnE E +xnx E +vx Exx +x kE |{i Ex*

(iv) +M +E Z, |ME Yi E l M E l ={li |{i Ex*
(v)
]- E Ih Ex
2.1.3 E nx +Vi J{I i È E V xS n Vi *

G
i n E x
+v E nx
+Vi È E
J
1
={li È E
J
b. E.xn
V E{
E.E. E
b.+i V
xnE (k), xnE (iExE B |Sx), E{x S, vE + +iE J{IE E |ixv J{I
È M M*
2.2. x i
Ivx E nx, b E xnE xxEi xnE E l x i E {xM`x E M*
1. V E{
2. b.+i V
3. E.E. E
4. B.b.E
5. + { Jhb
M E +EE xnE - +vI

M E +EE xnE - n
xnE ({hx) - n
xnE (iExE B |Sx) - n
xnE (k) - n
Ivx E nx, +{E E{x E xM i n È +Vi E, x 19 Vx 2010 + 23 S 2011 *

2.3. {E i
E{x E b i + = i E xS E +vE E {i ix + x{nx vi ix E xvh EB xvi
E +n {E i M`x E M * i xS =Ji V +vI i ix n *
76
2.1.2.Powers
(i)
To investigate any activity within its terms of reference.
(ii)
To seek information on and from any employee.
(iii)
To obtain outside legal or other professional advice, subject to the approval of the Board of Directors.
(iv)
To secure attendance of outsiders with relevant expertise, if it is considered necessary.
(v) To protect whistle-blowers.

2.1.3. Attendance at the Audit Committee meetings held during the year are shown below:
Sl. No
Name of the Committee
No. of
No. of
Member
meetings held
meetings
during the period
attended.
1.
Shri. Sanjeevi
2.
Dr. K. Mohan Das
3.
Shri. Sanjiv Kapoor
4.
Shri. K. K. Suresh Kumar
5.
Dr. Aarti Vij
Director (Finance), Director (T&O), Company Secretary, representatives of statutory and internal auditors had
also attended the Audit Committee meetings.
2.2. Investment Committee
During the year under review, the Board of directors had reconstituted Investment Committee with the
directors mentioned below.
1.
Shri Sanjiv Kapoor
Non-official part-time director Chairman
2.
Dr. Aarti Vij
Non-official part-time director - Member
3.
Director (Marketing) Member
4.
Shri M.D. Sreekumar
Director (Technical & Operation) Member
5.
Director (Finance) - Member
During the year under review, the Investment Committee of the companys Board met two times: June 19,
2010 and March 23, 2011.
2.3. Remuneration Committee:
The Remuneration Committee has been constituted for determination of variable pay and performancerelated pay of Board level and below Board level executives of the company, within the prescribed limits. The
Committee consists of three members including the chairman as mentioned below.
77
x
V
{n
+vI
({i)
n
({i)
+vI
n
n
b. E.x n
V E{
b. +i V
+.{.Jhb
xH E iJ
{i E iJ
26.06.2007
26.06.2010
26.06.2007
03.12.2010
03.12.2010
01.04.2010
26.06.2010
-
2.3.1. +Vi È + V
E nx {E i 19 Vx, 2010 E BE l* È n ={li l*
3. xnE E {E
l B { Eh j, i E +vI B |v xnE + ix EiE xnE E xH Ei *
VxE =t M u =xE xnE{ E {E + i xvx E xh B Vi * +vI B |v xnE
+ ix EiE xnE E {S E +v EB =xE +vi E iJ iE +M +n iE, V {
, xH EB Vi *
l B { Eh j, i E u M E +EE ij xnE E ix E +v EB
xH EB Vi + b E |iE È + b u xH J-{I i, x i + {E i V
={ i E È ={li x EB ` 7500 E È E |nk EB Vi *
2010-11 E nx xnE E |nk {E E h xS n Vi :
G
J
78
xnE
{n
E {E
(` J )
B. +{{x
+vI B |v xnE
18.70
E.E. E
xnE ({hx)
15.83
B.b. E
xnE (iExE B |Sx)
15.81
+.{. Jhb
xnE (k)
14.67
Name
Position
Date of appointment
Date of cessation
Shri. Sanjeevi
Chairman(Ceased)
26.06.2007
26.06.2010
Dr. K. Mohan Das
Member (Ceased)
26.06.2007
26.06.2010
Shri. Sanjiv Kapoor
Chairman
03.12.2010
Dr. Aarti Vij
Member
03.12.2010
Shri. R.P. Khandelwal
Member
01.04.2010
2.3.1. Meetings held and attendance

During the year, the remuneration committee had met once on June 19, 2010. All members were present at
the meeting.
3. Remuneration of directors
Ministry of Health & Family Welfare (MoHFW), Govt. of India appoints Chairman & Managing Director and 3
Functional Directors. The remuneration and terms and conditions of their directorship are decided by
Department of Public Enterprises. The Chairman & Managing Director and the Functional Directors are
appointed for a period of five years or till the date of their superannuation or until further orders, whichever is
earlier.
Non-official part-time Independent Directors are also appointed by the Ministry of Health & Family Welfare,
Govt. of India for a period of three years and are paid a sitting fee of ` 7500 for attending each meeting of the
Board and the Board appointed Sub Committees viz. Audit Committee, Investment Committee and
Remuneration Committee.
The details of the remuneration paid to the Directors during 2010-11 are given below:
Sl. No.
Director
Shri. M. Ayyappan
Position
Chairman & Managing
Director
18.70
15.83
Director (Marketing)
Shri M.D. Sreekumar
Director (Technical &
Total Remuneration
(` in lakh)
Operation)
15.81
Director (Finance)
14.67
79
4. x xE È
{U ix E x È E iJ, + lx
G J
nxE
lx
42 E x È-19 i, 2008
+{x 3.00 V
ixi{
43 E x È-18 i, 2009
+{x 4.00 V
x< n
24.09.2009 E lMi È
{x 11.30 V
x< n
44 E x È- 24 i, 2010
vx 12.00 V
x< n
27.09.2010 E lMi È (E E +) +{x 3.00 V
x< n
18 i, 2009 E +Vi 43 E x È xnE E H E v l E +ix E vx

EB BE E{ {i E M *
< E E x È : iJ, , lx
nxE
lx
06.09.2011
vx 12.00
x< n
5. |E]Eh:
{] vi iE { i{h E< xnx x , +li E{x E vE, xnE |vx, E
in +n E l iE |Ei E E{x E xnx E VE E{x E i E l x { i P
Ei *
E{x u E< M +x{x, E vE Mix +{I+ { E vE |vE u E{x { Vx,
+I{ +{i Ex E E< x *
E{x VJ |vx EG Gxi Ex E |G *
E nx + {U ix V Exx E v Exp E u V EB MB ]{i E xn
E +x{x E M *
Ji E< E n E x x b M , V =q E B x *
6.S E vx
E{x E <] +{x E Ji E J {Ii h |Ei Ei *
80
4.
General Body meetings:
Date, Time and Venue of the last three AGMs

Sl. No
Date
Time
Venue
42nd AGM - 19th September, 2008
3.00 PM
Thiruvananthapuram
43rd AGM - 18th September, 2009
4.00 PM
New Delhi
Adjourned meeting on 24.09.2009
11.30 AM
New Delhi
44th AGM -24th September, 2010
12.00 Noon
New Delhi
Adjourned meeting 27.09.2010
3.00 PM
New Delhi
(lack of quorum)
In the 43rd Annual General Meeting conducted on 18th September, 2009, one special resolution passed for
Alteration of Articles of Association regarding Power of Directors.
AGM of the current year: Date, Time and Venue
Date
Time
Venue
06.09.2011
12.00 Noon
New Delhi
5. Disclosures:
There have been no materially significant related party transactions, i.e., transactions of the company of a
material nature with its promoters, the directors or the management, subsidiaries or relatives etc. that may
have potential conflict with the interests of the company at large.
There were no cases of non-compliance by the company and penalties, strictures imposed on the company
by any statutory authority on any statutory payment requirements.
The company is in the process of putting in place a Risk Management Programme.
Presidential directives issued by the Central government in respect of Official Language Implementation
have been complied with during the year and also in the last three years.
There were no items of expenditure debited in books of accounts, which are not for the purposes of the
business.
6. Means of communication:
The company publishes its annual audited statement of accounts in the official website also.
81
7.b n E |Ih
E{x b E n E |Ih { {{i W ni * {U E nx |Ii xnE E h xS n Vi :G J
xnE
EG
+v (n)
1.
xnE (k)
E{] +x {
6 xnE ExC
2 nx
2.
xnE (k)
Sx M Bbx
xV] EG
7 nx
8. E{] +x E +x{x E |h-{j

J {IE E +x{x |h{j {] E +i n Vi E E{x x {{i { E{] +x E i E
{x E *
82
7. Training of Board members:

The company lays adequate emphasis on training of Board members. Details of the directors trained during
the last year are given below:Sl. No.
1.
Director
Director (Finance)
Programme
6th Directors Conclave on
Duration (days)
2 days
Corporate Governance
2.
Director (Finance)
Global Advance Management
7 days
Programme at China
8. Certificate of compliance of Corporate Governance

The compliance certificate of the auditors that the company has substantially complied with the conditions
of corporate governance is given at the end of the report.
83
|h-{j
n
BSBB <E ]b
b { < E Y{x J B..15 (3) 2007-b { < (V B)-V B-99 nxE 9 +| 2010 E xn] V
x 31 S 2011 E {i E B BSBB <E ]b u E{] +x E i E +x{x E
VS E *
E{] +x E i E +x{x, |v E Vn * E{] +x E i E xSi Ex EB E{x
u +{x< M< VS =E |G + Exx iE i * x i J{I + x E{x E k
h { E +H *
il nB MB {]Eh + =k VxE E +x |hi Ei E E{x x ={H b
{ < E Y{x xn] V E{] +x E i E +x{x E l*
+M {] E ni E B +x{x x i E{x E i V BE +x + x |v u +Vi
E{x E E E nIi |i *
J{IE
+xnx & n
xn JE
84
CERTIFICATE
To the Members of
HLL Lifecare Ltd.
We have examined the compliance of conditions of Corporate Governance by HLL Lifecare Ltd. for the year
ended on March 3, 2011, as stipulated by DPE O.M. No. F. No. 15(3)/2007-DPE (GM)-GL-99 dated April 9,
2010.
The compliance of the conditions of Corporate Governance is the responsibility of the management. Our
examination was limited to procedures and implementation thereof, adopted by the company for ensuring
the conditions of Corporate Governance. It is neither an audit nor an expression of opinion on the financial
statements of the company.
In our opinion and to the best of our information to the explanations given to us, we certify that the company
had complied with the conditions of Corporate Governance as stipulated in the above mentioned DPE O.M.
We further state that such compliance is neither an assurance as to the future viability of the company nor
the efficiency or effectiveness with which the management has conducted the affairs of the company.
Auditors
M/s. Ananthan & Sundaram
85
+xnx Bhb n
xn JE
Ei, 123, E xM
xhE, Ex ({.+), ixi{
n : 0471-2491601, 2491602
<- : ananthan_sundaram@hotmail.com
lx : E{ x< n
nxE& 10.08.2011
BSBB <E ]b E n E J{IE E {]

({ n ix ]C ]b)
E.
J.
M.
P.
x BSBB <E ]b ({ nix ]C ]b) E 31 S, 2011 iE E Mx ix {j

+ =E l +xr = iJ E {i E -x J + xEn | h E J{I E *
k h E{x E |xv E Vn * J{I E +v { <x k h { |E] Ex
Vn *
x +{x J{I i x { Ei J{I xE E +x S * =x xE +{I Ei
E k h iE +ll h H , E HH +x |{i Ex E B J{I E
Vx xE x{nx Ei * J{I VS E +v { x Ih, k h J il |E]Eh
EB E |h * J{I <i EB MB J ii E Ex il |xv u x MB
i{h |CEx E +iH E k h E |iiEh E Ex * E
J{I +{x E B HH +v |nx Ei *
E{x +vx 1956 E v 227 (4B) E i E iE i E Exp E u V EB E{x (J{IE
E {]) +n, 2003 il E{x (J{IE E {]) (vx) +n, 2004 E u +{Ii il =Si Z
E E M< VS E +v { il nB MB Sx + {]Eh E +x =H +n E { 4 xn]
{ xxx {] Ei *
{] Ei :
(E) V iE {i + , J{I E =q E B +E SxB B {]Eh
|{i B *
(J) i il V iE VS |E] i , Exxx +{Ii Mi -Ji E{x u J MB
*
(M) < {] u |i{ni ix-{j + -x J + xEn | h E{x E Ji E +xE *
, < {] u |i{ni ix {j, -x J + xEn | h, E{x +vx,

1956 E v 211 E ={v (3) xn] J xE E l +x{x Ei *
(P) VxE E +x E E{x x E{x +vx 1956 E v 274 E ={v (1) E Jb
(U) E{x { M x *
il =k VxE B nB MB {]Eh E +x, xxEi E +vx :
1. nxn + xn {]Eh |{i x E M * {IE u +O E, |{i
+O, |ii V + x V {] E +vx *
2. ` 74.37 J E W vx EB i {Vx+ E E E { i *
3. E{x u x E +vx J xEn B E + B vi niB i E xn JE lx E Y
E i E E +x ix-{j {i n E { |E] E Vi *
86
ANANTHAN & SUNDARAM

Sivakarthi, 123, Sankar Nagar

Neeramankara, Kaimanam (P.O), Thiruvananthapuram
Phone : 0471-2491601, 2491602
E-mail : ananthan_sundaram@hotmail com
Place : Camp at New Delhi
Date: 10.08.2011
AUDITORS REPORT TO THE MEMBERS OF HLL LIFECARE LTD.

(Formerly Hindustan Latex Ltd.)
A.
We have audited the attached Balance Sheet of HLL LIFE CARE LTD. (Formerly Hindustan Latex Ltd.) as
at 31st March 2011, the Profit and Loss Account and the Cash Flow Statement for the year ended on that
date annexed thereto. These financial statements are the responsibility of the Companys Management.
Our responsibility is to express an opinion on these financial statements based on our audit.
B.
We conducted our audit in accordance with auditing standards generally accepted in India. Those
standards require that we plan and perfom the audit, obtain reasonable assurance about whether the
financial statements are free of material misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by management, as well
as evaluating the overall financial statement presentation. We believe that our audit provides a
reasonable basis for our opinion.
C.
As required by the Companies (Auditors Report) Order, 2003 and the Companies (Auditors Report)
(Amendment) Order, 2004 issued by the Central Government of India in terms of Section 227 (4A) of the
Companies Act, 1956, and on the basis of such checks as we considered appropriate and according
to the information and explanations given to us, we annex herewith our report on the matters specified
in paragraphs 4 and of the said Order as under:
D.
We report that:
a.
We have obtained all the information and explanations which to the best of our knowledge and
belief were necessary for the purpose of audit.
b.
In our opinion proper books of accounts as required by the law have been kept by the Company so
far as it appears from our examination of those books;
c.
The Balance Sheet, Profit and Loss Account and Cash flow statement dealt with by this Report are
in agreement with the books of account;
In our opinion, the Balance Sheet, Profit and Loss Account and Cash Flow Statement dealt with by
this report comply with the accounting standards, referred to in sub-section (3C) of the section 211
of the Companies Act, 1956.
d.
According to our information, clause (g) of sub-section (I) of section 274 of the Companies Act,
1956, is not applicable to the company, since it is a Government Company.
In our opinion and to the best of our information and according to the explanation given to us, subject
to the following:
1.
Balance confirmation from Debtors and Creditors are not received in all the cases. Balances,
Advance outstanding, Advance received, Security Deposits and Earnest Money Deposits are subject
to confirmation by parties.
2.
Credit balance of ` 74.37 lacs remain as outstanding of the projects pending reconciiation.
3.
The cash and bank balances held by the Company under trust and the relative liabilities are
disclosed as contra items in the Balance Sheet in accordance with the opinion of the Expert
Advisory Committee of the Institute of Chartered Accountants of India.
87
={H E +x:
=H Ji = { ]{{h E l {gM V E{x +vx 1956 E u +{Ii VxE Ui iE il
i xi Ei J ri E +x{ È B { ni *
(i) ix-{j 31 S, 2011 iE E E{x E EE{ xvi *
(ii) =H iJ E {i E E{x E -x J xvi +
(iii) V iE E =H iJ E {i EB xEn | h vi *
Ei +xnx Bhb n
xn JE
. xI xn
Zn
ni . 020120
B. +. x. 000148B
88
Subject to the above:

The said accounts read with Notes thereon, give the information required by the Companies Act, 1956, in the
manner so required and give a true and fair view in conformity with the accounting principles generally
accepted in India.
(i)
In so far as it relate to the Balance Sheet, of the state of affairs for the Company as at 31st March 2011.
(ii)
In so far as it relates to the Profit and Loss Account, of the profit of the Company for the year ended on
that date, and
(iii)
In so far as it relates to the Cash Flow Statement, of the cash flows for the year ended on that date.
For ANANTHAN & SUNDARAM

V. MEENAKSHI SUNDARAM
Partner, M.No. 020120
F.R. No. 000148S
89
k 2010-2011 EB BSBB <E E n E

J{IE E {] E +xv
(i)
(ii)
(iii)
(iv)
(v)
(vi)
(vii)
(viii)
(ix)
(x)
90
(E) E{x +S {{k E li + { nJx Eb Ji , VE {hiE h,

Jn , lx + BE {Sx J V {h h E l +M +tix + vx E Wi *
(J) E n x |v u +S {{k E |iI i{x EB M * V , |vx x +S {{k E
|iI i{x E B E< E |h x J +i: B i{x E +k + {{ii { ]E-]{{h
x E V Ei * |iI i{x { {< M< Mi iE x l il B Mi EB J E<
Vx x x M *
(M) E n x +S {{k E {{i x{]x x l, <B S +vi k h E i <
J { |i x *
(E) i {] E l {b iS E + E nx |v u i , ESS , {EM , S
E + <Vx hb E |iI VS E nx E M * i{x E +k lSi *
(J) E{x E +E il E E |Ei E v |xv u {x E M iS E |iI i{x E E
|h Sx B =Si *
(M) E{x iS E =Si Eb Ji il |iI i{x { i{h i{E Mi x { M*
E{x x E{x +vx 1956 E v 301 E +vx J MB V] |i{ni E{x, +x H
E/ |ii +|ii E< @h x Ei *
E{x x E{x +vx 1956 E v 301 E +vx J MB V] |i{ni E{x, +x H
E/ |ii +|ii E< @h x Ei il <B < Jb E ={ Jb (J), (M), (P), (S) il
(U) E +vx {]M M x *
il n M< Sx + {]Eh E +x +E il E E |Ei E +x{ iS il
+S {{k E G B + + E G EB lSi {{i +iE xjh |h E< |J
E {] x E vx + *
n M< Sx E +x, E nx E{x +vx, 1956 E v 301 E +xh , V] |]i
Ex EB E< ` E lB x *
E{x x Vxi E< V Ei x E * V , {] Ei E vE =kvE E S E
n E Eh +|nk `10,000/- v V E +vx *
E{x x +iE J{I Ex EB x] xn JE E xH E *
+iE J{I E EIj Ji E{x E +E il E E |Ei E +x{ * E{]Eh {h
E +vx v |SxiE VJ + E{x u B MB v {Vx E il xi + +xiE G
nx EB Exp {hx M`x Gb] Vx EB +iE J{I E EIj f V*
x E{x +vx 1956 E v 209 (1) (P) E +vx Mi Eb E +xIh Ex EB i E u
x x E +x E{x u =i{ni E bM + j vi xB J E {E I E
il E |iIi& +J E xE J M *
(E) +J E +x, + iE V x E ` 22.15 J E E E UbE, xv, < B
+<, +-E, G E, vx E, E, =i{n E, ={ E + +x vE n =Si |vE E
l +x vE n V Ex E{x x { xi *
(J) nB MB Sx B {]Eh E +x, E n E Eh V EB + E, G E, vx E,
E, E, =i{n E ={E x *
E{x E 31 S 2011 iE E< Si x x + = iJ {i k {i k E<
Eb x JS x E *
ANNEXURE TO AUDITORS REPORT TO THE MEMBERS OF HLL LIFECARE LTD.

FOR THE FINANCIAL YEAR 2010-11
(i)
(a) The company is maintaining records showing particulars and situation of fixed assets, which
needs further updating and modification with full particulars like quantitative details, year of
purchase, location and unique identification number.
(b) The fixed assets were physically verified during the year by the Management. However, the
management has not laid down procedure for physical verification of fixed assets and hence
frequency and adequacy of such verification could not be commented upon. Discrepancies noticed
on physical verification were not material and no adjustment has been made in the accounts for
such discrepancies.
(c)
(ii)
There was no substantial disposal of fixed assets during the year and hence, the preparation of
financial statements on going concern basis is not affected on this account.
(a) The stocks of finished goods, raw materials, packing materials, work-in-progress and engineering
stores have been physically verified by the management during the year, except the inventories
lying with third parties. In our opinion, the frequency of verification is reasonable.
(b) The procedures for physical verification of inventory followed by management are reasonable and
adequate in relation to the size of the company and nature of its business.
(c)
(iii)
The company is maintaining proper records of inventory and material discrepancies were not
noticed on physical verification.
The company has not granted or taken any loans, secured or unsecured to / from companies, firms or
other parities covered in the register maintained under section 301 of the Companies Act, 1956.
Since the company has not granted or taken any loans, secured or unsecured to/from companies,
firms or other parties covered in the register maintained under section 301 of the Companies Act,
1956, requirements of reporting under sub-clauses (b), (c), (d), (f) and (g) of this clause do not apply.
(iv)
In our opinion and according to the information and explanations given to us, there are reasonably
adequate internal control procedures commensurate with the size of the company and nature of its
business for the purchase of inventory and fixed assets and for the sale of goods and services. To the
best of our knowledge, no major weaknesses in internal control system were either reported or
noticed by us during the course of our audit.
(v)
According to the information given to us, there are no contracts or arrangements during the year that
need to be entered into a register in pursuance of Section 301 of the Companies Act, 1956.
(vi)
The Company has not accepted any deposits from public. However, we report that an amount of
Rs.10,000 is outstanding under fixed deposit not repaid due to dispute between the legal heirs.
(vii)
The company has appointed Chartered Accountant firms to undertake the internal audit of all their
Units. In our opinion, the scope of internal audit is generally commensurate with the size and nature
of business of the Company.
(viii)
We have broadly reviewed the books of account maintained by the Company pursuant to the Rules
made by the Central Government for the maintenance of cost records under Section 209(1)(d) of the
Companies Act, 1956, in respect of Bulk Drugs and Formulations produced by the Company and we
are of the opinion that prima facie, the records have been made and maintained.
(ix)
(a) According to the records, the Company has been generally regular in depositing undisputed
statutory dues including Provident Fund, ESI, Income Tax, Wealth Tax, Service tax, Excise Duty,
Cess and other statutory dues with the appropriate authorities, except customs duty of ` 22.15
lacs, which is still not remitted.
(b) According to the information and explanations given to us, there are no dues of Income Tax, Sales
Tax, Wealth Tax, Service Tax, customs Tax, Excise Duty or Cess not deposited on account of any
dispute.
(x)
The company has no accumulated losses as on 31st March, 2011 and it has not incurred any cash
losses in the finacial year ended on that date or in the immediately preceding financial year.
91
+J E i{x E +v { il nB MB Sx B {]Eh E +x E{x x k M`x E

E n { +nM iG x E * E nx E{x x E< @h{j V x E *
(xii)
nB MB Sx B {]Eh E +x, E{x x Vxi E +v { , @h{j + +x |ii E
M JE @h +O Ei x E *
(xiii) S] xv, xv {{E n xv/<] EB M E ] Exx E |vx, E{x EB
M x *
(xiv)
E{x , @h{j il +x x x-nx ]bM x Ei *
(xv)
E{x x k l ES u B @h EB M] n VE i xvx E{x E i { |iE
x *
(xvi)
, n @h =`B MB =q EB |H EB MB *
(xvii) E{x E +J il S E E{x E ix-{j B xEn {n< h { O VS E +v { +
nB MB Sx B {]Eh E +x E{x x nPv x EB +{v +v { =`< M< xv il <
=] ={M x E *
(xviii) E n x, E{x x E{x +vx 1956 E v 301 E +vx xB J V] i {] E{x
E E E +vx +]x x E *
(xix)
E nx @h{j V x E M , +i& |ii xx E |x x =ì *
(xx)
E nx E{x x VxE xM u E< E =` *
(xxi)
x{ni J{I Gv il |v |{i +nx E +v { {] Ei E J{Ivx E
nx E{x { u E< vJW vx + {] x E M M*
(xi)
Ei +xnx Bhb n
xn JE
lx : E{ x< n
nxE : 10-08-2011
92
. xI xn
Zn
ni . 020120
B. +. x. 000148B
(xi)
On the basis of verification of records and according to the information and explanations given to us,
the Company has not defaulted in repayment of dues to Financial Institutions or Banks. The Company
has not issued any debentures during this year.
(xii) According to the information and explanations given to us, the Company has not granted any loans and
advances on the basis of security by way of pledge of share, debentures and other securities.
(xiii) The provisions of any special statue applicable to chit fund, nidhi or mutual benefit fund/societies are
not applicable to the Company.
(xiv) The Company is not dealing or trading in shares, debentures and other investments.
(xv)
The company has given guarantee for loans taken by employees from financial institutions, the terms
and conditions of which are not prejudicial to the interest of the company.
(xvi) In our opinion, the term loans have been applied for the purpose for which they were raised.
(xvii) According to the records of the Company and on the basis of an overall examination of the balance
sheet and cash flow statement for the current year and the information and explanations given to us, we
report that funds raised on short-term basis have not been used during the year for long-term investment
and vice-versa.
(xviii) During the year, the Company has not made any preferential allotment of shares to parties or companies
covered in the Register maintained under Section 301 of the Companies Act, 1956.
(xix) Since no debentures have been issued during the year, question of creating securities or charge does
not arise.
(xx)
The company has not raised any money through public issue during the year.
(xxi) Based on the audit procedures performed and the representation obtained from the management we
report that a fraud on or by the company has been noticed or reported during the year under audit.
V. MEENAKSHI SUNDARAM
Partner, M.No. 020120
F.R. No. 000148S
Place : Camp at New Delhi
Date : 10-08-2011
93
i J il J {I M
E |vx xnE, hVE J {I
il {nx n, J {I b, Sz
M{x
. { b B/ B-Eb/II/4-241/BSBB/2011-12/55
nxE 05.09.2011

+vI B |v xnE
BSBB <E ]b,
ixi{
n ,
: BSBB <E ]b, ixi{ E 31 S 2011 E {i E J { E{x +vx,
1956 E v 619 (4) E ii i E xjE J{IE E ]{{h*
*****************
BSBB <E ]b, ixi{ E 31 S, 2011 E {i E J { E{x +vx 1956 E

v 619 (4) E ii i E xjE J {IE E ]{{h <E l +Oi Ei *
< {j E {i E{ nVB*
n,
(B. Sv)
|vx xnE, hVE J {I B
{nx n, J{I b
MxE : ={H
<bx + x, { i, 139, i Mv c, Sz - 600 034

C : 044-2833 0142/044-28330145
<- : mabchennai@cag.gov.in
94
Indian Audit and Accounts Department

Office of the Principal Director of Commercial Audit
and Ex-Officio Member, Audit Board, Chennai
CONFIDENTIAL
No. PDCA/CA-Cordn/II/4-241/HLL/2011-12/55
Dated 05.09.2011
To
The Chairman & Managing Director
HLL Lifecare Limited
Thiruvananthapuram.
Sir,
Sub :
Comments of the Comptroller and Auditor General of India under Section 619 (4) of the
Companies Act, 1956 on the accounts of HLL Lifecare Limited, Thiruvananthapuram for the
year ended 31 March 2011.
*****************
I forward herewith the Comments of the Comptroller and Auditor General of India under Section 619
(4) of the Companies Act, 1956 on the accounts of HLL Lifecare Limited, Thiruvananthapuram for the year
ended 31st March 2011.
The receipt of this letter may kindly be acknowledged.
Yours faithfully,
(A. ROY CHOUDHURY)

PRINCIPAL DIRECTOR OF COMMERCIAL AUDIT AND
EX-OFFICIO MEMBER, AUDIT BOARD
Encl : as above
Indian Oil Bhavan, I Floor, 139, Mahatma Gandhi Road, Chennai - 600 034
Fax : 044-28330142 / 044 - 28330145
E-mail : mabchennai@cag.gov.in
95
BSBB <E ]b E 31 S 2011 E {i E J { E{x +vx 1956

E v 619(4) E +vx i E xjE B J {IE E ]{{h
E{x +vx 1956 E +vx xvi k {]M {J E +v { 31 S 2011 E {i E BSBB
<E ]b, ixi{ E k h i Ex E{x E |vx E =kni * i xn JE
l E E xE u xvi J {Ih + +x xE E +v { ij J{I E +v { E{x
+vx 1956 E v 227 E +vx, <x k h { H Ex EB E{x +vx 1956 E v 619 (2)
E +vx i E xjE B J {IE u xH vE J{IE =kn * =xE u =xE nxE
10 +Mi 2011 E J{I {] E +x EB MB *
x, i E xjE J{IE E i E{x +vx 1956 E v 619 (3) () E +vx
BSBB <E ]b, ixi{ E 31 S 2011 E {i k h E +x{E J{I +Vi E
* +x{E J{I vE J {IE E EE EMWi E {S E x ij { E M il
vE J{IE E {UiU + E{x E EE il SxiE {I E EU J Eb iE Ji: i *
J {I E +x VxE E< i{h n + V E{x +vx 1956 E v 619(4) E +vx vE
J {IE E {] E E< ]{{h +x{E =` E*
i E xjE J{IE E i
(B.Sv)
|vx xnE, hVE J {I
B {nx n, J{I b
lx : Sz
iJ : 05/09/11
96
COMMENTS OF THE COMPTROLLER AND AUDITOR GENERAL OF INDIA

UNDER SECTION 619(4) OF THE COMPANIES ACT, 1956 ON THE ACCOUNTS OF HLL
LIFECARE LIMITED, THIRUVANANTHAPURAM FOR THE YEAR ENDED 31st MARCH 2011
The preparation of financial statements of HLL LIFECARE LIMITED, THIRUVANANTHAPURAM for the year
ended 31st March 2011 in accordance with the financial reporting framework prescribed under the Companies
Act 1956, is the responsibility of the management of the Company. The statutory auditor appointed by the
Comptroller and Auditor General of India under Section 619 (2) of the Companies Act, 1956 is responsible
for expressing opinion on these financial statements under Section 227 of the Companies Act, 1956 based
on independent audit in accordance with auditing and assurance standards prescribed by their professional
body, the Institute of Chartered Accountants of India. This is stated to have been done by them vide their Audit
Report dated 10 August 2011.
I, on behalf of the Comptroller and Auditor General of India have condutcted a supplementary audit under
Section 619(3)(b) of the Companies Act, 1956 of the financial statements of HLL LIFECARE LIMITED,
THIRUVANANTHAPURAM for the year ended 31st March 2011. This supplementary audit has been carried
out independently without access to the working papers of the statutory auditor and is limited primarily to
inquiries of the statutory auditor and company personnel and a selective examination of some of the accounting
records. On the basis of my audit nothing significant has come to my knowledge which would give rise to any
comment upon or supplement to statutory auditor's report under Section 619 (4) of the Companies Act 1956.
For and on behalf of the

Comptroller and Auditor General of India
(A. ROY CHOUDHURY)

PRINCIPAL DIRECTOR OF COMMERCIAL AUDIT AND
EX-OFFICIO MEMBER, AUDIT BOARD
Place : Chennai
Dated : 05.09.2011
97
31 S, 2011 E ix-{j
+xS
xv i
+v E xv
{V
+Ii il +v
@h xv
|ii @h
+lMi E ni
E
xv E |Vi
+S {{k
E E
xx :
x E
S E {V
1,553.50
14,042,50
1,553.50
12,470.75
3
4
16,059.79
351.37
32,007.16
8,771.72
327.58
23,123.55
23,013.02
11,338.44
11,674.58
1,581.17
13,255.75
785.42
22,422.43
10,173.79
12,248.64
230.41
12,479.05
785.42
5,739.31
19,814.51
5,092.95
4,314.60
4,445.08
39,406.45
30,073,24
5,312.00
11,776.75
4,457.23
1,437,28
2,985.62
25,968.88
24,419.15
20,545.81
894.65
21,440.46
30,073.24
15,370.20
739.60
16,109.80
24,419.15
17,965.99
32,007.16
9,859.08
23,123.55
7
8
9
10
11
12
(E)
Ex] E +x x E +vx < {Vx+ E Ec E
xx : S niB + lB
(E) S niB
(J) lB
(J)
Ex] E +x x E +vx < {Vx+ E Ec E
x S {{k
E
1
2
5
6
x
S {{k, @h {M
iS
v nxn
Ec E
+x S {{k
@h il {M
(E-J)
(` J )
2011-12
2010-11
13
14
+xS 1 26 iE Ji E xi *
x< n
10.08.2011
b E i
B.+{{x
+vI B
|v xnE
98
< iJ E {] Mx *
Ei +xxix Bhb xn
xn JE
x. 000148 B
b. B.E. {hb
xnE
+.{. Jhb
xnE (k)
.B.vx x
E{x S B `
={vI ( B B)
. xI xn
Zn
n . 020120
BALANCE SHEET AS ON 31st MARCH 2011

(` in lacs)
SCH
2010-11
2009-10
1,553.50
1,553.50
14,042.50
12,470.75
Secured Loan
16,059.79
8,771.72
Deferred Tax Liability
SOURCES OF FUNDS
SHAREHOLDERS' FUND
Share Capital
Reserves & Surplus
LOAN FUNDS
351.37
327.58
32,007.16
23,123,.55
Gross Block
23,013.02
22,422.43
Less: Depreciation
11,338.44
10,173.79
11,674.58
12,248.64
TOTAL
APPLICATION OF FUNDS
FIXED ASSETS
Net Block
Capital Work-in-progress
INVESTMENTS
1,581.17
230.41
13,255.75
12,479.05
785.42
785.42
CURRENT ASSETS, LOANS & ADVANCES

Inventories
5,739.31
5,312.00
Sundry Debtors
19,814.51
11,776.75
Cash & Bank Balances
10
5,092.95
4,457.23
Other Current Assets
11
4,314.60
1,437.28
Loans & Advances
12
4,445.08
2,985.62
39,406.45
25,968.88
30,073.24
24,419.15
20,545.81
15,370.20
(A)
Cash and Bank balances of Projects held under Trust as per Contra
Less: CURRENT LIABILITIES & PROVISIONS
a) Current Liabilities
13
b) Provisions
14
(B)
Advances received for projects held under Trust as per Contra

Net current assets
(A-B)
TOTAL
894.65
739.60
21,440.46
16,109.80
30,073.24
24,419.15
17,965.99
9,859.08
32,007.16
23,123.55
Schedule 1 to 26 form part of Accounts

New Delhi
10.08.2011
M. Ayyappan
Chairman
& Managing Director
Dr. A.K. Panda

Director
Vide our report of even date attached

Firm No. 000148S
R.P. Khandelwal
Director (Finance)
V.A. Sasidharan Nair

Company Secretary
& SVP (CAS)
V. Meenakshi Sundaram
Partner
Membership No : 020120
99
31 S 2011 E {i E -x J
(` J )
+xS
+
G B B
15
xx : =i{n E
x G
+x +
16
E
J{ +
17
i ]E + |GMi ]E (xx) Vb: (E)/r 18
V + <vx SV
V SV
ES E ix + i
19
+x =i{nx
20
|xE
21
{hx
22
SV
k SV
23
B {vx
{ EB Jn i E
24
È
E
{Ev Vx (x)
E E { E
+E EB |vx - S
+lMi E
+E EB |vx - Mi
E E n
xVx EB ={v
xVx
(E) |ii
(J) |ii { E
(M) B+ xv EB +Ii
(P) x +Ii +ih (v 205 (2B) E +vx
vE +Ii +ih i)
ix {j +M MB
k h { ]{{h
+Vx |i ()
+Vx |i (E)
x< n
10.08.2011
b E i
B.+{{x
+vI B
|v xnE
100
b. B.E. {hb
xnE
+.{. Jhb
xnE (k)
25
2010-11
2009-10
51,691.96
127.63
51,564.33
2,555.52
54,119.85
44,177.90
171.61
44,006.29
2,541.74
46,548.03
13,783.57
7.86
2,206.25
130.74
9,941.30
2,184.93
4,193.80
5,238.75
126.95
524.37
1,439.22
8,092.73
3,522.57
51,393.04
2,726,81
22.60
2,749.41
882.13
23.79
0.00
1,843.49
1,843.49
11,142.28
723.79
1,980.73
145.15
9,165.07
1,618.76
4,009.64
4,663.05
66.30
756.05
1,279.07
8,691.36
76.46
44,317.72
2,230.31
31.09
2,261.40
798.77
184.22
(214.98)
1,493.39
1,493.39
233.03
38.71
38.51
233.03
39.60
1,533.24
x
1,220.76
x
1,186.67
1,186.67
961.31
961.31
26
< iJ E {] Mx *
Ei +xxix Bhb xn
xn JE
x. 000148 B
.B.vx x
. xI xn
E{x S B `
Zn
={vI ( B B)
n . 20120
PROFIT & LOSS ACCOUNT FOR THE YEAR ENDED 31st MARCH 2011
(` in lacs)
SCH
INCOME
Sales & Services
Less: Excise duty
Net Sales
Other Income
TOTAL
EXPENDITURE
Material consumed
(Less)/ Add: Decrease /(increase) in stock of
finished goods & stock in process
Power & fuel charges
Water charges
Employees salaries & benefits
Other production expenses
Administrative expenses
Marketing Expenses
Insurance charges
Finance charges
Depreciation & Amortisation
Value of finished goods purchases - trading
Contract Expenses
2010-11
2009-10
51,691.96
127.63
51,564.33
2,555.52
54,119.85
44,177.90
171.61
44,006.29
2,541.74
46,548.03
17
13,783.57
11,142.28
18
7.86
2,206.25
130.74
9,941.30
2,184.93
4,193.80
5,238.75
126.95
524.37
1,439.22
8,092.73
3,522.57
51,393.04
2,726.81
22.60
2,749.41
882.13
23.79
0.00
1,843.49
1,843.49
723.79
1,980.73
145.15
9,165.07
1,618.76
4,009.65
4,663.05
66.30
756.05
1,279.07
8,691.36
76.46
44,317.72
2,230.31
31.09
2,261.40
798.77
184.22
(214.98)
1,493.39
1,493.39
233.03
38.71
38.51
233.03
39.60
0.00
1,533.24
NIL
1,220.76
NIL
1,186.67
1,186.67
961.31
961.31
15
16
19
20
21
22
23
24
PROFIT FOR THE YEAR

Prior Period adjustment (Net)
25
PROFIT FOR THE YEAR BEFORE TAX
Provision for Income Tax - Current year
Deferred Tax
Provision for Income Tax - Previous years
PROFIT AFTER TAX
PROFIT AVAILABLE FOR APPROPRIATIONS
APPROPRIATIONS:
(a) Proposed Dividend
(b) Tax on Proposed Dividend
(c) Reserve for CSR Fund
(d) Transfer to General Reserve (including transfer to Statutory
Reserve u/s 205 (2A)
BALANCE CARRIED TO BALANCE SHEET
Notes to the Financial Statement
26
Earnings per Share (Basic)
Earnings per Share (Diluted)
New Delhi
10.08.2011
M. Ayyappan
Chairman
& Managing Director
Dr. A.K. Panda

Director

Firm No. 000148S
R.P. Khandelwal
Director (Finance)

Company Secretary
& SVP (CAS)
Partner
101
2010-11 E xEn |
E
|Sx EE{ xEn |

E E {
Vx;
|nk V
{{k E G { (x)
|{i V
S {V {ix E { |Sx
S {V {ix EB Vx
v nxn (r)/E
+x |{ (r)/E
iS (r)/E
{ il +x n (r)/E
|Sx EE{ x x Ec
|nk + E
|Sx EE{ x Ec (E)
x EE{ xEn |
+S {{k E G
S {V E |Mi
+S {{k E G |{i
|{i V
x
x EE{ x xEn (J)
kx EE{ xEn |
nPEx @h |{i
+x @h |{i
|nk V
|nk
|nk E
kx EE{ xMi x xEn (M)
xEn B xEn iE x r/(E)
(E)+(J)+(M)
+v E + xEn B xEn iE
+v E +i xEn B xEn iE
] xEn il xEn iE
l xEn SE
+xSi E E l
(` J )
2010-11
2009-10
2,749.41
2,261.40
1,445.27
524.37
(19.42)
(129.16)
4,570.47
1,279.07
756.05
1.53
(197.89)
4,100.16
(8.037.75)
(4,328.35)
(420.09)
5,243.09
(2,972.63)
(802.09)
(3,774.72)
1,459.05
(857.01)
823.96
(1,091.72)
4,434.44
(831.72)
(3,602.72)
(942.24)
(1,350.76)
83.23
129.16
(2,080.61)
(6,417.82)
(3,311.12)
172.83
197.89
(278.72)
(3,014.70)
(279.90)
7,567.95
(524.37)
(233.03)
(39.60)
(505.63)
(191.82)
(756.05)
(155.35)
(26.40)
6,491.05
635.72
(1,635.26)
(1,047.23)
4,457.23
5,092.95
5,504.47
4,457.23
65.59
27.13
5,027.36
4,430.10
5,092.95
4,457.23
1. ={H xEn | h i xn JE E lx u V B B-3 xn] {I |h E +vx i E
M *
2. < E |iiEh E +x{ x E + {U E +Eb E V +E , {xMEh E M *
3. +xSi E E l ` 3,567.09 J V B B/ V B EB Vx E { xSi
EB Vx ={M EB ={v x *
4. xEn | x E +vx {Vx xv E x-nx + ` 30,073.24 J (` 24,419.15 J) E
x *
x< n
10.08.2011
b E i
< iJ E {] Mx *
Ei +xxix Bhb xn
xn JE
x. 000148 B
B.+{{x
b. B.E. {hb +.{. Jhb
.B.vx x
xI xn
+vI B
xnE
xnE (k)
E{x S B `
Zn
|v xnE
={vI ( B B)
n . 020120
102
CASH FLOW FOR THE YEAR 2010-2011
A.
CASH FLOWS FROM OPERATING ACTIVITIES

Profit before tax
Adjustments for:
Depreciation
Interest Paid
Profit on Sale of Assets (Net)
Interest Received
Operating Profit Before Working Capital Changes
Adjustments for Changes In Working Capital
(INCREASE)/Decrease in Sundry Debtors
(INCREASE)/Decrease in Other Receivables
(lNCREASE)/Decrease in Inventories
(INCREASE/(Decrease) in Trade and Other Payables
Cash Generated from Operations
Income Tax Paid
Net Cash from Operating Activities (A)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of Fixed Assets
Capital Work in Progress
Proceeds from Sale of Fixed Assets
Interest received
Investments
Net Cash from Investing Activities (B)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Long Term Borrowings
Proceeds from Other Borrowings
Interest paid
Dividend Paid
Dividend Tax Paid
Net Cash Used In financing Activities (C)
Net Increase/(Decrease) in Cash & Cash Equivalents(A)+(B)+(C)
Cash and Cash Equivalents at Beginning of Period
Cash and Cash Equivalents at End of Period
Cash And Cash Equivalents Comprise
Cash and Cheques in Hand
Balance with Scheduled Banks
(` in lacs)
2010-11
2009-10
2,749.41
2,261.40
1,445.27
524.37
(19.42)
(129.16)
4,570.47
1,279.07
756.05
1.53
(197.89)
4,100.16
(8,037.75)
(4,328.35)
(420.09)
5,243.09
(2,972.63)
(802.09)
(3,774.72)
1,459.05
(857.01)
823.96
(1,091.72)
4,434.44
(831.72)
3,602.72
(942.24)
(1,350.76)
83.23
129.16
(2,080.61)
(6,417.82)
3,311.12
172.83
197.89
(278.72)
(3,014.70)
(279.90)
7,567.95
(524.37)
(233.03)
(39.60)
6,491.05
635.72
4,457.23
5,092.95
(505.63)
(191.82)
(756.05)
(155.35)
(26.40)
(1,635.25)
(1,047,23)
5,504.47
4,457.23
65.59
5,027.36
5,092.95
27.13
4,430.10
4,457.23
The above Cash Flow Statement has been prepared under the indirect method set out in the AS - 3 issued by the
Institute of Chartered Accountants of India.
2 The previous years figures have been re-grouped whereever necessary in order to conform to this years presentation.
3 Balance with scheduled banks includes ` 3,567.09 lacs which is not available for use being earmarked as margin
money for LCs/BGs
4. Transactions of project funds held under Trust and balance of ` 30,073.24 lacs (previous year ` 24,419.15 lacs)
are not included in the Cashflow
New Delhi
10.08.2011
M. Ayyappan
Chairman
& Managing Director
Dr. A.K. Panda

Director

Firm No. 000148S
R.P. Khandelwal
Director (Finance)

Company Secretary
& SVP (CAS)
Partner
103
(` J )
+xS - 1 {V
|vEi
|i 1000/- ` E 2,00,000/- x
xMi, +nk B {h: |nk ` 1,000/|i E 155350 x
E
+xS - 2 +Ii il +v
x +Ii
+l
Vb: E nx /x J +ih
B+ xv EB +Ii
E
+xS - 3 @h xv
E) |ii @h :
]] E + <b
xEn =v @h
n @h {B
n p n @h ( B $ 19.35 J)
n p Gi E J -=v ( B $ 75.16 J +
16.00 J)
E
2010-11
2009-10
2,000.00
2,000.00
1,553.50
1,553.50
1,553.50
1,553.50
1,247.75
1,533.24
14,003.99
38.51
14,042.50
11,249.99
1,220.76
12,470.75
0.00
12,470.75
10,615.88
154.85
862.70
3,543.53
155.95
1,141.49
4,426.36
16,059.79
3,930.75
8,771.72
]{{h :
1. |ii xEn =v @h
E) E{x E O S {{k E o]vE*
J) Ex E UbE E{x E xi {{k { Vxi SV*
M) {V{{ E Ex i { Vxi E { E vE*
2. |ii n @h
E) Ex E UbE E{x E xi {{k { |l SV*
J) x<b E { E vE
M) {V{{ E Ex i { Vxi E { E vE*
3. n @h ` 298.33 J V k E +i BE E +i n * ({U ` 320.55 J)
4. n Gi E J-=v {V n E |{h EB ` 1,530.39 J , V ={vi E +x +M nPE
EB fE n Vi n @h {ii EM* Gi E J -n =v E M {xG EB
O E +i E + *
5. ` 2,269.08 J E n p Gi @h Vx V E u |ii E M *
104
(` in lacs)
2010-11
2009-10
2,000.00
2,000.00
1,55,350 equity shares of Rs. 1,000/- each
1,553.50
1,553.50
Total
1,553.50
1,553.50
12,470.75
11,249.99
1,533.24
1,220.76
14,003.99
12,470.75
38.51
0.00
14,042.50
12,470.75
10,615.88
3,543.53
Rupee Term Loans
154.85
155.95
Foreign Currency Term Loan (US$ 19.35 lacs)
862.70
1,141.49
4,426.36
3,930.75
16,059.79
8,771.72
SCHEDULE - 1 SHARE CAPITAL

Authorised
2,00,000 Equity shares of Rs. 1,000/- each.
Issued subscribed & fully paid up
SCHEDULE - 2 RESERVES AND SURPLUS

General Reserve
Opening Balance
Add: Transfer from P & L Account during the year
Reserve for CSR Fund

Total
SCHEDULE - 3 LOAN FUNDS

a) Secured Loans:
From State Bank of India :
Cash Credit Loan
Foreign Currency Buyers Credit (US$ 75.16 lacs &

Euro 16.00 lacs)
Total
Note:I.
Cash Credit Loan is secured against:

(a) Hypothecation of the entire Current Assets of the Company.
(b) Collateral charge over the fixed assets of the company excluding Land & Buildings
(c) Equitable Mortgage as collateral over the land with building at Poojappura
2.
Term Loans are secured against:

(a) First charge over the fixed assets of the company excluding Land & Buildings
(b) Equitable Mortgage over the land at Noida
(c) Equitable Mortgage as collateral over the land with building at Poojappura
3.
Term Loans include ` 298.33 lacs payable within one year from the end of the financial year (previous year
` 320.55 lacs)
4.
Foreign Buyers Credit includes ` 1,530.39 lacs for capital items procurement, which are to be rolled over further for
long term, subject to availability, or else shall be converted into term loan. The remaining portion of buyers credit are
for import of materials for resale
5.
Foreign Currency Buyers Credits are secured by Margin Money Deposit amounting to ` 2,269.08 lacs.
105
(` J )
2010-11
2009-10
+xS - 4 +lMi E ni (x) E{x +vx 1956
{ +E +vx 1961 E |vx E | E Eh
E) +lMi E ni
E (E)
J) +lMi E {{k
(i) .+.B.Mix
(ii) nMv @h EB |vx
(iii) E EB |vx
(iv) ] { E EB |vx
(v) x EB |vx
(vi) +x
E (J)
+lMi E ni - x (E - J)
106
833.49
833.49
730.19
730.19
1.25
256.45
0.00
28.91
47.90
147.61
482.12
351.37
4.15
143.65
19.54
57.75
177.52
402.61
327.58
(` in lacs)
SCHEDULE - 4 DEFERRED TAX LIABILITY (NET) - on account of

effect of Provision of I.T Act 1961 over Companies Act 1956
a)
Depreciation
Total (a)
b)
Deferred Tax Asset
i)
V.R.S Payment
ii) Provision for doubtful debts
iii) Provision for Customs Duty
iv) Provision for overtime arrear
v) Provision for Bonus
vi) Others
Total (b)
Deferred Tax Liability - Net (a - b)
2010-11
2009-10
833.49
833.49
730.19
730.19
1.25
256.45
0.00
28.91
47.90
147.61
482.12
4.15
143.65
19.54
0.00
57.75
177.52
402.61
351.37
327.58
107
108
{h i
{^ {
<i
j x
xS Vbx
] Mb
+i +i
E
{U E +Eb
1
2
3
4
5
6
7
24.62
484.79
3,949.03
17,160.44
618.57
34.42
150.56
22,422.43
16,293.74
1-4-2010 E
(`)
164.23
650.42
57.44
50.33
19.82
942.24
6,417.82
4.86
322.08
24.70
0.01
351.65
289.13
E E
{vx
E]i
24.62
484.79
4,108.40
17,488.78
651.31
84.74
170,38
23,013.02
22,422.43
17.57
1,231.29
8,353.30
410.90
26.19
134.54
10,173.79
9,004.05
31.03.2011 31.03.2010
E
iE
/{vx
EB
{
4.89
182.44
0.14
1,176.12
263.20
58.58
17.28
10.77
0.01
12.48
1,445.28
280.63
1,279.07
109.33
(` J )
x E
W 31.03.2011 31.03.2010
31.03.2010
E
E
iE
24.62
24.62
22.46
462.33
467.22
1,413.59
2,694.81
2,717.74
9,266.22
8,222.56
8,807.14
452.20
199.11
207.67
36.95
47.79
8.23
147.02
23.36
16.02
11,338.44 11,674.58
12,248.64
10,173.79 12,248.64
7,289.69
5. +{x< M< i xx V *
j B x E EU n E v v J |h +{x< M< , V xS Si V *
Mi
2010-11 (` J )
2009-10 (` J )
+CE j
2,147.79
2,777.51
ixi{ j
2,926.66
2,953.49
M j
2,346.96
2,320.97
B + +< x
1,897.08
1,897.08
E
9,318.49
9,949.05
6. E xix
` J
i) EB
1,439.22
ii) {EE
6.05
+xS E +x 1,445.27
7. E{] }] E Mi ix E +v x{iE +v { {vi E M * ` 5,000/- Mi E +x {{k V { i i E M , E
+iH +x {{k i {ri +{x M *
3. ] | ]SM + +xvx lx ( B ] B +<) 99 E +v E B {]] { 430.10 BEc +]i * V , k j,

i E =E +xnx E |iI E Vi *
4. ] Bi <x, +CE, ixi{ E i E {k xi J EB E Mi ` 4,36,375/- <i *
]{{h :
1. {h i E E) E E u x:E +ii 11.44 BEb il 7.14 BEb E ]Ex ` 2/- *
J) Ex]E +tME Ij E b E |nk EB ` 3,75,691/- {h i { E +xi E + *
2. {]] { +]i E xxJi *
E) E E { E {]] E 3 BEb + <i EB 99 E Mi ` 1,30,45,742/- *
J) < 60 EB {]] { +]i Ex E Mi ` 92,40,606/- *
M) x +J +tME E |vE (x<b), =k |n {]] { +]i E E + ` 2,61,93,890/- *
G.
.
+xS - 5 +S {{k
109
Addition
9,004.05
22,422.43
289.13
1,279.07
4.89
182.44
1,176.12
58.58
10.77
12.48
1,445.28
109.33
0.14
263.20
17.28
0.01
280.63
10.173.79
22.46
1,413.59
9,266.22
452.20
36.95
147.02
11,338.44
Depreciation Depreciation
Withdrawn reserve upto
31.3.2011
DEPRECIATlON/AMORTlSATlON
Upto
Depreciation
31.03.2010
for the
Year
4.86
322.08
24.70
0.01
351.65
As on
31.03.2011
24.62
484.79
17.57
4,108.40
1,231.29
17,488.78
8,353.30
651.31
410.90
84.74
26.19
170.38
134.54
23,013.02 10,173.79
Deduction
GROSS BLOCK
FREE HOLD LAND

24.62
LEASE HOLD LAND
484.79
BUILDING
3,949.03 164.23
PLANT & MACHINERY
17,160.44 650.42
FURNITURE & FIXTURE
618.57
57.44
MOTOR VEHICLES
34.42
50.33
INTANGIBLE ASSETS
150.56
19.82
Total
22,422.43 942.24
FIGURES FOR THE
PREVIOUS YEAR
16,293.74 6,417.82
Particulars
As on
1-4-2010
12,248.64
24.62
462.33
2,694.81
8,222.56
199.11
47.79
23.36
11,674.58
As on
31.03.2011
7,289.69
24.62
467.22
2,717.74
8,807.14
207.67
8.23
16.02
12,248.64
As on
31.03.2010
NET BLOCK
(` in lacs)
Straight line method has been adopted in respect of certain items of Plant & Machinery as indicated below.
Original Cost
2010-11
2009-10
` in lacs
` in lacs
Akkulam Plant
2,147.79
2,777.51
Thiruvananthapuram Plant
2,926.66
2,953.49
Belgaum Plant
2,346.96
2,320.97
MRI Machine
1,897.08
1,897.08
Total
9,318.49
9,949.05
` in lacs
6.
Allocation of depreciation :
i) For the year
1,439.22
ii) Prior Period
6.05
Depreciation as per Schedule
1,445.27
7.
Cost of computer software is amortized equally over a period of three years on pro-rata basis. Written down value method of depreciation has been adopted on all the
remaining assets other than assets costing less than ` 5,000 each which have been fully depreciated
Note:
1.
Cost of Free hold land includes a) ` 2/- being the token value of 11.44 acres and 7.14 acres of land transferred by the Govt. of Kerala free of cost
b) ` 3,75,691/- being the tentative price of freehold land paid to Karnataka Industrial Area Development Board.
2.
Cost of Lease hold land includes the following
a) `1,30,45,742/- being the cost of 3 acres of leasehold land and building at Balaramapuram, Kerala for 99 years
b) `92,40,606/- being the allotment of 0.25 acres of plot in Mumbai on lease for 60 years.
c) `2,61,93,890/- being the value of 1.24 acres of leasehold land allotted in the New Okhla Industrial Development Authority (NOIDA), Uttar Pradesh for 90 years.
3.
430.10 acres of land is allotted on lease for a period of 99 years from Central LeprosyTeaching and Research Institute (CLTRI), Tamilnadu. However approval from the
Ministry of Finance, Government of India on the same is awaited.
4.
Building includes cost of open well amounting to ` 4,36,375/- constructed in the landed property owned by Centre for Earth Sciences, Akkulam, Trivandrum.
5.
Methods of depreciation adopted are as follows.
1.
2.
3.
4.
5.
6.
7.
Sl
No.
Schedule 5 : Fixed Assets
(` J )
2010-11
2009-10
+xS - 6 S {V E
S Ex EB +xhvx {b {{k
S E
{ SV
x< {Vx+ { +EE
E
+xS - 7 x
nPEE :
<|M +{i |<] ]b {h { |nk ` 10/- |i
E Bx <x]CS ]b {h { |nk ` 10/- |i
E 20,000 x * (Mi {) - +xri
E
110
735.07
735.00
37.85
73.25
1,581.17
196.48
27.74
6.20
0.00
230.42
783.42
783.42
2.00
785.42
2.00
785.42
(` in lacs)
2010-11
2009-10
Assets Pending Commissioning
735.07
196.48
Civil work in-progress
735.00
27.74
Consultancy Charges
37.85
6.20
Incidental Expenses on New Projects
73.25
0.00
1,581.17
230.41
783.42
783.42
2.00
2.00
785.42
785.42
SCHEDULE-6 CAPITAL WORK-IN-PROGRESS
Total
SCHEDULE-7 INVESTMENTS
Long Term :
78,34,188 Equity Shares of `10/- each fully paid up in Life Spring
Hospital Pvt.Ltd. (At Cost) - unquoted
20,000 Equity Shares of ` 10/- each fully paid in Kerala Enviro
Infrastructures Ltd (At Cost) - unquoted
Total
111
(` J )
2010-11
2009-10
+xS - 8 iS
ESS (Mi {)
{EM O (Mi {)
x b B ={V (Mi {)
+x O, x {V, <i x +n (Mi {)
|v u {xEi + |hi +V
n E l ESS (Mi {)
E
i :
(xxi Mi { x v )
xi =i{n
VE {hx =i{n
=i{n
i (G EB M )
J
(E + J)
q/+v {{k (E Ji x v {)
|GMi E (Mi {)
xIh EB {b x (Mi {)
={ n (Mi {)
Jx O (Mi {)
xx :
+|H ]E E |E |vx
Vb : E nx |vx
xx :^ Ji b MB/{xEi
+|H ]E E +i |vx
112
(` J )
67.65
28.46
47.86
48.25
1,277.28
957.71
568.19
34.75
0.57
23.24
2,861.74
902.21
1,011.66
535.87
40.90
0.67
14.59
2,505.90
1,373.24
196.06
374.72
281.72
2,225.74
5,087.48
22.93
480.61
89.65
79.42
27.47
5,787.56
1,512.88
337.19
418.91
18.70
2,287.68
4,793.58
15.71
426.53
115.24
2.40
26.19
5,379.64
48.25
5,739.31
67.65
5,312.00
(` in lacs)
2010-11
2009-10
1,277.28
902.21
Packing Materials (at cost)
957.71
1,011.66
General Stores and Consumables (at cost)
568.19
535.87
34.75
40.90
SCHEDULE - 8 INVENTORIES
Raw Materials (at cost)
Other materials, machinery, Spare parts, building

materials etc (at cost)
Tools revalued & certified by management
0.57
0.67
23.24
14.59
2,861.74
2,505.90
1,373.24
1,512.88
Social Marketing Products
196.06
337.19
Trading Products
374.72
418.91
Finished Goods (in transit for sale)
281.72
18.70
2,225.74
2,287.68
(A + B)
5,087.48
4,793.58
22.93
15.71
Raw Materials with others (at cost)

A
Finished goods:
(Lower of cost or Net Realisable Value)
Manufactured Products
Scrapped/Surplus Assets (at lesser of cost or net realisable value)

Work-in-process (at cost)
480.61
426.53
Goods pending inspection (at cost)
89.65
115.24
Gift items (at cost)
79.42
2.40
Stationery (at cost)
27.47
26.19
5,787.56
5,379.65
48.25
67.65
5,739.31
5,312.00
Less:
(` in lacs)
Opening Provision for Obselete Stock
67.65
Add : Provision during the year
28.46
Less: Written Off /written back
47.86
Closing Provision for Obselete Stock
48.25
113
(` J )
2010-11
2009-10
+xS - 9 v nxn
(E) U: x +vE +v EB E
v Z MB
|ii
+|ii
(J) nMv Z M
|E |vx
Vb : E nx |vx
xx: {xEi/^ Ji b MB
|vx
(M) +x @h - v Z MB
|ii
+|ii
E
+xS - 10 Eb il E
Ec, ]{ + SE
E :
+xSi E :
E) S Ji
J) < < B Ji ( B b 0.91 J)
M) v V
P) v V Vx (OhvE E +vx)
E
+xS - 11 +x S {{k
{Vx+ |{
j |{i È E
|ni V
{M {
V {
xi |ix/{ E
E
114
` J
27.18
3,806.64
` J
772.02
422.63
377.87
28.48
772.02
` J
184.86
15,795.83
3,833.82
4,219.94
15,980.69
19,814.51
7,556.81
11,776.75
65.59
27.13
1,005.95
40.14
414.18
3,567.09
5,092.95
472.74
70.94
378.31
3,508.11
4,457.23
294.61
3,540.43
958.10
118.31
3.20
96.01
380.35
4,314.60
3.21
116.30
241.36
1,437.28
(` in lacs)
2010-11
2009-10
3,833.82
4,219.94
15,980.69
7,556.81
19,814.51
11,776.75
SCHEDULE - 9 SUNDRY DEBTORS

a) Outstanding for period exceeding six months
considered good
Secured
Unsecured
` in lacs
27.18
3,806.64
` in lacs
b) Considered doubtful
772.02
Provision - Opening
422.63
Add: Provision during the year
377.87
Less:Written back /written off
28.48
Balance Provision
c) Other debts - Considered Good
Secured
Unsecured
Total
772.02
` in lacs
184.86
15,795.83
SCHEDULE -10 CASH AND BANK BALANCES

Cash,Stamps and Cheque in hand
65.59
27.13
1,005.95
472.74
Bank balances:
With Scheduled Banks in:
a)
Current Account
b)
E.E.F.C. Account (USD 0.91 lacs)
c)
Fixed Deposit
d)
Fixed Deposit Margin Money (under lien)
40.14
70.94
414.18
378.31
3,567.09
3,508.11
5,092.95
4,457.23
294.61
958.10
3,540.43
118.31
On Advances
3.20
3.21
On Deposits
96.01
116.30
380.35
241.36
4,314.60
1,437.28
Total
SCHEDULE -11 OTHER CURRENT ASSETS
Receivable from Projects
Contract fee receivable from Clients/Customers
Interest accrued
Export Incentives/Duty draw back

Total
115
(` J )
2010-11
2009-10
+xS - 12 @h + +O
xEn i { v +l |{i EB Vx
E) |ii + v Z MB
986.95
162.00
208.54
162.48
0.21
2,364.24
3.06
1,753.51
418.65
271.84
194.65
4,445.08
410.22
243.07
251.28
2,985.62
(` x ({U x) V E{x E +vE

u n + E nx E +vEi E ` x)
J) +|ii + v Z MB
(I) ES E {M ` 26.81 J ({U
` 31.25 J) V E{x E +vE u
n + E nx E +vEi E ` 308.81 J
` J
nMv Z M
|E |vx
Vb : E nx |vx
xx : ]] Ji b M/{xEi
|vx
(II) xnE ( E nx E +vEi
E ` 0.84 J)
M) +|ii nMv Z MB + +x +O
nMv Z M
|E |vx
Vb : E nx |vx
xx : ^ Ji b M/{xEi
|vx
+E {M
V
{ |nk
E
116
3.58
2.82
1.08
0.32
3.58
` J
392.589
419.51
1.39
28.32
392.58
(` in lacs)
2010-11
2009-10
986.95
162.00
208.54
162.48
0.21
3.06
2,364.24
1,753.51
Advance Income Tax
418.65
410.22
Deposits
271.84
243.07
Pre-paid Expenses
194.65
251.28
4,445.08
2,985.62
SCHEDULE-12 LOANS & ADVANCES

Recoverable in cash or in kind or for value to be received
Secured and considered good (Includes ` NiI (previous year
a)
` Nil) due by officers of the company and maximum balance

outstanding at any time during the year ` Nil)
b) Unsecured and considered good:
I)
Advance to staff includes ` 26.81 lacs

(previous year ` 31.25 lacs) due by officers of the company
and maximum balance outstanding at any time during the year
` 308.81 lacs
` in.lacs
II)
Considered doubtful
3.58
Opening Provision:
2.82
1.08
Less : Written back/off
0.32
Balance Provision
3.58
Directors (Maximum amount outstanding at any time

during the year ` 0.84 lacs)
c) Other advances unsecured considered good
` in.lacs
Considered doubtful
392.58
Provision - Opening
419.51

Less: Written off I back
Balance provision
Total
1.39
28.32
392.58
117
(` J )
2010-11
2009-10
+xS - 13 S niB
O, + + E v xn
I, P + v =t
+x
+x niB
v V
={Si V Ei +n
E{] E Eh +|{ E B |vx
n ={nx |
n O{ < B |
j +O
iE & B B il +x +O
E
1,813.02
6,528.73
5,650.66
0.10
18.78
3.06
679.69
119.97
5,479.20
252.60
20.545.81
554.96
5.542.16
8,147.21
0.10
16.06
3.06
231.46
153.87
412.00
309.32
15,370.20
+xS - 14 |vx
+i / |ii
E EB |vx
Evx EB |vx
B ] EB |vx
x/x{nx r Mix EB |vx
E
233.03
38.71
198.95
1.00
422.96
894.65
233.03
39.60
110.48
1.00
355.49
739.60
42,569.33
5,400.98
2,048.26
622.16
220.26
830.97
51,691.96
41,663.19
113.64
1,559.64
213.32
211.95
416.17
44,177.90
+xS - 15 G B B
E G
È +
{ +
]]M + +
{ =i{n <nn
Mi r n
E
118
(` in lacs)
2010-11
2009-10
- Micro, Small and Medium Enterprises
1,813.02
554.96
- Others
6,528.73
5,542.16
Other liabilities
5,650.66
8,147.21
0.10
0.10
18.78
16.06
3.06
3.06
Gratuity Premium Payable
679.69
231.46
Group EL Premium Payable
119.97
153.87
5.479.20
412.00
252.60
309.32
20,545.81
15,370.20
233.03
233.03
38.71
39.60
198.65
110.48
1.00
1.00
Provision for Bonus/Performance ralated payments
422.96
355.49
Total
894.65
739.60
42,569.33
41,663.19
Income from contracts
5,400.98
113.64
Income from consultany services
2,048.26
1,559.64
Income from testing services
622.16
213.31
Product subsidy on Saheli
220.26
211.95
Cost Escalation Benefits
830.97
416.17
51,691.96
44,177.90
SCHEDULE -13 CURRENT LIABILITIES

Sundry creditors for materials services and expenses
Fixed deposit
Interest accrued but not due
Provision for Amount non-recoverable due to fraud
Advance from Customers/Clients

Advance from distributors C&FA & others
Total
SCHEDULE -14 PROVISIONS
Interim Dividend I Proposed Dividend
Provision for Dividend Tax
Provision for Taxation
Provision for FBT
SCHEDULE 15 SALES & SERVICES

Gross Sales
Total
119
(` J )
2010-11
2009-10
+xS - 16 +x +
V |{i :
E) +{EE V {
J) +x {
ES + E
{k/q {k E G {
VE {hx { |ix
+ xC G { <nn
|n EB }i xx E Mi
E U]/E {/+x xi |ix
x =i - Sg
v |{i:
E) q Ehb/v n E G
J) xn E G
M) J {{/q +n E G
P) n
b.) {xEi EB +vE |vx/@h
S) {^ E
U) +x v +
E
+xS - 17 J{ +
ESS
EE + x b
{EM O
E
120
122.26
6.90
3.42
3.38
64.11
351.48
599.79
399.19
0.00
195.94
1.94
1.83
1.53
59.16
291.67
327.17
228.71
499.85
106.01
40.87
184.84
4.60
134.64
38.40
495.63
2,555.52
71.51
42.47
170.53
5.65
141.01
0.83
501.94
2,541.74
7,707.05
1,655.88
4,420.64
13,783.57
4,777.43
2,329.07
4,035.78
11,142.28
(` in lacs)
2010-11
2009-10
122.26
195.94
b) On others
6.90
1.94
Rent from Staff quarters
3.42
1.83
SCHEDULE - 16 OTHER INCOME

Interest receipt:
a) On short-term deposit
Profit on sale of assets/scrapped assets
3.38
1.53
64.11
59.16
Subsidy on Saheli and Novex sales
351.48
291.67
Cost of free sample supplied
599.79
327.17
Duty Rebate / Duty drawback/Other Export incentives
399.19
228.71
499.85
106.01
71.51
40.87
42.47
184.84
170.53
Incentive on Social Marketing
Exchange Fluctuation
Miscellaneous receipt
a) Sale of waste condoms/Misc.Items
b) Sale of tender forms
c) Sale of empty drums/scrap etc.
d) Insurance claims
4.60
5.65
134.64
141.01
38.40
0.83
495.63
501.94
2,555.52
2,541.74
Raw Materials
7,707.05
4,777.43
Chemicals and General Stores
1,655.88
2,329.07
Packing Materials
4,420.64
4,035.78
13,783.57
11,142.28
e) Excess provision/credits written back

f) Lease Rent
g) Other misc. income
Total
SCHEDULE -17 MATERIALS CONSUMED
Total
121
(` J )
2010-11
2009-10
+xS - 18
i E ]E B |GMi ]E r
+E ]E
i (Ml )
S E
E
2,287.68
426.53
2,714.21
3,008.77
429.23
3,438.00
J
E-J
2,225.74
480.61
2,706,35
7.86
2,287.68
426.53
2,714.21
723.79
+xS - 19 ES E ix + i
ix, k + x
xv +nx
ES Eh
+Vi U^ xv
ES V +nx
={nx
|{ ix {xIh
E
7,651.34
691.96
703.59
156.18
1.46
736.77
0.00
9,941.30
6,781.22
649.01
759.76
137.74
2.,54
315.17
519.63
9,165,07
+xS - 20 +x =i{nx
i il +xIh :
E) <i
J) x
+V E ={M
È E E ix
+x
=i{n E
E
127.85
286.49
69.17
808.53
880.44
12.45
2,184.93
226.77
269.38
67.29
648.94
391.94
14.45
1,618.76
+i ]E
i (Ml )
S E
E
122
(` in lacs)
2010-11
2009-10
2,287.68
3,008.77
426.53
429.23
2,714.21
3,438.00
2,225.74
2,287.68
SCHEDULE - 18
Increase in stock of finished goods and Stock-in-Process
Opening Stock
Finished Goods (including Goods in transit)
Work-in-Progress
A
Closing Stock
Finished goods (including Goods-in-transit)
Work-in-Progress
Total
480.61
426.53
2,706.35
2,714.21
A-B
7.86
723.79
SCHEDULE -19 EMPLOYEES' SALARIES & BENEFITS

Salaries, Allowances and Bonus
7,651.34
6,781.22
Contribution to P.F
691.96
649.01
Staff Welfare Expenses
703.59
759.76
Earned Leave Fund
156.18
137.74
Contribution to E.S.I
1.46
2.54
736.77
315.17
Gratuity
Pay revision arrears
0.00
519.63
9,941.30
9,165.07
I) Buildings
127.85
226.77
2) Machinery
286.49
269.38
69.17
67.29
Wages to Contract Labourers
808.53
648.94
Other expenses
880.44
391.94
12.45
14.45
2,184.93
1,618.76
Total
SCHEDULE - 20 OTHER PRODUCTION EXPENSES
Repairs & Maintenance of:
Consumption of tools
Excise duty
Total
123
(` J )
2010-11
2009-10
+xS - 21 |xE
E
152.07
226.31
58.25
27.84
ph il Jx O
145.36
127.85
bE, i il n
227.63
191.57
10.48
8.27
J{I E { E
1.10
0.28
Evx
0.00
0.07
J{I
3.34
5.49
12.96
16.76
1,196.27
1,047.67
182.94
114.28
|Ih EG
38.64
23.11
x-=i-Sg (x)
81.31
0.00
0.00
13.75
30.89
77.14
17.13
380.35
0.00
3.20
693.18
3.06
47.57
1.10
22.80
23.04
0.00
8.74
28.46
125.69
143.07
33.45
76.13
654.33
488.37
0.03
34.08
63.89
131.49
132.92
31.58
83.97
480.10
436.38
0.51
37.20
4,193.80
4,009.65
+xS - 22 {hx
Y{x B |S
c + +x G
}i xx ih
E
2,760.51
1,878.46
599.78
5,238.75
2,484.73
1,851.15
327.17
4,663.05
={E E
vE J{IE E v J {IE E {E
J {I E
+iE J{I E
j il {x
+xvx B E
+Mx B x] E JS E B |vx
^ Ji b MB +v EV
xMi VE ni JS
+v + nMv EV/+O EB |vx
E{] E Eh B x M JS E B |vx
^ Ji b MB +|Si {{k/b E
Ml x]
+S {{k E G/nn {{k { x
+|Si ]E/q {{k E B |vx
E SV
+x {{k E i il +xIh
<i E i il +xIh
ES E i
{ il E
v
nx
]
124
(` in lacs)
2010-11
2009-10
152.07
226.31
58.25
27.84
SCHEDULE - 21 ADMINISTRATIVE EXPENSES

Rent
Rates & Taxes
Printing and Stationery
145.36
127.85
Postage, Telegram & Telephone
227.63
191.57
10.48
8.27
Tax Audit fees
1.10
0.28
Taxation Matters
0.00
0.07
Audit expenses
3.34
5.49
12.96
16.76
1,196.27
1,047.67
182.94
114.28
Training program expenses
38.64
23.11
Exchange Fluctuation
81.31
0.00
0.00
13.75
Bad debt written off
30.89
77.14
Corporate Social Responsibility expenses
17.13
3.20
380.35
693.18
0.00
3.06
47.57
23.04
1.10
0.00
22.80
8.74
Auditors remuneration in respect of Statutory Auditors

Audit fee
Internal Audit fee

Travelling & Conveyance
Research & Development Expenses
Provison for expenses due to loss on fire
Provision for bad & doubtful debts/Advances

Provision for non recoverable expenses due to fraud
Book value of obsolete assets/stores written off
Goods lost in transit
Loss on sale of Fixed Assets/scrapped assets
Provision for Obsolete Inventories/scrapped assets
28.46
63.89
Bank Charges
125.69
131.49
Repairs & maintenance of other assets
143.07
132.92
Repairs & maintenance of buildings
33.45
31.58
Staff recruitment expenses
76.13
83.97
Consultancy & Service Charges
654.33
480.10
Miscellaneous Expenses
488.37
436.38
0.03
0.51
34.08
37.20
4,193.80
4,009.65
Advertisement & Publicity
2,760.51
2,484.73
Freight & Other Selling Expenses
1,878.46
1,851.15
Donation
Royalty
Total
SCHEDULE - 22 MARKETING EXPENSES
Free sample distribution

Total
599.78
327.17
5238.75
4,663.05
125
(` J )
2010-11
2009-10
+xS - 23 k SV
V :
xEn =v @h
+vE @h
+x
E
+xS - 24
{ EB Jn MB i E Ei
{ =i{n
VE {hx bb =i{n
E
+xS - 25 {EE Vx
{EE :
ES E ix B Wn
|xE
{ SV
SV
v
Y{x, |S B G |zx
SV
b
(E) E
xx : {EE +
+x +
={H O
SV
i il +xIh
Mi r n
(J) E
x ()/+ (J - E)
126
230.54
77.01
216.82
524.37
621.14
64.76
70.15
756.05
5,638.03
2,454.70
8,092.73
7,674.25
1,017.11
8,691.36
0.09
5.93
0.00
6.06
0.00
0.00
0.33
3.23
15.64
5.38
7.72
1.16
0.00
1.35
11.94
0.00
0.70
28.25
33.47
2.09
0.00
2.68
0.00
0.00
38.24
22.60
12.79
7.64
0.48
0.00
4.93
33.50
59.34
31.09
(` in lacs)
2010-11
2009-10
230.54
621.14
SCHEDULE - 23 FINANCE CHARGES

Interest on:
Cash Credit Loan
Term Loan
77.01
64.76
Others
216.82
70.15
Total
524.37
756.05
Trading Products
5,638.03
7,674.25
Social Marketing Branded Products
2,454.70
1,017.11
Total
8,092.73
8,691.36
SCHEDULE - 24 VALUE OF FINISHED GOODS PURCHASES TRADING
SCHEDULE - 25 PRIOR PERIOD ADJUSTMENT

Prior Period Expenses:
Employees Salaries & Wages
0.09
5.38
Administrative Expenses
5.93
7.72
Consultancy charges
0.00
1.16
Depreciation
6.06
0.00
Misc expenses
0.00
1.35
Advertisement, Publicity & Sales Promotion expenses
0.00
11.94
Insurance Charges
0.33
0.00
Freight
3.23
0.70
15.64
28.25
33.47
12.79
Materials consumed
2.09
7.64
Depreciation
0.00
0.48
Rates & Taxes
2.68
0.00
Repairs & Maintenance
0.00
4.93
(A) TOTAL
Less: Prior Period Income
Other Income
Cost escalation claim
0.00
33.50
(B) TOTAL
38.24
59.34
Net (Expense)/Income (B-A)
22.60
31.09
127
+xS - 26
31 S, 2011 iE E k h E ]{{h
1. lE J xi
i) {{Mi Jv
k h {{Mi Mi v E +vx |nx +v { + E{x +vx 1956 E v 211 (3M) =Ji

J xE E +x i EB Vi *
ii) +S {{k
+S {{k {{Mi Mi { Si E EE n M< * Mi x] Gb] E x V E M ,
|ME * x< {VxB/xB E {Sxx EB JS B V S {V E E { x Vi
* | Ex E |l {Vx Mi +i E VBM * n x< {Vx/xB 3 k
E +v Exi x EB MB i i V |i EM*
{^ E {^ +v { {vi E M *
+S {{k E Mi =v { V (i +i n { {Ei) + +S {{k E +vOh EB {
+{ |xE *
x +i 1 (XV) V, S Ex E B {VEi EB Vi *
iii) x
n E< +l E + E E |vx i = E Ex E |vx nE x Mi { |E] EB Vi *
iv) ]E E Ex
ESS , hb B +iH {V E Ex EB +ix E <i E Vi * S E, Gh
li/xIhvx O E Mi { nJ Vi * +|H f +V E =xE ={M EE { vx
JE {xEx EB Vi + {xEi Mi { Vi * xi i /{ EB Jn M E
Ex, V E M =i{n E i xxi Mi x |{ E +v { E M * ]E xi/
G i VE < 30 Vx iE {i i , E x { B Vi *
v)
+xvx B E
+xvx B E { {V E +S {{k E x = iE x Vi * +xvx B E { V
<E JS B { |i EB MB *
vi) xk n
E) ={nx
={nx ni Vx xM E O{ ={nx xEn Sx Vx E +x i Vx xM u |vx EB
Ei Ex E +v { |Ei E Vi il Vx xM u =`B M E +x xvE E Vi *
xv |E]x/{xx
31.3.11 iE
31.3.10 iE
^ n
8.00%
8.00%
ix r
5.00%
5.00%
xv (` J )
2,447.22
2,272.74
x v
|I{i x] =v v
|I{i x] =v v
+h n
+ E +v { 1%
+ E +v { 1%
3% iE
3% iE
Ei (` J )
{iE x |vx (` J )
iE ={Vi V (` J )
={nx EB >{ (` J )
O{ ={nx xi E +vx |i
ES E Ei (` J )
128
3,111,61
679.69
211.71
10.00
2,514.24
401.29
180.80
10.00
10.00
10.00
SCHEDULE - 26
NOTES TO THE FINANCIAL STATEMENT AS AT 31ST MARCH 2011
1.
SIGNIFICANT ACCOUNTING POLICIES
i)
Accounting convention
The financial statements are prepared under historical cost convention on accrual basis and in accordance
with the accounting standards referred to in Sec 211(3c) of the Companies Act, 1956.
ii)
Fixed Assets
Fixed Assets are stated at historical cost less accumulated depreciation. Cost includes all incidental
expenditure net of CENVAT credit wherever applicable. Revenue expenses incurred for identification of new
projects/new line of businesses are treated as capital work in progress. This will be absorbed into the
project cost in the first year of commencing the business. If the new project/new line of business do not
materialize within a period of three financial years, the entire expenses shall be charged to Revenue in the
3rd year. Leasehold land value has been amortized over the lease period. The cost of fixed assets includes
interest on borrowings (calculated at the weighted average rates) and administrative expenses specifically
attributable to the acquisition of fixed assets.
Exchange differences are capitalized to the extent dealt with in 1 (xv) below.
iii) Investments
Investments are stated at cost less provision for diminution other than temporary, if any.
iv) Valuation of Inventories
The weighted average formula is used for the valuation of raw materials, stores and spares. Work-in progress,
materials in transit/under inspection are carried at cost. Unused Loose Tools are revalued every year takinginto account the useful life of the tools and carried at the revalued cost. Finished goods manufactured/goods
purchased for trading are valued at lower of cost/net realizable value, including excise duty, wherever
applicable. Manufactured / traded finished goods in stock whose shelf life expires upto 30th June are taken
at NIL value.
v)
Research and Development
Capital expenditure on Research and Development is treated in the same manner as Fixed Assets. The
revenue expenditure on Research and Development is charged off in the year in which it is incurred.
vi) Retirement Benefits
a) Gratuity
Gratuity Liability is estimated based on the actuarial valuation provided by LIC of India at the end of the year
as per LICs Group Gratuity Cash Accumulation Scheme and is funded as per the demand raised by LIC.
The Fund disclosures / Assumptions
As on 31.03.11
As on 31.03.10
Discount Rate
8.00%
8.00%
Salary Escalation
5.00%
5.00%
2,447.22
2,272.74
Fund value (` in lacs)

Valuation Method
Projected Unit Credit Method
Withdrawal rate
1 % to 3% depending on age
Acturial value (` In lacs)
3,111.61
2,514.24
Provision made in the books (` in lacs)
679.69
401.29
Interest earned actual (` in lacs)
211.71
180.80
Upper limit for Gratuity (` in lacs)
10.00
10.00
Sum insured per employee under

Group Gratuity Policy (` in lacs)
10.00
10.00
129
J) U]] +{h
U]] xx vi xk n i Vx xM E BE Vx u xvE E Vi * Vx xM u
n E M< E M V E + |i E M< *
xv |E]x/{xx
31.3.11 iE
31.3.10 iE
^ n
8.00%
8.00%
ix r
5.00%
5.00%
739.29
541.08
xv (` J )
x {ri
|I{i x] =v v
|I{i x] =v v
+h n
+ E +v { 1% iE 3%
+ E +v { 1% iE 3%
858.47
685.81
Ei (` J )
119.97
153.87
{iE x |vx (` J )
57.45
45.32
ii ={Vi V (` J )
+Vi U^ EB >{
300 nx
300 nx
M) SUE xk Vx
+ B E +vx +nM E Eh { niB = E -x J E + |i EB MB *
P) WMk SEi
E{x E {V 01.07.2005 iE ES (=E/=E {i {ix i)-E xx <xx E{x ]b
E O{ SEi Vx E +vx i E M *
vii) x/x{nx vi Mix
+vE z ES E B x E |vx, xi |{i P E l |]i nPEx Zi E
+x =i{nEi v |ix Vx E +v { x M * b i + b i E xS i E E{E,
VxE =t M u V Mxn E +x x{nx vi x ({ + {) i *
viii) V xi
G G E + ]] E UcE E i E G E (x {) ] * n |{i E
+v { {Ei EB Vi * x { V, xi E + V E xi n { vx JE +x{i E +v
{ E E Vi * xnxE + V |nx +v { |nx E Vi * +Sx E |M + |{h
{ |M vi EE{ V xx V |nx E Vi ;
E) ni{h È E , È E M |Mi E +x{i E { *
J) +x È E , vi +Eh E l È E i E +x ni { Ex E +v { *
ix) { |nk JS
|i ` 2000/- il = E E n vi { |nk JS V E + |i EB MB *
x)
+S {{k
+tv vi E{x +vx, 1956 E +xS XIV xvi n E +x li E M *
01.04.1993 +S {{k |i ` 5,000/- = E Mi E {vx E {vx E iJ E vx J x
{hi E Vi * +S {{k {vx/E]i { E x{iE +v { nB Vi *
+v {i/q il x{]x EB {b +S {{k E xxi /x M { xi + ""q/
+v {{k'' E +vx {k S MEi EB Vi *
130
b)
Leave Encashment
The retirement benefit relating to leave encashment is funded through a scheme of the LlC of lndia. The
annual demand raised by LlC is charged to the revenue.
The Fund disclosures / Assumptions
As on 31.03.11
As on 31.03.10
Discount Rate
8.00%
8.00%
Salary Escalation
5.00%
5.00%
Fund value (` in lacs)
739.29
541.08
Valuation Method
Withdrawal rate
Acturial value (` in lacs)
858.47
685.81
Provision made in the books (` in lacs)
119.17
153.87
57.45
45.32
300 days
300 days
Interest earned actual (` in lacs)

Upper limit for Earned Leave
c) Voluntary Retirement Benefits

The entire liability on account of payments under VRS are charged off to the Profit and Loss Account in the
same year.
d) Post Employment Medical Benefits
The Employees (including his/her spouse) on the rolls of the Company as on 01.07.2005 is covered under
Group Medical Insurance Scheme of M/s National Insurance Company Ltd.
vii) Bonus/Performance Related Payment
Provision for bonus for employees other than officers is made on the basis of Productivity Linked Incentive
Scheme as per the Long Term Agreement entered into with the recognized trade unions. Executives at the
Board level and below the Board level are covered for Performance Related Bonus (PRP) as per the
guidelines issued by the Department of Public Enterprise.
viii) Revenue Recognition
Sales comprise of value of sale of goods (net of returns) excluding sales tax and discounts but including
excise duty. Insurance claims are accounted on receipt basis. Interest on investments is booked on a time
proportion basis taking into account the amounts invested and the fixed rate of interest. Revenue from
Diagnostics services is recognized on accural basis. Revenue from Infrastructure Development Division
and Procurement Consultancy Division related activities are recognized as follows :
a) In case of turn key contracts, as a proportion of the progress billing to the contract value
b) In the case of other contracts, on the basis of completion of obligation as per the terms of contract with the
agencies concerned.
ix) Prepaid Expenses
Prepaid expenses of items of ` 2000/- each and below are charged off to the revenue.
(x) Depreciation
Fixed Assets
Depreciation has been provided as per the rates prescribed under Schedule XIV of the Companies Act, 1956
as amended upto date. Additions to Fixed Assets from 01.04.1993 costing ` 5,000/- each or less are fully
depreciated irrespective of date of addition. The depreciation on additions to/ deductions from fixed assets
are provided on monthly pro-rata basis.
Fixed Assets retired/scrapped and pending disposal are stated at lower of book value/net realisable value
and grouped under inventories under the head Scraped / Surplus Asset .
131
x {V
{ri
E) ={Eh E l +Vi x {V E x EB ={H n |h E |M EE EB
Vi *
J) E |M EB +M { |{h EB x {V E vi x E {i +v E Si
E i n +Vx = E E l SV EB Vi *
xi) +i {{k
1.4.2003 JS B E{] }] E Mi + < E E +i {{k E { MEi EB Vi * E{]
}] E Mi |i +x{iE +v { 3 E +v x { {vi EB Vi * +n EB < E
E +v { i { {vi E Vi *
xii) {EE /+
|iE ` 5000/- +vE +x {EE + + {E E +vx {Ei E Vi *
xiii) v +
q ]C, +Ei O il Ehb E E + V Ec +v { {Ei EB Vi *
xi G vi E {/xi |ix, xi E {Ei EB Vi *
+|Si {{k/]] Ji b M O E , Ec +v { {Ei E Vi *
VE xvi V v nxn i EB n E< V + i =E {Sx x E *
xiv) n p x-nx
n n u i n x E +iH x-nx E x-nx E iJ { |Si x n {Ei EB
Vi * n È u i E UcE +x n p +Vx/n i E x n { n nB Vi * < n
x x] -x J Vi EB Vi * n p @h, i x n { Ei EB Vi
*
xv) nvEx n p pE n E +ih l{x { x +i (+li, VE l{x E +v =E
| E iJ x +vE ), V {U k h { Eb EB MB {] EB +M , V
iE E nxE 31.3.2009 E i E E +vSx E +x {{k E Mi E B Vi EB MB
Ex M {{k vi + {{k E E {vi E VBM*
xvi) x hb/+iH {V/ESS /i =i{n
v Sx n E O/i =i{n E v n E< xEx E |vx B =i{n E ={Mi/Gi E v
iExE |{i Ex E n {Ei EB Vi *
xvii) E +xnx
E) x <nn E { +xnx E +M +Ii V EB Vi *
J) G vi V +xnx/<nn (=i{n <nn z) +x + E +vx +M { |E] EB
Vi V E =i{n <nn, G + + E +vx |E] EB Vi *
xviii) Jhb {]M
E{x x {] Ex M Jb V {Vx n E , J xE 17 E +x <E Jhb {]M EB MxvE =i{n,
l I =i{n, { =i{n, B B È E { {Sx E * <E +, xxJi xn] J xi, Jb
{]M EB {x E Vi :
(i) Jb V +xi Jb V i Jb EB v +Y/xV G B +x + *
(ii) Jb {h xSi Ex E B v +Y/xV JS Jhb { S EB Vi * {h { E{x
vi JS + Jb E +xV JS E ""+xvx '' E +vx EB Vi *
(iii) E{x E {h { vi Jhb EB +xV + E + ""+xvx +'' E +vx EB Vi *
(iv) Jhb {{k + ni+ vi Jhb E l v +Y * +xvx E{x {{k B
niB E{x E {h { xvi {k + ni+ E |ixvi Ei + E Jb EB xV
x *
132
Machinery Spares
Method of depreciation
a) Machinery spares acquired with the equipment are depreciated using the same rates and method
applicable for the original machinery.
b) In the case of Machinery spares procured separately for future use, rate equivalent to accumulated
depreciation for the expired life of the relative machinery are charged in the year of acquisition along
with the depreciation for the year.
(xi) Intangible Assets
Cost of computer software and License fee incurred from 1.4.2003 are classified as intangible assets. The
cost of computer software is amortised equally over a period of 3 years on pro-rata basis. License fee paid
is amortized equally over the agreement period.
(xii) Prior Period Expenses/Income
Income and expenditure relating to prior period exceeding ` 5000/- in each case only is accounted under
prior period.
xiii) Miscellaneous Income
The revenue against realisation of waste latex, rejected materials and condoms are accounted on cash
basis.
Duty drawback/export incentive in respect of export sales are accounted in the year of export.
The realisation in respect of obsolete assets/materials written off are accounted on cash basis.
Interest income if any for delayed realisation from sundry debtors as stipulated in invoices is not recognised.
xiv) Foreign Currency Transactions
Transactions in foreign exchange other than those covered by forward contracts are accounted for at the
exchange rates prevailing on the date of transactions. Foreign currency receivables/payables other than
those covered by forward contracts are translated at the year end exchange rates. Gain or losses arising out
of such transaction are adjusted to the Profit & Loss Account. Foreign currency loans are valued at year end
exchange rates.
xv) Exchange differences on translation or settlement of long term foreign currency monetary items (ie.
whose term of settlement exceeds twelve months from the date of its origination) at rates different from those
at which they were initially recorded or reported in the previous financial statements, in so far as it relates to
acquisition of depreciable assets are adjusted to the cost of the assets as per Government of India notification
dated 31.03.2009 and will be amortized over the remaining life of the Asset.
xvi) General Stores/Spares Raw Materials/ Finished Products
The provision for loss if any in respect of slow moving items of materials/finished products are accounted
after obtaining the technical opinion regarding the usability/marketability.
xvii) Government Grants
a) Grants in the form of investment subsidy are credited to separate reserve.
b) Revenue grants/subsidy (other than product subsidy) relating to sales are disclosed separately
under other income, whereas product subsidy are disclosed under sales & services.
xviii) Segment Reporting
The Company has identified its reportable segments for Segment Reporting, in accordance with Accounting
Standard 17, as Contraceptive Products, Health Care Products, Trading Products, Services and Contracts
which are the primary groups. In addition, the following specific accounting policies have been followed for
segment reporting:
(i) Segment revenue includes sales and other income directly identifiable with/allocable to the
segment, including inter segment revenue.
(ii) Expenses that are directly identifiable with/allocable to segments are considered for determining
the Segment Result. Expenses which relate to the Company as a whole and not allocable to
segments are included under Unallocable Expenditure.
(iii) Income which relates to the Company as a whole and not allocable to segments is included in
Unallocable Income
(iv) Segment assets and liabilities include those directly identifiable with the respective segments.
Unallocable corporate assets and liabilities represent the assets and liabilities that relate to the
Company as a whole and not allocable to any segment.
133
xix) {k E +li
+li E Ei i {{k E +li E {Sx E Vi * B Ei { {k E M

E +xxi E Vi il n B |Ex =E J E E , i J E E M E P]
Vi *
xx) =v Mi
+E {{k Ex E =q JS B/+{ =v Mi {VEi E Vi *
{{k E +Vx EB { B @h { V + = { V E {{k E +v { vi {{k
{ +x{iE { +]i EB Vi *
xxi) {^
+Vi + {^ { n M< +S {{k E +S {{k E E { nJ Vi * {^ E + |n x
+v { {Ei E Vi *
(` J )
2. |ME niB
h
2010-11
2009-10
i)
+ E
E) E{x E r {b + E n, @h E { Ei x
EB MB il E{x +{ n E v |vx x EB
MB il xhvx {b xvh B V vi B
Ub nB MB *
20.49
10.37
ii)
E{x E J {b n E @h E {
Ei x E*
*3,715.80
2,694.61
iii)
(E) +vE EB ES + @h
EB E{x E M]
6.71
12.08
(J) +x EB ES + @h EB E{x
E M]
45.09
74.64
iv)
E M EB E M]
(x Vx )
8,261.09
8,062.81
v)
+x EB E M]
1,345.57
199.53
vi)
J-{j (x Vx )
7,458.59
547.88
vii)
{V J { Exi EB Vx EB È
E +xxi E + |vx x EB MB*
(+O E x)
1,810.95
257.72
viii)
EB +{ E B i U] n
1.95
4.60
*
{U |ME ni, nn u n EB V B V E 18-24% iE E h {Ei E M* t{

vE V E V + E + xME x uxi E v JE <x n EB V E n
2010-11 EB 12% iE E n { M * {U E < +Eb inx Vi E Vi *
3. JiE/{]Eh ]{{h
i)
@h {M 1981-82 E nx +h k E { ES E nB MB +l Mix ` 0.07 J ({U
` 0.09 J) VE V E |{i E Vx *
ii)
b M, S, l I =i{n il xC b B vi i E ]E { =i{n E ` 30.79
J {Ei E M * ({U ` 23.28 J)
iii)
nxn, xn il @h {M {]/-{ E +vx * xi G |{ n p, Vx E
+vx + <E {, n p Ex E x n V *
iv)
I, P - B v =t E +vx, 2006 E +vx |E] EB Vx EB +{Ii Sx E j iE xvi
E Vi + B {] E E{x ={v Sx E +v { {Sx E M< *
134
(xix) Impairment of assets

Impairment of assets is recognized when there is an indication of Impairment. On such indication the
recoverable amount of the assets is estimated and if such estimation is less than its carrying amount, the
carrying amount is reduced to recoverable amount.
xx) Borrowing Cost:
The borrowing cost incurred / attributable to the acquisition of the purpose of obtaining a qualifying asset are
capitalized.
Interest on loan taken specifically for the acquiring assets and the interest thereon are proportionately
allocated to respective assets based on asset value.
xxi) Leases
Fixed Assets acquired and given on lease are shown as part of fixed assets. Lease rental income is
accounted on accrual basis.
2. CONTINGENT LIABILITIES
Particulars
i)
(` in lacs)
2010-11
2009-2010
Income Tax
(a) Income Tax demands against the Company not
acknowledged as debt and not provided for in respect
of which the Company is in appeal and exclusive of the
similar matters in respect of pending assessments and interest.
20.49
10.37
*3,715.80
2,694.61
ii)
Claims against the Company not acknowledged as debts
iii)
(a) Companys guarantee for Employees Housing Loan

for Officers
6.71
12.08
(b) Companys guarantee for Employees Housing Loan

for others
45.09
74.64
iv)
Bank Guarantees to Govt. Departments. (Net of Margin Money)
8,261.09
8,062.81
v)
Bank Guarantees to others.
1,345.57
199.53
vi)
Letter of Credits (net of Margin Money)
7,458.59
547.88
vii)
Estimated amount of contracts remaining to be executed on

Capital Account and not provided for (Net of advances)
1,810.95
257.72
1.95
4.60
viii)
*
Pending rebate claim for which appeals filed
In the previous years Contingent Liability was calculated as Principal plus interest amount as claimed by the Claimant
ranging from 18-24%/ However keeping in view of Statutory Interest levies like Income Tax and principle of Natural
Justice the rate of interest for all these claims have been taken @12% for the year 2010-11, Corresponding figures for
the previous year is also adjusted accordingly.
3. EXPLANATORY/ CLARIFICATORY NOTES

i)
ii)
iii)
iv)
Loans and Advances include ` 0.07 lacs (Previous year ` 0.09 lacs) representing provisional payment
made to employees during 1981-82 as Onam Advance for which sanction from Government of India is
yet to be received.
The excise duty accounted on finished goods stock relating to Blood Bags, Sutures and Women Health
Care Products and Novex DS is ` 30.79 lacs (Previous Year ` 23.28 lacs)
Balance in Debtors, Creditors and loans and advances are subject to confirmation / reconciliation.
Receivable in Foreign Currency out of Export sales is subject to reconciliation and consequently Foreign
Currency Valuation gain or loss may vary.
The information required to be disclosed under the Micro, Small & Medium Enterprises Development
Act, 2006 has been determined to the extent such parties have been identified on the basis of information
available with the Company.
135
v)
vi)
vii)
viii)
ix)
x)
xi)
xii)
xiii)
xiv)
xv)
xvi)
136
Gh {c +i ]E ` 281.72 J ({U ` 18.70 J) E *

|{h B { |M E EU {VxB 31 S, 2011 iE n E M + j E Eb E +x +O {h
{ l{i E M * il{, EU Gb] , {Vx {iE + , < |E i Vx E {
` 74.37 J E{x {iE {Vx E E E { *
j xB n E +v {, 2010-11 E nx, ] Ex x 2008-09 E nx j E
Ehb,JE M xvE M, E{-] + ] M E +{i E B Mi +vx E l + =Si
E {]/ |ii E l* {] j u Ei E M * <E +x 2008-09 + 2009-10 E
B E{x E Mi u n ` 25.11 Eb l* E{x x { +xi +v { Mi u 2008-09
` 14.52 Eb + 2009-10 ` 3.2 Eb {Ei E * E nx Mi u ` 7.38 Eb {Ei
E M* 2009-10 E nx j x |Mxx ]] E] { Mi +vx E B i Ex E ni
E * 2008-09 E B i Ex E EB Mi E +x, +i xi Mi x E Eh E
nx ` 0.93 Eb Mi u n 2010-11 +{i EB {Ei E M *
i B V vE E v n n E Eh ` 10,000/- E n +vE V |nk x E M *
E{x x ESx BC{] |M Wx li +{x x] < Eb B 2 x<] Wx E xh EB
@h E +v { ` 89.27 J E ={Eh < l E{x ( E) |{i E l * {i E M< {k
B ={Eh E E < l E{x, E E l xi x E< J |] x E M< *
k E nx {VEi =v Mi ` 2.58 J *
<|M +{i |<] ]b, +Ex h], B B E l 50:50 x vh E l BE
H =t E { Mì E M* H =t E{x E {V E + E{x x ` 783.42 J E
Mnx n, =E u +Ex h], B B E l |i vE E E E +vx |iri+ E x
Ei * H =t E{x u 2010-11 E nx x ` 301.93 J E x < * x P]
{ S x E Vi , SE E xvi Ex E B +E *
E nx, SUE xk Vx E + E< +nM x * E nx +lMi V E { x MB
E< G |zx x *
E{x E b { < Mnx E +x B + EE{ EB x E E E 3% E Vx +
x EE, n i, +Ii xv E { +M Vx * 2010-11 E nx x ` 0.17 Eb E E
* ` 0.38 Eb E x E E EB BE +Ii xv, E x< Vi *
@h +O ` 906.06 J V n + = +vE E , E M Vxi , v Z
Vi *
| =k xk bE n E B +n EB SEi | E Ei *
<]]] + S]b +E=hb + <b u V J {ri xi xE (B B 21 + B B 27) xn] V
Ei J E i + |iiEh E B ri B |G+ E +xh E{x + =E H =t vi
Ei k h i EB MB *
v)
Closing Stock includes finished goods in transit for a value of ` 281.72 lacs (Previous Year
` 18.70 lacs).
vi)
A few projects of the Procurement & Consultancy Division are closed as on 31st March, 2011 and the
advances stand fully settled as per Ministry record. However, certain credit balances remain in the
project books thus ` 74.37 lacs remain as outstanding of the projects in the books of the Company,
pending reconciliation.
vii)
Based on the reference made from the Ministry, the Tariff Commission during the 2010-11 had undertaken
cost study for the supply of condoms, Oral Contraceptives Pills, Copper-T and Tubalring to the Ministry
during years 2008-09 and had submitted their Report/recommendation of fair price. This report was
accepted by the Ministry. In line with the same the total cost escalation for the years 2008-09 and
2009-10 were ` 25.11 Crores. The Company had earlier accounted ` 14.52 Crores in 2008-09 and
` 3.20 Crores in 2009-10 cost escalation benefit on provisional basis. The cost escalation benefit of `
7.38 Crores were accounted during the year. The Ministry had also referred to the Tariff Commission for
the cost study on the Pregnancy Test Kit during 2009-10. In line with the price recommended by the
Tariff Commission for the year 2008-09, being the last fixed price, the cost escalation claim of ` 0.93
Crores has been accounted during the year for the supplies made in 2010-11.
viii)
Matured fixed deposit of ` 10,000/- has not been paid due to dispute in claim from the legal heirs of the
deceased deposit holder.
ix)
The Company had received from M/s. Female Health Company (UK) equipments valuing ` 89.27 lacs
on loan basis for manufacturing of female condom FC2 Nitrile version at its unit located in Cochin
Export Processing Zone. No accounting entries have been passed as the property & title of the equipment
supplied vests with M/s. Female Health Company, U.K.
x)
Borrowing costs capitalized during the year is ` 2.58 lacs.
xi)
M/s, LIfe Spring Hospitals Private Limited was formed as a Joint Venture with 50:50 equity shareholdings
with M/s. ACUMEN FUND, USA. The Company has contributed ` 783.42 lacs towards the equity Share
Capital of the Joint Venture Company, thereby meeting the commitment under the Shareholders
agreement entered into with M/s. ACUMEN FUND INC. USA. The loss incurred by the Joint Venture
Company during 2010-11 is ` 301.93 lacs. Diminution in value in the investment, if any, is not
considered, since it is premature to assess the value of the shares.
xii)
During the year there was no payment towards voluntary retirement scheme. There was no sales
promotion expenses treated as deferred revenue expenditure during the year.
xiii)
As per the DPE guidelines Company is to spend minimum 3% of the Net Profit or CSR activities and
unspent amount, if any, need to be carried over as reserve fund. The Company has spent ` 0.17 Cr.
during the year 2010-11. For the unspent amount of ` 0.38 Cr. a reserve fund is created by appropriating
from the Profit.
xiv)
Loans and advances include ` 909.06 lacs that are aged two years and above, are considered good,
though unsecured.
xv)
Insurance premium includes installment of medical insurance premium paid for post-retirement
medical benefits.
xvi)
The consolidated financial statment which relates to the company and its joint venture, have been
prepared in accordance with the principles & procedures for the preparation and presentation of
consolidated accounts as set out in Accounting Standards (AS 21 & AS 27) issued by the Institute of
Chartered Accountants of India.
137
xvii)
|i EB E +Vx
MhE - x (` J )
E
bxx] - E nx EB
E +i J
E
+Vx |i (`)
xviii)
xix)
xx)
138
31-3-2011
31-3-2010
1,843.49
1,843.49
1,493.39
1,493.39
1,55,350
1,55,350
1,55,350
1,55,350
1,186.67
1,186.67
961.31
961.31
{U EB +Eb, V iE +E , S E +Ei+ E +x{ + xE]i J {hEi Ex

EB, {x& l{i B {x& MEi E M *
E{x +vx, E +xS VI E +vx +E E{x E x |< xvi {] |E]x + Jb
{]M G& {] I, II & III |ii E Vi *
i E xn JE E lx E Y E i E E +x ix-{j E{x u B MB Ec
E E x + vi ni+ E +vx |i{I n E { |E]x E M * |{h {Vx+ E
{{k + niB, +Sx {VxB + VE {hx {VxB {] - IV |E] E Vi *
xvii) Basic and Diluted Earnings Per Share
31.03.2011
31.03.2010
Numerator-Net Profit (` lacs)

Basic
Diluted
1,843.49
1,843.49
1,493.39
1,493.39
Denominator-Average number of equity

Shares outstanding during the year
Basic
Diluted
1,55,350
1,55,350
1,55,350
1,55,350
Earning per Share (`)

Basic
Diluted
1,186.67
1,186.67
961.31
961.31
xviii) Figures for the previous year have been rearranged and regrouped wherever necessary to suit current
years requirements and rounded off to the nearest lacs.
xix)
Companys General Business Profile as required under Schedule VI to the Companies Act, Related
Party Disclosure and Segment Reporting is presented in Annexure I,II & III respectively.
xx)
The cash and bank balances held by the Company under trust and the relative liabilities are disclosed
as contra items in the Balance Sheet in accordance with the opinion of the Expert Advisory Committee
of the Institute of Chartered Accountants of India. Assets and Liabilities of Procurement Projects,
Infrastructure projects and Social Marketing Projects are disclosed in Annexure - IV.
139
140
1
2
3
4
5
5
6
7
8
9
3
4
1
2
G
0
={ M (2)
MxvE =i{n
Eb
E bM
(i ={M)
]iE iE
S
<b hb
l I
=i{n
|Mxx ]]Eb
nI M
nI +nn
nI +nn
+nn
nVx
+nn
nI M
nI +nn
nI Vb
nI M
nI M
nI M
26.00
11.50
2,000.00
1,25,000.00
10,000.00
30.00
5.50
2.50
7.50
1,000.00
98.66
E.O
nI <E
3.32
0.37
0.79
37,818.00
936.00
1.45
0.04
0.01
0.24
0.17
0.16
103.71
-
90.63
{h
{h
1,316.00
|E
]E
l{i Ii
nI +nn
x]
G
=i{nx
6.66
23.67
4,47
1.25
3.86
0.09
1.03
769.72
58.68
1,335.78
{h
7.14
23.58
5.82
23.50
5,445.96
344.67
2,397.43
2,040.58
609.09
54.19
569.10
1,118.57
299.32
214.65
4.76
257.32
26,111.08
1,652.52
21,994.84
` J
6.42
5.67
81,964.00 70,505.00
6,208.00 5,294.00
26.54
4.51
1.25
3.87
0.23
0.90
1,001.03
58.68
1,327.78
{h {h
Jn
1.69
0.07
0.05
473.00
3.00
0.02
-
0.20
-
0.27
}i
|il{x
}i xx
{h
4. E{x +vx 1956 E +xS vi E +vx Ui +iH Sx

4. E (i) 2010-11 EB xi B { =i{n E =i{nx + {i E h
0.08
0.14
0.38
4,463.00
207.00
0.02
0.16
0.01
4.38
<
{i /q
{h
2.86
0.24
1.12
44,341.00
1,640.00
4,28
0.08
0.01
0.25
0.15
0.02
334.82
-
84.70
{h
+i
]E
141
Emergency Pills
Preventol
Female condom
6.
7.
8.
9.
Hydrocephalus Shunt Pieces
Women Healthcare
Products
Pregnancy Test Card Million Pcs.
4.
5.
6.
Sub Total (2)
Suture
3.
Dozens
Pieces
Blood Bag
Tissue Expander
2.
Million Pcs.
Million Pcs.
Million Tablets
Million Tablets
Million Pairs
Million Pcs.
Million Tablets
1.
HEALTHCARE
PRODUCTS
Sub Total (1)
Copper T
Tubal Ring
5.
Non-Steroidal OCPs
4.
Million Cycle
Kgs
Consumption)
Steroidal OCPs
Million Pcs.
UNIT
Condom
Bulk Drug (Captive
CONTRACEPTIVES
PRODUCTS
PARTICULARS
3.
1.
2.
SL
NO.
4. ADDITIONAL INFORMATION REQUIRED UNDER SCHEDULE VI OF THE COMPANIES ACT, 1956
26.00
10,000.00
1,25,000.00
2,000.00
11.50
7.50
2.50
5.50
30.00
98.66
1,000.00
0.37
3.32
936.00
37,818.00
0.79
0.16
0.17
0.24
0.01
0.04
1.45
103.71
90.63
QTY
QTY
1,316.00
OPENING
STOCK
INSTALLED
CAPACITY
6.66
QTY
PURCHASES
23.58
7.14
6,208.00
81,964.00
6.42
0.90
0.23
3.87
1.25
4.51
26.54
58.68
1,001.03
1,327,85
QTY
SALEABLE
PRODUCT
ION
VALUE
` in lacs
23.50
5.82
5,294.00
70,505.00
5.67
1.03
0.09
3.86
1.25
4.47
23.67
58.68
769.72
5,445.96
2,397.43
344.67
54.19
609.09
2,040.58
26,111.08
257.32
4.76
214.65
299.32
1,118.57
569.10
1,652.52
1,335.78 21,994.84
QTY
SALES
0.07
1.69
3.00
473.00
0.05
0.02
0.20
0.27
QTY
FREE
REPLACEMENT
AND FREE
SAMPLES
0.14
0.08
207.00
4,463.00
0.38
0.01
0.16
0.02
4.38
QTY
SHELF LIFE
EXPIRED/
SCRAPPED
4. A (i) PRODUCTION AND TURNOVER DETAILS OF MANUFACTURED AND TRADED PRODUCTS FOR THE YEAR 2010-11
0.24
2.86
1,640.00
44.,341.00
1.12
0.02
0.15
0.25
0.01
0.08
4.28
334.82
84.70
QTY
CLOSING
STOCK
142
1
2
3
4
5
6
7
8
9
10
11
12
G
0
VE {hx =i{n
Eb
(VE {hx)
]<b + {
(VE {hx)
={ M (3)
{ =i{n + +x
V < Cx
+x Pf
S - ]bM
nix
H O x]
b M V]
V
H +vx ]
{] B<b
< xE
J(x] x{Ex)
+x =i{n
={ M (4)
M (1)+(2) +(3)+(4)
Vb : =i{n E
È B {
nI j
]E ]x
nVx
nI +nn
+nn
+nn
nI +nn
+nn
nI +nn
+nn
nI +nn
nI <E
nI +nn
x]
8.71
212.44
{h
Jn
24.01
- 35,120.00
15,431.00 41,116.00
0.55
4.76
1.00
27,00
101.00
0.27
66.00 1,59,800.00
0.59
1.23
2.00
0.30
-
1.38
78.76
{h
{h
|E
]E
l{i
Ii
{h
G
=i{nx
24.01
53,300.00
26,652.00
5.23
26.00
87.00
0.22
1,57,646.00
1.14
0.30
7.94
250.32
{h
1,382.93
3,056,83
1,827.88
91.16
409.96
17.77
292.61
5.77
12.56
9.18
55.25
4,715.79
10,552.97
43,492.94
127.63
8,071.39
51,691.96
150.27
1,232.66
` J
505.00
0.05
2.00
-
0.09
907.00
-
0.40
}i
<
|il{x {i /q
}i xx
{h
{h
4. E (i) (E) 2010-11 EB xi B { =i{n E =i{nx + {i E h
0.00
0.00
11,481.00
0.09
2.00
14.00
0.00
2,220.00
0.68
0.00
0.00
2.15
40.40
{h
+i
]E
143
Steroidal OCPs
(Social Marketing)
Gloves
Blood Collection Monitor Pieces
Blood Bag Refrigerator Pieces
Syringes
Blood Transfusion Set
Plast Aid
0.30
0.22
87.00
26.00
5.23
43,018.00
88,420.00
24.01
7.94
250.32
0.30
1.14
- 1,57,646.00
QTY
4,715.79
55.25
9.18
12.56
5.77
292.61
17.77
409.96
149.36
1,827.88
3,056.83
1,382.93
150.27
1,232.66
VALUE
VALUE
in lacs
lacs
`` in
Grand Total
Services
Contract & Consultancy
Add: Excise Duty
51,691.96
8,071.39
127.63
43,492.94
1.23
1,59,800.00
101.00
27.00
4.76
41,116.00
88,420.00
24.01
8.71
QTY
QTY
SALES
SALES
Total (1)+(2)+(3)+(4)
2.00
0.59
66.00
0.27
1.00
0.55
15,431.00
1.38
212.44
QTY
QTY
PURCHASES
PURCHASES SALEABLE
SALEABLE
PRODUCT
PRODUCT
ION
ION
10,552.97
Million Pcs.
Million Pcs.
Pieces
Pieces
Million Pcs.
Million Pcs.
Dozens
78.76
QTY
QTY
OPENING
OPENING
STOCK
STOCK
Sub Total (4)
12 Other Products
Napkins)
11 Sakhi (Sanitary
10 Needle Destroyer
Suture - Trading
Metric Tons
J.E Vaccine
Iron ore
Million Doses
Million Cycles
QTY
QTY
QTY
Million Pcs.
INSTALLED
INSTALLED
CAPACITY
CAPACITY
UNIT
UNIT
TRADING PRODUCTS
AND OTHERS
Sub Total (3)
Condom
(Social Marketing)
PRODUCTS
SOCIAL MARKETING
PARTICULARS
PARTICULARS
SL
SL
NO.
NO.
2.00
0.05
505.00
0.09
QTY
QTY
FREE
FREE
REPLACEMENT
REPLACEMENT
AND
AND FREE
FREE
SAMPLES
SAMPLES
907.00
0.40
QTY
QTY
SHELF
SHELF LIFE
LIFE
EXPIRED/
EXPIRED/
SCRAPPED
SCRAPPED
0.00
0.00
0.68
2,220.00
0.00
14.00
2.00
0.09
12,117.00
0.00
0.00
2.15
40.40
QTY
QTY
CLOSING
CLOSING
STOCK
STOCK
144
1
2
3
4
5
5
6
7
8
9
3
4
1
2
G
0
MxvE =i{n
Eb
E bM
(i ={M)
]iE iE
S
<b hb
l I
=i{n
|Mxx ]]Eb
={ M (2)
nI M
nI +nn
2.57
0.01
0.00
0.36
0.32
6.01
1.00
26.00
1.53
0.31
9.63
0.22
2,000.00
95.00
1,25,000.00 35,118.00
10,000.00 1,404.00
30.00
5.50
2.50
0.00
7.50
nI M
nI +nn
nI Vb
nI M
nI M
nI M
nI +nn
+nn
nVx
+nn
1,000.00
98.66
E.O
nI <E
164.75
{h
{h
1,316.00
|E
]E
l{i Ii
nI +nn
x]
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
{h
Jn
5.95
25.11
` J
19.69
4.00
1.50
6.87
0.07
2.21
893.30
58.60
3.56
24.74
0.02
0.00
0.00
0.00
--
0.25
0.00
0.00
0.00
0.06
0.74
1,.338.87
2,578.25
7,140.44
0.00
0.00
0.60
0.00
0.00
0.03
0.00
71.00
0.00
0.00
0.18
0.00
0.15
0.00
8.70
}i
}i
<
|il{x |il{x {i /q
}i xx
{h
{h
{h
2,702.92
0.02 0.00
1.32
0.00 0.00
449.99 3,408.00 0.00
69.09 180.00 19.00
504.87
674.24
116.40
470.87
6.27
485.64
24,964.81
1,947.14
1,384.43 20,759.38
{h
8.21
7.62
2.00
26.00
70,715.00 64,607.00
7,199.00 7,468.00
19.00
4.05
1.51
7.12
0.04
2.10
991.00
57.60
1,319.75
{h
G
=i{nx
4. E{x +vx 1956 E +xS vi E +vx Ui +iH Sx

4. E (i) 2009-10 EB xi B { =i{n E =i{nx + {i E h
3.32
0.37
0.79
0.00
37,818.00
936.00
1.45
0.04
0.01
0.24
0.17
0.16
103.71
-
90.63
{h
+i
]E
145
Emergency Pills
Preventol
Female condom
7.
8.
9.
Sub Total (2)
Pregnancy Test Card Million Pcs.
6.
Million Tablets
Women Healthcare
Products
5.
Dozens
Suture
Hydrocephalus Shunt Pieces
Pieces
Million Pcs.
3.
2.
Million Pcs.
Million Tablets
M.Tablets
Million Pairs
Million Pcs.
Million Tablets
Million Cycle
Kgs
Million Pcs.
UNIT
4.
Blood Bag
Tissue Expander
1.
HEALTHCARE
PRODUCTS
Sub Total (1)
Copper T
Non-Steroidal OCPs
4.
Tubal Ring
Steroidal OCPs
3.
6.
Bulk Drug (Captive

Consumption)
5.
Condom
2.
CONTRACEPTIVES
PRODUCTS
PARTICULARS
1.
SL
NO.
26.00
10,000.00
1,25,000.00
2,000.00
9.63
7.50
0.00
2.50
5.50
30.00
98.66
1,000.00
0.31
1.53
1,404.00
35,118.00
95.00
0.22
0.32
0.36
0.00
0.01
2.57
1.00
6.01
164.75
QTY
QTY
1,316.00
OPENING
STOCK
INSTALLED
CAPACITY
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
QTY
PURCHASES
25.11
5.95
7,199.00
70,715.00
2.00
8.21
2.10
0.04
7.12
1.51
4.05
19.00
57.60
991.00
1,319.75
QTY
SALEABLE
PRODUCT
ION
VALUE
` in lacs
24.74
3.56
7,468.00
64,607.00
26.00
7.62
2.21
0.07
6.87
1.50
4.00
19.69
58.60
893.30
0.00
0.02
0.00
0.00
0.00
0.02
QTY
FREE
REPLACE
MENT
7,140.44
2,578.25
1,338.87
69.09
0.00
0.00
180.00
449.99 3,408.00
1.32
2,702.92
24,964.81
485.64
6.27
470.87
116.40
674.24
504.87
1,947.14
1,384.43 20,759.38
QTY
SALES
0.00
0.60
19.00
0.00
0.00
0.00
0.06
0.00
0.00
0.00
0.25
0.74
QTY
0.03
0.00
0.00
0.00
71.00
0.00
0.00
0.15
0.00
0.18
8.70
QTY
0.37
3.32
936.00
37,818.00
0.00
0.79
0.16
0.17
0.24
0.01
0.04
1.45
103.71
90.63
QTY
FREE
SHELF LIFE CLOSING
REPLACE EXPIRED/
STOCK
MENT
SCRAPPED
AND FREE
SAMPLES
146
1
2
3
4
5
6
7
8
9
10
11
12
13
14
G
0
VE {hx =i{n
Eb
(VE {hx)
]<b + {
(VE {hx)
={ M (3)
{ =i{n + +x
V < Cx
+x +
b +bb ]
S - ]bM
nix
H O x]
b M V]
V
H +vx ]
{] B<b
+ + B VVx
< xE
J(x] x{Ex)
+x =i{n
={ M (4)
M (1)+(2) +(3)+(4)
Vb : =i{n E
|
nI j
]E ]x
]E ]x
nVx
nI +nn
+nn
+nn
nI +nn
+nn
nI +nn
nI {E]
+nn
nI +nn
nI <E
nI +nn
x]
3.38
231.16
{h
Jn
0.00
0.00
0.00
0.00
0.00
4,774.00
21,298.00 38,018.00
0.30
9.60
3.00
40.00
1.00
47.00
1.14
0.00
6,186.00 2,78,100.00
2.28
1.27
0.10
0.00
4.00
0.00
0.00
1.41
4.15
24.05
{h
{h
|E
]E
l{i
Ii
6.14
169.32
{h
0.00
0.00
0.00
4,774.00
0.00 42,641.00
0.00
9.35
0.00
42.00
0.00
48.00
0.00
0.84
0.00 2,83,295.00
0.00
2.96
0.00
0.01
0.00
0.00
0.00
1.41
0.00
0.00
{h
G
=i{nx
3,057.25
2,838.41
185.43
94.64
532.13
30.95
164.63
22.77
22.42
21.91
25.34
0.00
25.13
2,162.35
9,183.36
42,119.74
171.61
1,886.55
44,177.90
113.35
831.13
717.78
` J
272.00
0.00
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.03
925.00
0.00
0.00
2.00
0.00
0.00
0.44
0.00
0.00
0.00
972.00
0.00
0.00
0.00
0.00
0.00
0.00
0..09
0.00
0.00
0.00
6.69
}i
}i
<
|il{x |il{x {i /q
}i xx
{h
{h
{h
4. E (i) (E) 2009-10 EB xi B { =i{n E =i{nx + {i E h
0.00
0.00
0.00
15,431.00
0.55
1.00
0.00
0.27
66.00
0.59
0.00
2.00
0.00
1.38
78.76
{h
+i
]E
147
Steroidal OCPs
(Social Marketing)
Sub Total (3)
1.41.
0.00
0.00
1.27
2,78,100.00
0.00
47.00
40.00
9.60
38,018.00
4,774.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
VALUE
22.42
1.41
0.00
0.01
2,162.35
25.13
0.00
25.34
21.91
2,83,295.00
2.96
22.77
164.63
30.95
532.13
94.64
185.43
2,838.41
3,057.25
113.35
831.13
717.78
` in lacs
0.84
48.00
42.00
9.35
42,641.00
4,774.00
6.14
169.32
QTY
SALES
Service Charges
44,177.90
171.61
1,886.55
Add: Excise Duty
9,183.36
0.00
4.00
0.10
2.28
6,186.00
1.14
1.00
3.00
0.30
21,298.00
0.00
0.00
0.00
3.38
0.00
QTY
SALEABLE
PRODUCT
ION
42,119.74
0.00
0.00
4.15
231.16
QTY
PURCHASES
Total (1)+(2)+(3)+(4)
Million Pcs.
Pieces
Million Pkt
Million Pcs.
Million Pcs.
Dozens
Metric Tons
24.05
QTY
QTY
OPENING
STOCK
INSTALLED
CAPACITY
Sub Total (4)
Other Products
Napkins)
Sakhi (Sanitary
13
14
Needle Destroyer
12
ORS Jaljeevan
11
Pieces
Syringes
Blood Transfusion Set
Blood Bag Refrigerator Pieces
Plast Aid
Gloves
Suture - Trading
10
Solar Dry lodised Salt
Blood Collection Monitor Pieces
Million Pcs.
Iron ore
Metric Tons
J.E Vaccine
Million Doses
Million Cycle
Million Pcs.
UNIT
TRADING PRODUCTS
AND OTHERS
Condom
(Social Marketing)
PRODUCTS
SOCIAL MARKETING
PARTICULARS
SL
NO.
0.00
272.00
0.00
0.00
QTY
FREE
REPLACE
MENT
0.00
2.00
0.00
0.00
925.00
0.03
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.44
QTY
0.00
0.00
0.09
0.00
0.00
0.00
0.00
0.00
0.00
972.00
0.00
0.00
0.00
0.00
6.69
QTY
0.00
2.00
0.00
0.59
66.00
0.27
0.00
1.00
0.55
15,431.00
0.00
0.00
0.00
1.38
78.76
QTY
FREE
SHELF LIFE CLOSING
REPLACE EXPIRED/
STOCK
MENT
SCRAPPED
AND FREE
SAMPLES
4. E (ii) 2010-11 E J ESS E {hiE h

h
x]
I. Ehb
]C +p
E.O.
Ex +
E.O.
xEb Eb
nI +nn
+x
E
II. xx ]S
J
E{ E
J
+x
E
V. b M
+nn
<
+nn
{ {]
E.O.
+x
E
VI. <b hb
Ex c
]
+x
E
VII. ] M
Ex c ]M J
+x
E
VIII.S
S
J
<
+nn
+x
E
IX. l I =i{n
B { +<
E.O
E.O
+x
E
X. |Mxx ]] Eb
E V
J
E]
J
J
{]E b{ {
+x {=S
J
E]x
J
+iE E]x
J
<x]
J
] E+
J
E
XI. Ehb
x] i
+nn
{ M
+nn
+x
E
XII. +x
+x
E M
148
+E ]E
{h
Jn
{h
2,68,011.00
35,316.94
27,100.00
1.77
256.48
258.77
41.22
18.76
669.16
1,244.40
34,87,163.00 4,684.89
1,81,475.95 1,351.28
4,12,176.00
702.77
3.00
41.40
1,807.18
8,587.53
0.00
1,319.16
0.00
1.45
139.41
140.86
0.00
2,363.61
2.41
36.15
0.80
38.14
11.87
10,116.83
+i ]E
{h
( : ` J )
={M
{h
4,51,335.50
23,961.29
34,990.00
0.50
700.67
254.85
57.40
21.47
684.96
1,719.35
33,03,838.50
1,80,646.38
4,04,286.00
4.27
4,240.70
1,355.21
686.59
38.69
1,791,39
8,112.58
0.00
3.03
201.81
204.85
0.00
693.54
0.00
0.85
55.18
56.04
0.00
2,989.23
0.00
3.63
286.04
289.67
0.00
207.99
0.00
282.86
2.40
74.07
0.80
87.13
0.01
198.67
0.00
233.87
18.74
11.87
119.21
188.76
45.21
1,00,836.01
57.34
132,26
449.49
921.96
20.56
14,483.42
24.51
20.48
139.041
271.97
38.91
96,469.42
51.57
123.65
429.66
838.75
1,750.00
450.00
10,68,500.00
8,04,800.00
16,25,000.00
6.26
0.61
4.19
15.38
8.63
31.05
66.12
2,090.00
5,626.00
39,25,000.00
38,16,734.00
78,50,000.00
5.22
7.86
14.05
73.82
34.32
90.53
225.80
340.00
1,076.00.00
3,81,000.00
1,35,000.00
8,50,000.00
0.95
1.30
1.34
2.61
3.78
18.41
28.39
3,500.00
5,000.00
46,12,500.00
44,86,534.00
86,25,000.00
10.53
7.17
16.90
86.59
39.17
103.18
263.54
23,04,914.00
8,10,000.00
20,130.00
82.59
11.30
14.80
334.91
443.60
72,81,148.00
58,93,950.00
3,57,450.00
217.26 14,96,579.00
74.65 17,17,450.00
300.46
23,025.00
301.03
893.40
42.93
23.36
19.98
289.85
376.12
80,89,483.00
49,86,500.00
3,54,555.00
256.92
62.59
295.28
346.09
960.88
50.00
0.18
17,30
17.48
275.00
1.03
2.20
3.23
25.00
0.09
3.32
3.41
300.00
1.12
16.18
17.30
0.00
0.00
0.06
0.06
35,000.00
0.00
8.70
14.24
22.94
0.00
0.00
0.00
1.50
1.50
35,000.00
0.00
8.70
12.80
21.50
91,000.00
1,70,500.00
0.00
16.12
5.95
36.31
58.38
14,56,700.00
26,01,344.00
0.00
183.63 5,43,500.00
88.70 14,48,888.00
80.89
0.00
353.22
67.07
48.58
23.04
138.69
10,04,200.00
13,22,956.00
0.00
132.68
46.07
94.16
272.91
440.13
28,146.68
0.00
28,586.80
39.10
45.73
119.07
203.89
36.51
6,789.42
161.20
27,507.90
315.43
7,428.20
27,669.10
28.63
45.15
91.95
165.73
10,64,594.00
7,15,485.00
20,79,094.00
47,77,850.00
3,891.00
1,93,948.00
3,15,705.00
81,000.00
0.93
22.11
5.41
20.67
2.16
6.27
2.17
1.02
60.73
2,38,60,000.00
2,28,81,050.00
2,31,40,000.00
2,35,30,000.00
22,505.00
22,44,100.00
22,61,900.00
-3500.00
20.41 12,38,675.00
706.25
0.00
55.66 15,43,910.00
92.30
45,38,895
12.08
2,708.00
40.45 1,49,921.00
11.10 2,59,557.00
-0.06
47,000.00
938.19
1.05
0.00
3.39
19.15
1.53
4.73
1.52
0.59
31.96
2,36,85,919.00
2,35,96,535.00
2,36,75,184.00
2,37,68,685.00
23,688.00
22,88,127.00
23,18,048.00
30,500.00
20.29
728.36
57.68
93.81
12.71
41.99
11.75
0.37
966.96
0.02
0.05
0.86
1.10
38.09
40.05
0.77
0.77
38.53
18.58
161.13
218.24
0.01
0.02
0.64
0.44
32.12
33.20
0.78
0.80
33,894.44
38.75
19.24
167.10
225.09
0.00
0.00
2,464.33
5,040.00
0.40
14,145.66
2,560.00
0.07
2,826.42
2,480.00
034
13,783.57
2.46
9.77
1,763.67
6,825.93 1,775.90
12.93
10.35
1,790.79
7,743.63 1,814.06
4. A (ii) Statement showing quantitative particulars of raw materials for the year 2010-11
(Value:
PARTICULARS
UNIT
OPENING STOCK
QTY
VALUE
PURCHASE
QTY
VALUE
CLOSING STOCK
QTY
VALUE
in Lacs)
CONSUMPTION
QTY
VALUE
I. CONDOM
Latex wet
kgs
Foils
Rls.
Silicone Oil
kgs
Naked Condom
Mpcs
Others
Total
II. NON-STEROIDAL OCP
Centchroman
kgs
Foils
kgs
Others
Total
III. STEROIDAL OCP
Norgestral USP
Levo Norgestral
Ethinyl Estradiol
Foils
Others
Total
IV. COPPER-T
Teeblend
Polypropelyne
Insertion Tube
Tyvek pouches
Copper Collar
Others
Total
V. BLOOD BAG
Labels
Needles
PVC Pellets
Others
Total
2,68,011.00
35,316.94
27,100.00
1.77
256.48
258.77
41.22
18.76
669.16
1,244.40
34,87,163.00
1,69,290.73
4,12,176.00
3.00
4,684.89
1,351.28
702.77
41.40
1,807.18
8,587.53
4,51,335.50
23,961.29
34,990.00
0.50
700.67
254.85
57.40
21.47
684.96
1,719.35
33,03,838.50
1,80,646.38
4,04,286.00
4.27
4.240.70
1,355.21
686.59
38.69
1,791.39
8,112.58
0.00
1,319.16
0.00
1.45
139.41
140.86
0.00
2,363.61
0.00
3.03
201.81
204.85
0.00
693.54
0.00
0.85
55.18
56.04
0.00
2,989.23
0.00
3.63
286.04
289.67
2.41
36.15
11.87
10,116.83
0.80
38.14
18.74
11.87
119.21
188.76
0.00
236.59
47.60
1,00,836.01
0.00
282.86
57.34
132.26
449.49
921.96
2.40
74.07
20.56
14,483.42
0.80
87.13
24.51
20.48
139.04
271.97
0.01
198.67
38.91
96,469.42
0.00
233.87
51.57
123.65
429.66
838.75
Kg.
Kg.
Nos.
Nos.
Nos.
1,750.00
450.00
10,68,500.00
8,04,800.00
16,25,000.00
6.26
0.61
4.19
15.38
8.63
31.05
66.12
2,090.00
5,626.00
39,25,000.00
38,16,734.00
78,50,000.00
5.22
7.86
14.05
73.82
34.32
90.53
225.80
340.00
1,076.00
3,81,000.00
1,35,000.00
8,50,000.00
0.95
1.30
1.34
2.61
3.78
18.41
28.39
3,500.00
5,000.00
46,12,500.00
44,86,534.00
86,25,000.00
10.53
7.17
16.90
86.59
39.17
103.18
263.54
Pcs
Pcs
Kg
23,04,914.00
8,10,000.00
20,130.00
82.59
11,30
14.80
334.91
443.60
72,81,148.00
58,93,950.00
3,57,450.00
217.26 14,96,579.00
74.65 17,17,450.00
300.46
23,025.00
301.03
893.40
42.93
23.36
19.98
289.85
376.12
80,89,483.00
49,86,500.00
3,54,555.00
256.92
62.59
295.28
346.09
960.88
50.00
0.18
17.30
17.48
275.00
1.03
2.20
3.23
25.00
0.09
3.32
3.41
300.00
1.12
16.18
17.30
0
0
0.00
0.06
0.06
35,000.00
0
8.70
14.24
22.94
0
0
0.00
1.50
1.50
35,000.00
0
8.70
12.80
21.50
91,000.00
1,70,500.00
0
16.12
5.95
36.31
58.38
14,56,700.00
26,01,344.00
0
183.63 5,43,500.00
88.70 14,48,888.00
80.89
0
353.22
67.07
48.58
23.04
138.69
10,04,200.00
13,22,956.00
0
132.68
46.07
94.16
272.91
440.13
28,146.68
0.00
28,586.80
39.10
45.73
119.07
203.89
36.51
6,789.42
161.20
27,507.90
27,669.10
28.63
45.15
91.95
165.73
315.43
7,428.20
7,743.63
12.93
10.35
1790.79
1,814.06
10.64,594.00
7,15,485.00
20,79,094.00
47,77,580.00
3,891.00
1,93,948
3,15,705.00
81,000.00
0.93
22.11
5.41
20.67
2.16
6.27
2.17
1.02
60.73
2,38,60,000.00
2,28,81,050.00
2,31,40,000.00
2,35,30,000.00
22.505.00
22,44,100
22,61,90.00
-3500.00
20.41 12,38,675.00
706.25
0.00
55.66 15,43,910.00
92.30 45,38,895.00
12.08
2,708.00
40.45 1,49,921.00
11.10 2,59,557.00
-0.06
47,000.00
938.19
1.05
0.00
3.39
19.15
1.53
4.73
1.52
0.59
31.96
2,36,85,919.00
2,35,96,535.00
2,36,75,184.00
2,37,68,685.00
23,688.00
22,88,127.00
23,18,048.00
30,500.00
20.29
728.36
57.68
93.81
12.71
41.99
11.75
0.37
966.96
0.02
0.05
0.00
0.86
1.10
38.09
40.05
0.77
0.77
0.00
38.53
18.58
161.13
218.24
0.01
0.02
0.00
0.64
0.44
32.12
33.20
0.78
0.80
0.00
38.75
19.24
167.10
225.09
0.00
0.00
2,464.33
5,040.00
0.40
14.145.66
2,560.00
0.07
2,826.42
2,480.00
0.34
13,783.57
kgs
kgs
kgs
kgs
VI. HYDROCEPHALUS SHUNT

Silicone Rubber
Mtr
Others
Total
VII. TUBAL RING
Silicone
Rubber Tubing
Others
Total
Ft.
VIII. SUTURE
Suture
Needles
Others
Total
Mtr.
Pcs.
IX. WOMEN HEALTHCARE PRODUCTS

APIs
Kgs
Foils
Kgs
Others
Total
X . PREGNANCY TEST CARD
Silica Gel
Nos.
Cassettes
Nos.
Plastic Dropper
Nos.
Aluminium Pouch
Nos.
Outer Carton
Nos.
Inner Carton
Nos.
Inserta
Nos.
Wallet Makesure
Nos.
Total
XI. FEMALE CONDOM
Nitrile sheath
Pcs
PU Ring
Pcs
Others
TOTAL
XII. OTHERS
Others
Grand Total
6,825.93
2.46
9.77
1,763.67
1775.90
149
4. E (ii) 2009-10 E J ESS E {hiE h

h
x]
I. Ehb
]C +p
E.O.
Ex +
E.O.
xEb Eb
nI +nn
+x
E
II. xx ]S
J
E{ E
J
+x
E
V. b M
+nn
<
+nn
{ {]
E.O.
+x
E
VI. <b hb
Ex c
]
+x
E
VII. ] M
Ex c ]M J
+x
E
VIII.S
S
J
<
+nn
+x
E
IX. l I =i{n
B { +<
E.O
E.O
+x
E
X. |Mxx ]] Eb
E V
J
E]
J
J
{]E b{ {
+x {=S
J
E]x
J
+iE E]x
J
<x]
J
E
XI. Ehb
x] i
+nn
{ M
+nn
+x
E
XII. +x
+x
E M
150
+E ]E
{h
Jn
{h
3,74,032.00
28,297.44
27,533.00
0.38
249.16
241.65
48.89
2.15
735.38
1,277.23
0.00
1,266.37
0.00
1.76
116.93
118.69
0.00
2,880.98
2.41
37.88
0.80
51.34
5.25
57,791.08
450.00
2,450.00
13,69,500.00
6,40,000.00
22,10,000.00
6,59,420.00
7,51,500.00
19,275.00
31,42,784.00 2,713.69
1,81,475.95 1,282.96
4,16,769.50
641.59
4.01
46.02
1,605.00
6,289.27
+i ]E
{h
( : ` J )
={M
{h
2,68,011.00
35,316.94
27,100.00
1.77
256.48
258.78
41.22
18.76
669.16
1,244.40
32,48,805.00
1,83,982.50
4,17,200.50
2.62
2,706.38
1,265.83
649.26
29.41
1,671.22
6,322.10
0.00
3.22
258.88
262.09
0.00
1,319.16
0.00
1.45
139.41
140.86
0.00
2,828.19
0.00
3.53
236.40
239.93
0.00
207.99
0.00
202.39
2.41
36.15
0.80
38.14
0.00
176.74
0.00
215.59
7.09
22.06
92.71
174.00
45.21
47,855.72
64.01
101.73
357.87
726.00
11.87
10,116.83
18.74
11.87
119.21
188.76
33.38
95,529.97
52.36
111.92
331.37
711.23
1.26
4.46
5.65
12.64
15.40
12.36
51.77
5,550.00
2,750.00
40,48,500.00
44,57,224.00
85,00,000.00
20.20
1,750.00
3.74
450.00
15.88 10,68,500.00
86.92 8,04,800.00
46.12 16,25,000.00
77.64
250.49
6.26
0.61
4.19
15.38
8.63
31.05
66.12
4,250.00
4750.00
43,49,500.00
42,92,424.00
90,.85,000.00
15.20
7.59
17.34
84.19
52.88
58.95
236.14
62.81 1,05,40,607.00
332.19 23,04,914.00
10.63
60,18,000.00
85.36
81,000.00
12.29
4,09,900.00
288.36
20.130.00
335.95
456.81
421.68
1,162.72
82.59
11.30
14.80
334.91
443.60
88,95,113.00
59,59,500.00
4,09,045.00
312.42
84.69
285.85
457.85
1,140.80
600.00
0.24
18.32
18.56
5,230.00
3.40
15.39
18.79
50.00
0.18
17.30
17.48
5,780.00
3.47
16.41
19.88
0.00
0.00
0.00
0.00
35,000.00
0.00
9.35
13.67
23.02
0.00
0.00
0.00
0.06
0.06
35,000.00
0.00
9.35
13.61
22.96
0.00
0.00
0.00
0.00
0.00
51.18
51.18
7,94,500.00
11,63.400.00
0.00
137.74
36.06
22.63
196.43
91,000.00
1,70,500.00
0.00
16.12
5.95
36.31
58.38
7,03,500.00
9,92,900.00
0.00
121.62
30.11
37.50
189.23
718.18
25,765.00
0.00
6,138.19
55.62
44.00
51.74
151.36
91.15
11,643.63
0.00
1,418.09
2.74
14.79
955.85
973.38
440.13
28,146.68
0.00
4,934.05
39.10
45.73
118.41
203.23
369.21
9,262.86
0.00
2,622.23
19.25
13.06
889.19
921.50
38,11,325.00
17,50,900.00
32,47,725.00
47,77,850.00
4,450.00
93,610.00
1,22,200.00
3.86
56.17
9.94
20.88
2.50
5.22
0.47
99.04
2,26,22,200.00
2,42,06,000.00
2,42,00,000.00
2,52,57,600.00
24,700.00
25,68,398.00
26,91,000.00
20.41 10,64,594.00
758.76 7.15,485.00
66.05 20,70,094.00
103.96 47,77,580.00
12.77
3,891.00
45.54 1,93,948.00
15.27 3,15,705.00
1,022.76
0.93
22.11
5.41
20.67
2.16
6.27
2.17
59.71
2,53,68,931.00
2,52,41,415.00
2,53,68,631.00
2,52,57,870.00
25,259.00
24,68,060.00
24,97,495.00
23.34
792.82
70.58
104.17
13.11
44.49
13.57
1,062.09
7,45,035.00
6,58,017.00
26.92
12.92
23.73
63.57
1,46,288.00
3,80,956.00
205.58
9.22
37.44
252.24
0.02
4,536.00
0.86
1.10
38.09
40.05
8,91,322.98
10,34,437.00
3,789.70
231.64
2.1.04
23.08
275.76
0.00
0.27
2,427.34
1,11,400.00
2.07
11,179.27
81,000.00
1.68
2,464.33
30,400.00
0.65
11,142.28
4. A (ii) Statement showing quantitative particulars of raw materials for the year 2009-10
(Value:
PARTICULARS
UNIT
I. CONDOM
Latex wet
kgs
Foils
Rls.
Silicone Oil
kgs
Naked Condom
Mpcs
Others
Total
II. NON-STEROIDAL OCP
Centchroman
kgs
Foils
kgs
Others
Total
III. STEROIDAL OCP
Norgestral USP
kgs
Levo Norgestral
kgs
Ethinyl Estradiol
kgs
Foils
kgs
Others
Total
IV. COPPER-T
Teeblend
Kg.
Polypropelyne
Kg.
Insertion Tube
Nos.
Tyvek pouches
Nos.
Copper Collar
Nos.
Others
Total
V. BLOOD BAG
Labels
Pcs
Needles
Pcs
PVC Pellets
Kg
Others
Total
VI. HYDROCEPHALUS SHUNT
Silicone Rubber
Mtr
Others
Total
OPENING STOCK
QTY
VALUE
PURCHASE
QTY
VALUE
CLOSING STOCK
QTY
VALUE
in Lacs)
CONSUMPTION
QTY
VALUE
3,74,032.00
28,297.44
27,533.00
0.38
249.16
241.65
48.89
2.15
735.38
1,277.23
31,42,784.00
1,81,475.95
4,16,769.50
4.01
2,713.69
1,282.96
641.59
46.02
1,605.00
6,289.27
2,68,011.00
35,316.95
27,100.00
1.77
256.48
258.78
41.22
18.76
669.16
1,244.40
32,48.805.00
1,83,982.50
4,17,200.50
2.62
2,706.38
1,265.83
649.26
29.41
1,671.22
6,322.10
0.00
1,266.37
0.00
1.76
116.93
118.69
0.00
2,880.98
0.00
3.22
258.88
262.09
0.00
1,319.16
0.00
1.45
139.41
140.86
0.00
2,828.19
0.00
3.53
236.40
239.93
2.41
37.88
5.25
57,791.08
0.80
51.34
7.09
22.06
92.71
174.00
0.00
207.99
45.21
47,855.72
0.00
202.39
64.01
101.73
357.87
726.00
2.41
36.15
11.87
10,116.83
0.80
38.14
18.74
11.87
119.21
188.76
0.00
176.74
33.38
95,529.97
0.00
215.59
52.36
111.92
331.37
711.23
450.00
2,450.00
13,69,500.00
6,40,000.00
22,10,000.00
1.26
4.46
5.65
12.64
15.40
12.36
51.77
5,550.00
2,750.00
40,48.500.00
44,57,224.00
85,00,000.00
20.20
1,750.00
3.74
450.00
15.88 10,68,500.00
86.92 8,04800.00
46.12 16,25,000.00
77.64
250.49
6.26
0.61
4.19
15.38
8.63
31.05
66.12
4,250.00
4,750.00
43,49,500.00
42,92,424.00
90,85,000.00
15.20
7.59
17.34
84.19
52.88
58.95
236.14
62.81 1,05,40,607.00
10.63
60,18,000.00
12.29
4,09,900.00
335.95
421.68
332.19 23,04,914.00
85.36
81,000.00
288.36
20,130.00
456.81
1,162.72
82.59
11.30
14.80
334.91
443.60
88,95,113.00
59,59.500.00
4,09,045.00
312.42
84.69
285.85
457.85
1,140.80
6,59,420.00
7,51,500.00
19,275.00
600.00
0.24
18.32
18.56
5,230.00
3.40
15.39
18.79
50.00
0.18
17.30
17.48
5,780.00
3.47
16.41
19.88
VII. TUBAL RING

Silicone
Rubber Tubing
Others
Total
Nos.
0.00
0.00
0.00
0.00
0.00
35,000.00
0.00
9.35
13.67
23.02
0.00
0.00
0.00
0.06
0.06
35,000.00
0.00
9.35
13.61
22.96
VIII. SUTURE
Suture
Needles
Others
Total
Nos.
Pcs.
0.00
0.00
0.00
0.00
0.00
51.18
51.18
7,94,500.00
11,63,400.00
0.00
137.74
36.06
22.63
196.43
91,000.00
1,70,500.00
0.00
16.12
5.95
36.31
58.38
7,03,500.00
9,92,900.00
0.00
121.62
30.11
37.50
189.23
718.18
25,765.00
0.00
6,138.19
55.62
44.00
51.74
151.36
91.15
11,643.63
0.00
1,418.09
2.74
14.79
955.85
973.38
440.13
28,146.68
0.00
4,934.05
39.10
45.73
118.41
203.23
369.21
9,262.86
0.00
2,622.23
19.25
13.06
889.19
921.50
38,11,325.00
17,50,900.00
32,47,725.00
47,77,850.00
4,450.00
93,610.00
1,22,200.00
3.86
56.17
9.94
20.88
2.50
5.22
0.47
99.04
2,26,22,200.00
2,42,06,000.00
2,42,00,000.00
2,52,57,600.00
24,700.00
25,68,398.00
26,91,000.00
20.41 10,64,594.00
758.76 7,15,485.00
66.05 20,70,094.00
103.96 47,77,580.00
12.77
3,891.00
45.54 1,93,948.00
15.27 3,15,705.00
1,022.76
0.93
22.11
5.41
20.67
2.16
6.27
2.17
59.71
2,53,68,931.00
2,52,41,415.00
2,53,68,631.00
2,52,57,870.00
25,259.00
24,68,060.00
24,97,495.00
23.34
792.82
70.58
104.17
13.11
44.49
13.57
1,062.09
7,45,035.00
6,58,017.00
26.92
12.92
23.73
63.57
1,46,288.00
3,80,956.00
205.58
9.22
37.44
252.24
0.02
4,536.00
0.86
1.10
38.09
40.05
8,91,322.98
10,34,437.00
3,789.70
231.64
21.04
23.08
275.76
0.00
0.27
2,427.34
1,11,400.00
2.07
11,179.27
81,000.00
1.68
2,464.33
30,400.00
0.65
11,142.28
IX. WOMEN HEALTHCARE PRODUCTS

APIs
Foils
Others
Total
Kgs
Kgs
X . PREGNANCY TEST CARD

Silica Gel
Nos.
Cassettes
Nos.
Plastic Dropper
Nos.
Aluminium Pouch
Nos.
Outer Carton
Nos.
Inner Carton
Nos.
Inserta
Nos.
Total
XI. FEMALE CONDOM
Nitrile sheath
PU Ring
Others
TOTAL
XII. OTHERS
Others
Grand Total
Pcs
Pcs
151
4. E (iii) 2010-11 E ={H n il +ii O E

G.
.
+ii
%
` J
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
152
Ehb
]<b + {
xx ]<b + {
E{ ]
l I =i{n
b M
<b hb
] M
S
|Mxx ]] Eb
+x
E
7,776.13
553.31
289.67
120.08
1,814.06
898.28
16.18
140.23
966.96
0.33
12,575.24
E
%
` J
93.26
65.97
100.00
45.57
100.00
100.00
93.49
93.53
51.38
100.00
100.00
561.55
285.44
143.45
62.59
1.12
21.50
132.68
1,208.33
` J
6.74
34.03
54.43
6.51
6.47
100.00
48.62
-
8,337.68
838.75
289.67
263,53
1,814.06
960.87
17.30
21.50
272.91
966.96
0.33
13,783.57
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
4. A (iii) VALUE OF INDIGENOUS AND IMPORTED MATERIALS CONSUMED FOR THE YEAR 2010-11
SL.
NO
PARTICULARS
Condom
INDIGENOUS
VALUE
%
` in Lacs
IMPORTED
VALUE
%
` in Lacs
TOTAL
VALUE
%
` in Lacs
7,776.13
93.26
561.55
6.74
8,337.68
100.00
Steroidal OCPs
553.31
65.97
285.44
34.03
838.75
100.00
Non-Steroidal OCPs
289.67
100.00
289.67
100.00
Copper T
120.08
45.57
143.45
54.43
263.53
100.00
Woman health care products
1,814.06
100.00
1,814.06
100.00
Blood Bag
898.28
93.49
62.59
6.51
960.87
100.00
Hydrocephalus Shunt
16.18
93.53
1.12
6.47
17.30
100.00
Tubal Ring
21.50
100.00
21.50
100.00
Suture
140.23
51.38
132.68
48.62
272.91
100.00
966.96
100.00
966.96
100.00
11 Others
0.33
100.00
0.33
100.00
TOTAL
12,575.24
10 Pregnancy Test Card
1,208.33
13,783.57
153
4. E (iii) 2009-10 E ={H n il +ii O E
154
G.
.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
Ehb
]<b + {
xx ]<b + {
E{ ]
l I =i{n
b M
<b hb
] M
S
|Mxx ]] Eb
+x
E
` J
6,202.47
443.29
239.93
76.29
921.51
1,056.11
16.41
67.61
1,062.47
10,086.08
%
94.00
62.33
100.00
32.31
100.00
92.58
82.55
35.73
100.00
-
+ii
E
` J
` J
395.66
6.00
6,598.13
267.95
37.67
711.23
239.93
159.85
67.69
236.14
921.51
84.69
7.42
1,140.80
3.47
17.45
19.88
22.96
100.00
22.96
121.62
64.27
189.23
1,062.47
1,056.20
11,142.28
%
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
-
4. A (iii) VALUE OF INDIGENOUS AND IMPORTED MATERIALS CONSUMED FOR THE YEAR 2009-10
SL.
NO
PARTICULARS
Condom
INDIGENOUS
VALUE
%
` in Lacs
IMPORTED
VALUE
%
` in Lacs
TOTAL
VALUE
` in Lacs
6,202.47
94.00
395.66
6.00
6,598.13
100.00
Steroidal OCPs
443.29
62.33
267.95
37.67
711.23
100.00
Non-Steroidal OCPs
239.93
100.00
239.93
100.00
Copper T
76.29
32.31
159.85
67.69
236.14
100.00
Woman health care products
921.51
100.00
921.51
100.00
Blood Bag
1,056.11
92.58
84.69
7.42
1,140.80
100.00
Hydrocephalus Shunt
16.41
82.55
3.47
17.45
19.88
100.00
Tubal Ring
22.96
100.00
22.96
100.00
Suture
67.61
35.73
121.62
64.27
189.23
100.00
1,062.47
100.00
1,062.47
100.00
11 Others
TOTAL
10,086.08
10 Pregnancy Test Card
1,056.20
11,142.28
155
4. E (iv) +i E (.+<.B)
h
ESS
P]E il {V
{VMi
{ =i{n E G
E
4. E (v) n p
h
j
SV
G |zx
]
b + +x
E
2010-11 (` J )
691.78
122.08
19.42
4,007.46
4,840.74
2009-10 (` J )
315.15
396.99
1,954.27
3,126.57
5,792.98
2010-11 (` J )
88.10
37.84
158.85
34.08
1,103.86
1,422,73
2009-10 (` J )
54.48
8.84
135.01
37.20
0.00
235.53
2010-11 (` J )
5,045.17
81.05
5,126.22
2009-10 (` J )
5,181.66
109.25
5,290.91
2010-11 (` J )
55.41
5.80
3.80
65.01
6.12
2009-10 (` J )
48.43
4.85
1.29
54.57
3.06
4. J. n x +Vx (B + )
h
xi G/xx
c &
E
4. M. xnE E {E
h
ix
xv +nx
+xv
E
@h E
={nx E ni i E Vx xM E O{ ={nx Vx u xvE E Vi * <B | HMi i {

+xSi x + +i: x *
x< n
10.08.2011
b E i
B.+{{x
+vI B
|v xnE
156
b. B.E. {hb
xnE
+.{. Jhb
xnE (k)
r < iJ E {] Mx *
Ei +xxix Bhb xn
xn JE
x. 000148 B
.B.vx x
. xI xn
E{x S B `
Zn
={vI ( B B)
n . 020120
4. A (iv) Value of Imports (CIF)

2010-11 (` in lacs)
Particulars
Raw Materials
Components and Spares
Capital Goods
Purchase of Trading Products
Total
2009-10 (` in lacs)
691.78
315.15
122.08
19.42
4,007.46
4,840.74
396.99
1,954.27
3,126.57
5,792.98
4. A (v) Expenditure in Foreign Currency

2010-11 (` in lacs)
Particulars
Travelling
2009-10 (` in lacs)
88.10
54.48
Service Charges
Sales Promotion Expenses
37.84
158.85
8.84
135.01
Royalty
Freight and Other expenses
34.08
1,103.86
37.20
0.00
Total
1,422.73
235.53
4. B. Earning in Foreign Exchange (FOB Value)

2010-11 (` in lacs)
Particulars
2009-10 (` in lacs)
Export Sales Samples
5,045.17
5,181.66
Freight & Insurance

Total
81.05
5,126.22
109.25
5,290.91
4. C. Remuneration to Directors
2010-11 (` in lacs)
Particulars
2009-10 (` in lacs)
Salary
55.41
48.43
P.F. Contribution
Perquisites
Total
5.80
3.80
65.01
4.85
1.29
54.57
0.21
3.06
Loan Outstanding
The Gratuity Liability is funded through Group Gratuity Scheme of LlC of India. As such, the premium is not
ascertainable on individual basis and hence not included.
New Delhi
10.08.2011
M. Ayyappan
Chairman
& Managing Director
Dr. A.K. Panda

Director
R.P. Khandelwal
Director (Finance)

Firm No. 000148S
Company Secretary
Partner
& SVP (CAS)
157
+xS - 26.3 (xix) =Ji +xv - I

V Eb
1. {VEi
{V o 0
ix {j
iJ
2. E nx V]< M< {V ( W { )
VxE xM
+vE xM
x xM
xV xVx
x
3. xv E Oh il {xVx E li ( W { )
E niB
E {{k
(|i{I n E UcE)
(|i{I n E UcE)
5
4 7
xv i
|nk {V
1
+Ii il +v
5
1 4
|ii @h
1
0 5
xv E |Vi
x +S {{k/S {V E
1
4 6
1 5
4 9
+ - =k E /(x)
1
n %
|i +Vx {
1 1
+ - { E /(x)
+
x
Si x
4. E{x E x{nx ( W { )
{i/+x +
5
x S {{k
(+lMi E ni E x)
1
+|ii @h
x
5. E{x E ix |J =i{n/ + E x x (k i E +x)

=i{n h
n Ec o (+< ] Ec)
1. { MxvE c Eb
3 1 2
2. E{ ]
3 1 3
3. -b/Bx
3 0 4
x< n
10.08.2011
b E i
B.+{{x
+vI B
|v xnE
158
r < iJ E {] Mx *
b. B.E. {hb
xnE
+.{. Jhb
xnE (k)
.B.vx x
E{x S B `
={vI ( B B)
Ei +xxix Bhb xn
xn JE
x. 000148 B
. xI xn
Zn
n . 020120
ANNEXURE I REFERRED TO IN SCHEDULE - 26.3. (xix)

State Code
1. Registration Details
Reg. No. 0
Balance Sheet
Date
2. Capital raised during the year (amount in Rupees Thousands)

Public Issue
Rights Issue
Bonus Issue
N
0 1
Private Placement
3. Position of mobilisation and deployment of funds (amount in Rupees Thousands)

Total Liabilities
Total Assets
(excluding contra items)
(excluding contra items)
5
6 2
6 2
Source of Funds
Paid-up Capital
1
Reserve & Surplus

1
Secured Loans
1
7 6
Accumulated Losses
Earning per share in Rupees

1
+ - Profit/(Loss) after Tax

+
Dividend Rate %
1
Total Expenditure (Net)
+ - Profit/(Loss) before Tax

+
Misc. Expenditure
Investments
4. Performance of Company (amount in Rupees Thousands)

Turnover/Other Income
5
Net Current Assets

(Net of Deferred Tax Liability)
1
Unsecured Loan
Application of Funds
Net Fixed Assets/Capital Work in Progress
1
0 4
5. Generic names of three principal products/services of Company (as per monetary terms)
Product Description
Item Code No. (ITC Code)
1. Male Contraceptive Rubber Condoms
2. Copper T
3. Mala D/N
New Delhi
10.08.2011
M. Ayyappan
Chairman
& Managing Director
Dr. A.K. Panda

Director
R.P. Khandelwal
Director (Finance)

Firm No. 000148S
Company Secretary
Partner
& SVP (CAS)
159
+xS - 26.3 (xix) =Ji +xv - II

J xE 18 E +x vi {] E v |E]Eh
k E x
nix ]C { xVx
|zx x (jhE-ESS
iE, YxE, vl
i E {VEh +vx
E +vx x)
x
C xjh M
(` J )
< |M +{i
|<] ]b (i
E{x +vx, 1956
E +vx {VEi E{x)
50%
2010-11
2009-10
2010-11
2009-10
813.89
0.00
38.40
447.67
0.00
4.80
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
39.69
0.00
21.57
0.00
0.00
26.85
0.00
0.00
0.00
0.00
0.00
1,45
0.92
0.00
0.00
0.00
1.02
0.00
295.12
68.20
0.00
2.59
113.72
0.00
0.10
7.64
783.42
0.10
7.33
783.42
0.00
0.00
169.92
0.00
0.00
0.00
0.00
0.00
i)
+
G
{{k E G { /x
E +
ii) JS
G Ex
|v E
G |zx
ix B k (|i{i Ex M)
+x (|i{i M)
iii) {{k
v nxn
+O
x
iv) niB
JS EB |vx
+x niB
J |vx EE il =xE in
(i) J |vx EE :
B.+{{x
+vI B |v xnE
E.E. E
xnE ({hx)
B.b.E
xnE (iExE B |Sx)
+.{.Jhb
xnE (k)
(ii) J |vx EE E |nk {E E v Sx +xS 26.4 M ={v *
x< n
10.08.2011
b E i
B.+{{x
+vI B
|v xnE
160
b. B.E. {hb
xnE
+.{. Jhb
xnE (k)
r < iJ E {] Mx *
Ei +xxix Bhb xn
xn JE
x. 000148 B
.B.vx x
. xI xn
E{x S B `
Zn
={vI ( B B)
n . 020120
ANNEXURE II - Referred to in Schedule 26.3 (xix)

Disclosure in respect of related party pursuant to Accounting Standard 18
Name of Entity
(` in Lacs)
Hindustan Latex Family Planning
Life Spring Hospitals Pvt. Ltd
Promotion Trust (A Trust under the
(A company registered under the
Travancore - Kochi Literary Scientific,
Indian Companies Act,1956)
Charitable Societies Regulation Act)

Whether Control exist
i)
Nil
50%
2010-11
2009-10
2010-11
2009-10
813.89
447.67
0.00
0.00
0.00
0.00
0.00
0.00
38.40
4.80
0.00
0.00
Sales Commission
0.00
0.00
0.00
0.00
Management Fee
0.00
0.00
0.00
0.00
Sales Promotion
39.69
26.85
0.00
0.00
0.00
0.00
1.45
1.02
21.57
0.00
0.92
0.00
295.12
2.59
0.00
0.10
68.20
113.72
7.64
7.33
0.00
0.00
783.42
783.42
Provision for Expenses
0.00
0.00
0.00
0.00
Other Liabilities
0.00
0.00
0.00
0.00
Income
Sales
Profit / Loss on sales of Assets
Rental Income
ii)
Expenses
Salaries & Allowances

(Reimbursable)
Other expenses
iii) Assets
Sundry Debtors
Advances
Investment in Shares
iv) Liabilities
Key Managerial Personnel and their relatives:

(i) Key Managerial Personnel:
M. Ayyappan
K.K.Sreekumar
M.D. Sreekumar
R.P. Khandelwal
(ii) Information regarding remuneration
26.4.C
Chairman & Managing Director

Director ( Marketing)
Director (Technical & Operations)
Director (Finance)
paid to Key Managerial Personnel are available in Schedule
New Delhi
10.08.2011
M. Ayyappan
Chairman
& Managing Director
Dr. A.K. Panda

Director

Firm No. 000148S
R.P. Khandelwal
Director (Finance)

Company Secretary
& SVP (CAS)
Partner
161
+xS 26.3 (xix) =Ji +xv - III

Jb {]M (B B - 17 E +x)
1.
|< Jb Sx
V Jb
x G + B
Jb {h
(` J )
MxvE
l I
27,494.01
8,212.38
6,780.91
MxvE
2.
V + E E {
xx:V
+x +xvx
Vc : { +v n
+x +xvx +
E E {
1,239.45
xH {V
MxvE
+]i +S {{k(E) 6,305.48

+]i S {{k(J) 17,684.25
23,989.73
(E + J)
+]i S niB
4,639.37
xH {V +]x
19,350.36
xH {V E
+xvx +
E xH {V
Exb Jb Sx - ME
ME W u V
i
i
xH {V
i
i E
l I { =i{n
161.25
l I { =i{n
4,429.30
4,207.89
8,637.19
3,851.62
4,785,57
x< n
10.08.2011
b E i
B.+{{x
+vI B
|v xnE
162
b. B.E. {hb
xnE
(411.18)
+.{. Jhb
xnE (k)
2,133.08
2,133.08
806.37
1,326.71
|{h B
È
E
{ B
B
3,676.04 5,400.98 51,564.32
|{h B
{ B
535.75
È
B
1,709.16
|{h B
{ B
69.96
785.84
855.80
1,731.53
(875.73)
È
B
9,338.55
9,338.35
6,977.40
2,360.95
E
3,234.43
524.37
67.19
22.60
83.94
2,749.41
E
10,804.74
34,149.41
44,954.15
18,006.29
26,947.86
4,274.85
31,222.71
2010-11
46,490.52
5,073.80
51,564.32
28,446.05
2,776.66
31,222.71
r < iJ E {] nJ
Ei +xxix Bhb xn
xn JE
x. 000148 B
.B.vx x
. xI xn
E{x S B `
Zn
={vI ( B B)
n . 020120
Annexure III - Referred to In Schedule 26. 3 (xix)

SEGMENT REPORTING (As per AS - 17)
1. PRIMARY SEGMENT INFORMATION
(` in Lacs)
SEGMENT REVENUE
Contraceptives
Net Sales & Services
27,494.01
Health
Care
Trading
Procurement &
Consultancy
Services
8,212.38 6,780.92
3,676.04
Contract
Services
Total
5,400.98 51,564.33
SEGMENT RESULTS
Contraceptives
Profit before Interest & Tax
1,239.45
Health
Care
Trading
Procurement &
Consultancy
Services
Contract
Services
161.25
(411.18)
535.75
1,709.16
Less: Interest
Total
3,234.43
524.37
Other unallocable expenditure
67.19
Add: Prior period items
22.60
Other unallocable income
83.94
Profit before tax
2,749.41
CAPITAL EMPLOYED
Contraceptives
Health
Care
6,305.48
4,429.30
Allocated Fixed Assets (a)
Trading
Procure
Contract
ment &
Services
Consultancy
Services
-
69.96
Total
10,804.74
Allocated Current Assets (b)
17,684.26
4,207.89 2,133.08
785.84 9,338.35
34,149.42
(a+b)
23,989.74
8,637.19 2,133.08
855.80 9,338.35
44,954.16
Allocated Current Liabilities
4,639.37
Capital Employed Allocation
19,350.37
806.37
1,731.53 6,977.40
18,006.29
4,785.57 1,326.71
3,851.62
(875.73) 2,360.95
26,947.87
Unallocable portion of
Capital Employed
4,273.87
TOTAL CAPITAL EMPLOYED

2.
31,221.74
SECONDARY SEGMENT INFORMATION - GEOGRAPHICAL

Revenue by Geographical market
India
46,490.53
Outside India
5,073.80
CAPITAL EMPLOYED
51,564.33
India
28,445.08
Outside India
2,776.66
31,221.74
New Delhi
10.08.2011
M. Ayyappan
Chairman
& Managing Director
Dr. A.K. Panda

Director

Firm No. 000148S
R.P. Khandelwal
Director (Finance)

Company Secretary
& SVP (CAS)
Partner
163
164
b E i
B.+{{x
+vI B
|v xnE
10.08.2011
x< n
|{i +xnx
S niB
niB
E
(` J )
26.28
20.70
5.58
354.68
+.{. Jhb
xnE (k)
38.85
30,073.23 24,419.15
130.90
58.03
299.47
10.00
12.03
100.26
164.42
2.969.85 2,758.01
628.36
433.12
80.36
26.95
35.00
14,931.66 16,548.35
51.12
154.90
16.80
25.39
3.15
221.33
276.62
0.44
1,438.88
429.96
5.23
73.06
7,672.08 3,631.82
664.70
(1.09)
67.68
180.00
59.10
227.39
172.16
155.65
105.74
428.40
45.32
2,976.45 23,492.74
23.73
0.16
87.78
47,938.17
400.00
.B.vx x
E{x S B `
={vI ( B B)
38.85
33,049.68
218.68
58.03
299.47
10.00
12.03
100.26
164.42
23.73
0.16
19.66
2,989.51 2,758.01
5.42 1,910.11
633.78 1,910.11
90.30
433.12
170.66
412.02
26.95
447.02
1.98 4,575.45 14,933.64 21,123.80
383.79 3,396.40
433.92 3,551.30
610.99 5,928.16
627.78 5,953.55
258.39 3,591.42
261.54 3,812.75
439.25 1,551.83
715.88 1,552.27
571.97
872.10 2,010.85 1,302.06
92.57
97.80
40.01
113.06
248.35 7,672.08 3,880.17
154.67
35.61
819.37
34.52
0.59
819.37
180.00
59.10
227.39
151.46
150.07
105.74
428.40
59.10
227.39
172.16
155.65
105.74
428.40
400.00
400.00
r < iJ E {] Mx *
Ei +xxix Bhb xn
xn JE
x. 000148 B
. xI xn
Zn
n . 020120
38.85
33,049.68 47,938.17
218.68
58.03
299.47
10.00
12.03
100.26
164.42
23.73
0.16
2,758.01 2,989.51 2,758.01

1,910.11
633.78 1,910.11
170.66
433.12
170.66
447.02
26.95
447.02
21,123.80 14,933.64 21,123.80
3,551.30
433.92 3,551.30
5,953.55
627.78 5,953.55
3,812.75
261.54 3,812.75
1,552.27
715.88 1,552.27
1,302.06 2,010.85 1,302.06
97.80
113.06
3,880.17 7,672.08 3,880.17
34.52
819.37
34.52
180.00
68.27
180.00
38.85
33,049.68 47,938.17
218.68
58.03
299.47
10.00
12.03
100.26
164.42
23.73
0.16
2,989.51
633.78
433.12
26.95
14,933.64
433.92
627.78
261.54
715.88
2,010.85
97.80
113.06
7,672.08
819.37
68.27
59.10
227.39
172.16
155.65
105.74
428.40
31.03.2011 31.03.2010 31.03.2011 31.03.2010 31.03.2011 31.03.2010 31.03.2011 31.03.2010 31.03.2011 31.03.2010 31.03.2011 31.03.2010 31.03.2011 31.03.2010
+S {{k
b. B.E. {hb
xnE
J {Vx
J {Vx 2
Bx +< BS E
+
{ B B B < +
{Vx (@E & {]x)
Bx b {
B b
xE
{ B B B < {VxB
ixi{ bE EV
bE EV
M bE EV
Bx + BS B
V{ {Vx
E ]
VE Eh M
< B +<
E
Bx < +< B B
+ E +vx {Mg
E {Vx
V BS B
+< { (|{h)
+< { (MWn)
Bx +<
b BS B
B { <
V VMi bE
<]
B + BS B (|{h)
E M
{VxB
{{k
BSBB E l E
+vx {b {Vx
+x S {{k
xv
+xS 26.3 (xx) =Ji +xv - IV

31 S, 2011 E Exvx {c {Vx E {{k B niB
165
M. Ayyappan
Chairman
& Managing Director
Total
Grant Received
Current Liabilities
LIABILITIES
Total
(` in lacs)
26.28
180.00
354.68
-
429.96
3,631.82
(1.09)
2,976.45
0.16
-
0.59
87.78
23.73
571.97
92.57
40.01
154.67
19.66
5.42
1.98
382.79
610.99
258.39
439.25
59.10
227.39
59.10
227.39
172.16
155.65
105.74
428.40
23,492.74
45.32
-
872.10
248.35
35.61
180.00
400.00
-
Partner
33,049.68 47,938.17
0.16
38.85
68.27
218.68
58.03
299.47
10.00
12.03
100.26
164.42
23.73
2,010.85 1,302.06
97.80
113.06
7,672.08 3,880.17
819.37
34.52
- 2,989.51 2,758.01
1,910.11
633.78 1,910.11
90.30
433.12 170.66
412.02
26.95 447.02
4,575.45 14,933.64 21,123.80
3,396.40
433.92 3,551.30
5,928.16
627.78 5,953.55
3,591.42
261.54 3,812.75
1,551.83
715.88 1,552.27
151.46
150.07
105.74
428.40

Company Secretary
& SVP (CAS)
30,073.23 24,419.15
38.85
67.68
130.90
58.03
299.47
10.00
12.03
100.26
164.42
-
1,438.88
5.23
73.06
7,672.08
664.70
2,969.85 2,758.01
628.36
433.12
80.36
26.95
35.00
14,931.66 16,548.35
51.12
154.90
16.80
25.39
3.15
221.33
276.62
0.44
R.P. Khandelwal
Director (Finance)
Dr. A.K. Panda

Director
20.70
5.58
-
59.10
227.39
172.16
155.65
105.74
428.40
180.00
400.00
-
1,302.06
3,880.17
34.52
180.00
400.00
-
1,302.06
3,880.17
34.52

Firm No. 000148S
33,049.68 47,938.17
0.16
38.85
68.27
218.68
58.03
299.47
10.00
12.03
100.26
164.42
23.73
2,010.85
97.80
113.06
7,672.08
819.37
2,758.01 2,989.51 2,758.01

1.910.11
633.78 1.910.11
170.66
433.12
170.66
447.02
26.95
447.02
21,123.80 14,933.64 21,123.80
3,551.30
433.92 3,551.30
5,953.55
627.78 5,953.55
3,812.75
261.54 3,812.75
1,552.27
715.88 1,552.27
172.16
155.65
105.74
428.40
33,049.68 47,938.17
0.16
38.85
68.27
218.68
58.03
299.47
10.00
12.03
100.26
164.42
23.73
2,010.85
97.80
113.06
7,672.08
819.37
2,989.51
633.78
433.12
26.95
14,933.64
433.92
627.78
261.54
715.88
59.10
227.39
31.03.2011 31.03.2010 31.03.2011 31.03.2010 31.03.2011 31.03.2010 31.03.2011 31.03.2010 31.03.2011 31.03.2010 31.03.2011 31.03.2010 31.03.2011 31.03.2010
Fixed Assets
New Delhi
10.08.2011
Sukhi Sansar Project

Sukhi Sansar Project 2
NIHK
AYUSH
PMSSY Residential Projects
(Rishikesh & Patna)
NVBDCP
MCD
NACO
PMSSY Projects
Trivandrum MC
Salem MC
Bangalore MC
NRHM
JIMPER Project
Malabar Cancer Centre
Social Welfare Dept.
ESIC
SAARC
NEIFM, Pasighat under
AYUSH
Kasuali Project
CGHS
IPC (Procurement)
IPC (Gaziabad)
NIB
RIMS
WBUHS
CAPE
MAHARAJA JAGAR SINGH
MEDICAL RELIEF SOCIETY
NRHM (Procurement)
Grand Total
Projects
ASSETS
Cash and Bank
held under trust with HLL
Annexure IV referred to in Schedule 26.3 (xx)

Assets and Liabilities of projects under implementation as on 31st March 2011
31 S, 2011 E Ei ix-{j - B B 27 E +x
(` J )
xv i
+v E xv
{V
+Ii il +v
@h xv
|ii @h
+lMi E ni
E
xv E |Vi
+S {{k
E E
xx :
x E
S E {V
x
S {{k, @h {M
iS
v nxn
Ec E
+x S {{k
@h il {M
(E)
Ex] E +x x E +vx {b {Vx+ E Ec E
xx : S niB + lB
(E) S niB
(J) |vx
(J)
Ex] E +x x E +vx {b {Vx+ EB {M
x S {{k (E-J)
]] Ji b MB Vi x EB v
E
2010-11
2009-10
1,553.50
13,481.37
1,553.50
12,060.58
16,193.10
383.31
31,612.28
8,898.21
349.65
22,861.94
23,372.95
11,413.25
11,959.70
1,581.18
22,770.72
10,219.25
12,551.47
230.41
2.00
2.00
5,741.79
19,820.11
5,142.23
4,314.60
4,520.40
39,539.13
30,073.24
5,316.97
11,777.01
4,675.89
1,437.28
3,042.09
26,249.24
24,419.15
20,577.40
894.64
21,472.04
30,073.24
18,067,09
2.31
31,612.28
15,435.05
739.60
16,174.65
24,419.15
10,074.59
3.47
22,861.94
x< n
10.08.2011
b E i
B.+{{x
+vI B
|v xnE
166
b. B.E. {hb
xnE
+.{. Jhb
xnE (k)
r < iJ E {] nJ
Ei +xxix Bhb xn
xn JE
x. 000148 B
.B.vx x
. xI xn
E{x S B `
Zn
={vI ( B B)
n . 020120
CONSOLIDATED BALANCE SHEET AS ON 31st MARCH 2011 - AS Per AS 27

(` in lacs)
SOURCES OF FUNDS
SHAREHOLDERS FUND
Share Capital
Reserves & Surplus
LOAN FUNDS
Secured Loan
TOTAL
APPLICATION OF FUNDS
FIXED ASSETS
Gross Block
Less: Depreciation
Net Block
Capital Work-in-progress
INVESTMENTS
CURRENT ASSETS LOANS & ADVANCES
Inventories
Sundry Debtors
Cash & Bank Balances
Loans & Advances
(A)
Cash and Bank balances of Projects held under Trust as per Contra
Less: CURRENT LIABILITIES & PROVISIONS
a) Current Liabilities
b) Provisions
(B)
Advances received for Projects held under Trust as per Contra
Net current assets
(A-B)
Miscellaneous Expenditure to the extent not written off or adjusted
TOTAL
New Delhi
10.08.2011
M. Ayyappan
Chairman
& Managing Director
Dr. A.K. Panda

Director
2010-11
2009-10
1,553.50
13,481.37
1,553.50
12,060.58
16,193.10
384.31
31,612.28
8,898.21
349.65
22,861.94
23,372.95
11,413.25
11,959.70
1,581.18
22,770.72
10,219.25
12,551.47
230.41
2.00
2.00
5,741.79
19,820.11
5,142.23
4,314.60
4,520.40
39,539.13
30,073.24
5,316.97
11,777.01
4,675.89
1,437.28
3,042.09
26,249.24
24,419.15
20,577.40
894.64
21,472.04
30,073.24
18,067.09
2.31
31,612.28
15,435.05
739.60
16,174.65
24,419.15
10,074.59
3.47
22,861.94

Firm No. 000148S
R.P. Khandelwal
Director (Finance)

Company Secretary
& SVP (CAS)
Partner
167
31 S 2011 E {i E Ei -x J - B B 27 E +x
(` J )
+
G B B
xx : =i{n E
x G
+x +
E
J{ +
i ]E + |GMi ]E (xx) Vb : (E)/r
V + <vx SV
V SV
ES E ix + i
+x =i{nx
|xE
{hx
SV
k SV
B {vx
]] Ji b MB |E
{ EB Jn i E
È
E
E
{Ev Vx (x)
E E { E
+E EB l - S
+lMi E
+E EB |vx - Mi
E E n
xVx EB ={v
xVx
(E) |ii
(J) |ii { E
(M) B + xv E B +Ii
(b) x +Ii +ih v 205 (2 B) E +vx vE
+Ii +ih i)
ix {j +M MB
2010-11
2009-10
51,941.85
127.63
51,814.22
2,570.63
54,384.85
44,345.08
171.61
44,173.47
2,547.18
46,720.65
13,801.69
7.86
2,206.25
130.74
10,054.38
2,184.93
4,392.08
5,262.06
126.95
546,04
1,468.62
1.16
8,092.73
3,522.57
51,798.06
2,586.79
22.52
2,609.31
882.13
34.66
1,692.52
1,692.52
11,157.86
723.79
1,988.94
145.15
9,299.41
1,618.76
4,179.84
4,701.35
66.30
676.84
1,305.29
1.16
8,691.36
76.46
44,723.51
1,997.14
30.83
2,027.97
798.77
195.38
(214.98)
1,248.80
1,248.80
253.03
38.71
38.51
233.03
39.60
-
1,382,27
x
976.17
x
x< n
10.08.2011
b E i
B.+{{x
+vI B
|v xnE
168
b. B.E. {hb
xnE
+.{. Jhb
xnE (k)
r < iJ E {] nJ
Ei +xxix Bhb xn
xn JE
x. 000148 B
.B.vx x
. xI xn
E{x S B `
Zn
={vI ( B B)
n . 020120
CONSOLIDATED PROFIT & LOSS ACCOUNT FOR THE YEAR ENDED 31st MARCH 2011 -AS Per AS 27
(` in lacs)
INCOME
Sales & Services
Less: Excise duty
Net Sales
Other Income
TOTAL
EXPENDITURE
Material consumed
(Less)/ Add: (Decrease)/increase in stock of finished goods &
Stock in process
Power & fuel charges
Water charges
Employees salaries & benefits
Other production expenses
Administrative expenses
Marketing expenses
Insurance charges
Finance charges
PrelIminary expenses Written off
Value of finished Goods Purchases - trading
Contract expenses
TOTAL
PROFIT FOR THE YEAR
Prior Period adjustment (Net)
PROFIT FOR THE YEAR BEFORE TAX
Provision for Income Tax - Current year
Deferred Tax
Provision for Income Tax - Previous years
PROFIT AFTER TAX
PROFIT AVAILABLE FOR APPROPRIATIONS
APPROPRIATIONS:
a) Proposed Dividend
b) Tax on Proposed Dividend
c) Reserve for CSR Fund
e) Transfer to General Reserve (including Transfer to Statutory
Reserve u/s 205 (2A)
BALANCE CARRIED TO BALANCE SHEET
New Delhi
10.08.2011
M. Ayyappan
Chairman
& Managing Director
Dr. A.K. Panda

Director
2010-11
2009-10
51,941.85
127.63
51,814.22
2,570.63
54,384.85
44,345.08
171.61
44,173.47
2,547.18
46,720.65
13,801.69
11,157.86
7.86
2,206.25
130.74
10,054.38
2,184.93
4,392.08
5,262.06
126.95
546.04
1,468.62
1.16
8,092.73
3522.57
51,798.06
2,586.79
22.52
2,609.31
882.13
34.66
1,692.52
1,692.52
723.79
1,988.94
145.15
9,299.41
1,618.76
4.179.84
4,701.35
66.30
767.84
1,305.29
1.16
8,691.36
76.46
44,723.51
1,997.14
30.83
2,027.97
798.77
195.38
(214.98)
1,248.80
1,248.80
233.03
38.71
38.51
233.03
39.60
-
1,382.27
NIL
976.17
NIL

Firm No. 000148S
R.P. Khandelwal
Director (Finance)

Company Secretary
& SVP (CAS)
Partner
169
2010-11 E Ei xEn |
E
|Sx EE{ xEn |

E E {
Vx;
|nk V
{{k E G { (x)
|{i V
]] Ji b MB |E
S {V {ix E { |Sx
S {V {ix EB Vx
v nxn (r)/E
+x |{ (r)/E
iS (r)/E
{ il +x n r/(E)
|E r/(E)
|Sx EE{ x x Ec
|nk + E
|Sx EE{ x Ec (E)
x EE{ xEn |
+S {{k E G
S {V E |Mi
+S {{k E G |{i
|{i V
x
x EE{ x xEn (J)
kx EE{ xEn |
nPEx @h |{i
+x @h |{i
|nk V
|nk
|nk E
kx EE{ xMi x xEn (M)
xEn B xEn iE x r/(E)
(E)+(J)+(M)
+v E + xEn B xEn iE
+v E +i xEn B xEn iE
] xEn B xEn iE
l xEn SE
+xSi E E l
(` J )
2010-11
2009-10
2,609.32
2,027.97
1,474.62
524.37
(19.42)
(129.16)
1.16
4,460.89
1,305.17
756.05
1.53
(197.89)
1.16
3,893.99
(8,043.12)
(4,347.21)
(417.60)
(5,209.83)
1,459.43
(1,056.19)
822.53
(875.60)
(3,137.21)
(802.09)
(3,939.30)
4,244.16
(831.72)
3,412.44
9,53.88
(1,350.76)
83.23
129.16
(2,092.25)
(6,502.32)
3,311.12
172.83
197.89
(278.72)
(3,099.20)
(285.18)
7,580.04
(524.37)
(233.03)
(39.60)
6,497.85
466.30
86.92
(379.14)
(756.05)
(155.35)
(26.40)
(1,230.02)
(916.79)
4,675.93
5,142.23
5,592.72
4,675.93
67.12
27.26
5,075.11
4,648.66
5,142.23
4,675.92
1. ={H xEn | h i xn JE E lx u V B B-3 xn] {I |h E +vx i E
M *
2. < E |iiEh E +x{ x E + {U E +Ec E V +E , {xMEh E M *
3. +xSi E E l ` 3,567.09 J V B B/ V B EB Vx E { xSi
EB Vx ={M EB ={v x *
4. xEn | x E +vx {c {Vx xv E xnx ` 30,073.24 J E x E M *
(Mi ` 24,419.15 J) *
x< n
10.08.2011
b E i
r < iJ E {] nJ
Ei +xxix Bhb xn
xn JE
x. 000148 B
B.+{{x
b. B.E. {hb +.{. Jhb
.B.vx x
. xI xn
+vI B
xnE
xnE (k)
E{x S B `
Zn
|v xnE
={vI ( B B)
n . 020120
170
CONSOLIDATED CASH FLOW FOR THE YEAR 2010-11

(` in lacs)
A.
CASH FLOWS FROM OPERATING ACTIVITIES

Profit before tax
Adjustments for:
Interest Paid
Profit on Sale of Assets (Net)
Interest Received
Prelelinary Expenses written off
Operating Profit Before Working Capital Changes
Adjustments for Changes In Working Capital
(INCREASE)/Decrease in Sundry Debtors
(INCREASE)/Decrease in Other Receivables
lNCREASE/(Decrease in Inventories
INCREASE/(Decrease) in Trade and Other Payables
INCREASE/(Decrease) in Preleminary expenses
Cash Generated from Operations
Income Tax Paid
Net Cash from Operating Activities (A)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of Fixed Assets
Capital Work in Progress
Proceeds from Sale of Fixed Assets
Interest received
Investments
Net Cash from Investing Activities (B)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Long Term Borrowings
Proceeds from Other Borrowings
Interest paid
Dividend Paid
Dividend Tax Paid
Net Cash Used In financing Activities (C)
Net Increase/(Decrease) in Cash & Cash Equivalents(A)+(B)+(C)
Cash and Cash Equivalents at Beginning of Period
Cash and Cash Equivalents at End of Period
Cash And Cash Equivalents Comprise
Cash and Cheques in Hand
Balance with Scheduled Banks
2010-11
2009-10
2,609.32
2,027.97
1,474.62
524.37
(19.42)
(129.16)
1.16
4,460.89
1,305.17
756.05
1.53
(197.89)
1.16
3,893.99
(8,043.12)
(4,347.21)
(417.60)
5,209.83
1,459.43
(1,056.23)
822.53
(875.60)
(3,137.21)
(802.09)
(3,939.30)
4,244.12
(831.72)
3,412.44
953.88
(1,350.76)
83.23
129.16
(2,092.25)
(6,502.32)
3311.12
172.83
197.89
(278.72)
(3,099.20)
(285.18)
7,580.04
(524.37)
(233.03)
(39.60)
6,497.85
466.30
4,675.93
5,142.23
86.92
(379.14)
(756.05)
(155.35)
(26.40)
(1,230.02)
(916.83)
5,592.72
4,675.89
67.12
5,075.11
5,142.23
27.26
4,648.63
4,675.89
The above Cash Flow Statement has been prepared under the indirect method set out in the AS - 3 issued by the
Institute of Chartered Accountants of India.
2 The previous years figures have been re-grouped whereever necessary in order to conform to this years presentation.
3 Balance with scheduled banks includes `3,567.09 lacs which is not available for use being earmarked as margin
money for LCs/BGs.
4 Transactions of project funds held under Trust and balances of ` 30,073.24 lacs (previous year ` 24,419.15 lacs)
are not included in the Cashflow.
New Delhi
10.08.2011
Firm No. 000148S
M. Ayyappan
Chairman
& Managing Director
Dr. A.K. Panda

Director
R.P. Khandelwal
Director (Finance)

Company Secretary
& SVP (CAS)
Partner
171
{VEi B xMi E
Ij E
BSBB <E ]b
{VEi B xMi E
BSBB x, {V{{,
ixi{
E, <xb - 695 012
n o 91-471-2354949 (5 <x)
i : ]C
C o : 91-0471-2356739
<-
: enquiry@lifecarehll.com
<] : www.lifecarehll.com
x<b
C]
BSBB <E ]b
{Ec C], {Ec
ixi{ - 695 005
n o : 2437270/2433602/2433459/
2432880/2432292
C o : 91-0471-2435013
BSBB <E ]b
+CE C], +CE,
ixi{ -695 017
n o : 0471-2441384,2442641,
2442642, 2442692, 2442697
C o : 0471-241383
BSBB <E ]b
ExM C], M
ExM, M -591 225
n o : 08333-279206, 279207, 279244,
279245, 279239
C o : 08333-321443
BSBB <E ]b
ESx { <EhE
Wx bWx, {] xo 16 B/1
ECExc, ESx - 682 037
n o : 0484 - 2413332, 2413293
BSBB <E ]b
x x]
{] xo 71, C] 7,
MbM, x - 122 050
n o : 0124 - 4030949
C o : 0124 - 4030949
<-
: thalikerappa@gmail.com
172
{hx E :
BSBB <E ]b
xo -14B, C] 62,
x<b (= |) - 201 301
n o : 0120-4071500
C o : 0120-4071513/4071627
EEk
BSBB <E ]b
] x. 901 9 i,
Eh bM,
224 B, B.V.. c
EEk-700 017
{S M
n o : 033-22905275
C o : 033-22905274
<
BSBB <E ]b
401/402, Sl i, r bM,
j {E E {U, B.].]x],
x, ] c, S, < - 400 071
n o : 022-25209951
022-67715000/01
C o : 022-25209950
<-
: hllwr @bom5.vsnl.net.in
Sz
BSBB <E ]b
Exp {hx E ( b/BS b)
xo. 185, {] xo. 1, M ],
100 ] { c, V xM,
S, Sz - 600 042
n o : 044 - 22453478/22551860/
22551868/22441727
C o : 044-22550764
<-
: hllmktsr@md3.vsnl.net.in
REGISTERED & CORPORATE OFFICE

Registered & Corporate Office
HLL Bhavan, Poojappura
Thiruvananthapuram
Kerala, India 695 012
Tel : 91-0471-2354949 ( 5 lines)
Grams : ROLATEX
Fax : 91-0471-2356739
E-mail : enquiry@ lifecarehll.com
Our Website : www.lifecarehll.com
REGIONAL OFFICE
NOIDA
Marketing office:
No.B-14A, Sector-62
Noida (U.P) 201 301
Phone: 0120-4071500
0120-4071609 (Mktg.)
Fax : 0120-4071513/4071627
FACTORIES
Peroorkada Factory
Peroorkada.
Thiruvananthapuram 695 005
Tel : 91-0471-2437270/2433602/2433459/
2432880/2432292
Fax : 91-0471-2435013
Akkulam Factory
Akkulam, Thiruvananthapuram-695017
Tel : 0471 - 2441384, 2442641, 2442642,
2442692, 2442697
Fax : 0471-2441383
Kanagala Factory, Belgaum
Kanagala, Belgaum 591225
Tel : 08333-279206, 279207, 279244,
279245, 279239
Fax : 08333-321443
Cochin Special Economic
Zone Division, Plot No.16A/1
Kakkanad, Cochin 682 037
Tel : 0484 - 2413332,2413293
Fax : 0484-2413293
Manesar Unit
Plot No.71, Sector 7
Gurgaon, Hariyana - 122050
Tel : 0124 4030949
Fax : 0124 4030949
Email : thalikerappa@gmail.com
KOLKATTA
Suite No. 901, 9th Floor
Krishna Building
224a A.J.C. Bose Road
Kolkatta-700 017
West Bengal
Phone : 033-22905275
Fax : 033-22905274
MUMBAI
401/402, 4th Floor
Sabari Samriddhi Building
Behind Maithri Park, S.T.Stand
SION Trombay Road
Chembur, Mumbai-400071
Phone : 022-25209951
022-67715000/01
Fax : 022-25209950
E-mail : Hllwr@Bom5.Vsnl.Net.in
CHENNAI
Central Marketing Office (CBD/HCD)
No.185, Plot No.1, Lingavel tower
100 ft. bye pass Road, Vijayanagar
Velachery , Chennai 600 042.
Tel : 044-22453478/22551860/
22551868/22441727
Fax : 044-22550764
E-mail : hllmktsr@md3.vsnl.net.in
173
BSBB <E ]b (b BS b)
xo.12, 100 ] c,
S ih c,
Ex E E {, S,
Sz - 600 042.
n o: 044 - 22435604, 22435607, 22433306
M
BSBB <E ]b
#2, 4 G, BC-x Ex
xb, M - 560 043
n o : 080 - 25424530
C o : 080 - 25424531
nn
BSBB <E ]b
3-5-816, h v E{C
4 i, ER Ei b,
nMb, nn - 560 029
n & C o: 040-23210041
Jx>
BSBB <E ]b
9/316, E xM
Jx> - 226 022
n o : 0522 - 2330945, 2320592
C o : 0522- 2738947/2330945
<-
: hlatex@satyam.net.in
174
HLL Lifecare Limited (WHD)

No.12, 100 Feet Road,
Velacherry Taramani Road,
Near Canara Bank, Velacherry,
Chennai 600042
Phone : 044 -22435604, 22435607, 22433306
BANGALORE
#2, 4th Cross
Ex-Servicemen Colony
Banaswadi
Bangalore- 560 043
Phone : 080 25424530
Fax : 080 25424531
HYDERABAD
3-5-816, Veena Dhari Complex
4th Floor, King Koti Road,
Hyderguda, Hyderabad-29.
Phone & Fax No : 040-23210041
LUCKNOW
HLL Lifecare Limited,
9/316, Vikas Nagar
Lucknow-226 022.
Tel : 0522-2330945, 2320592
Fax : 0522-2738947/2330945
E-mail : hlatex@satyam.net.in
175

Annual Report 2010-11 HLL Life Care Ltd.

Загружено:

Сведения о документе

Исходное описание:

Оригинальное название

Авторское право

Доступные форматы

Поделиться этим документом

Поделиться или встроить документ

Параметры публикации

Этот документ был вам полезен?

Это неприемлемый материал?

Авторское право:

Доступные форматы

Annual Report 2010-11 HLL Life Care Ltd.

Загружено:

Авторское право:

Доступные форматы

- S

Chairman & Managing Director

Shri R.K. Jain

Addl. Secretary & F.A, Ministry of Health & Family Welfare,

Shri K.K. Suresh Kumar

Shri M.D. Sreekumar

Shri Rakesh Prasad Khandelwal

Director (Technical & Operations)

Shri Sanjiv Kapoor

Dr. Aarti Vij

Non-Official Part-time Director

Non-Official Part-time Director

MOTTO, VISION & MISSION

Provide best value to the customer.

Social Sector initiatives.

Focus on quality and customer delight at all times

Social Sector Initiatives

M E l B J Vx l Ex, l I +i] xE E +x{ =i{n B B |nx Ex*

+xi +v { <E EE{, =i{n + + E | E +xIh B xjh Ex*

]/+i] xE E VS |h E +x{x EE il +SU E +Sh E |M u x,

Achieve organisational excellence through continual improvement by adoption of best technologies

Be an organisation meeting highest standards in Corporate Governance and Corporate Social

Compliance of applicable legal and other requirements;

Adopting appropriate operating and their involvement:;

Facilitating employee training and their involvement;

Pollution mitigation through adoption of best practices;

Periodic review of safety, health and environment management system.

LAB QUALITY POLICY

Continually improve the effectiveness of the management system.

BSBB <E ]b - +vI E h 2011

CHAIRMAN'S SPEECH 2011

xnE E {] il 31 S 2011 E {i EB E{x E J

|nk {V + x:E +Ih E +vEi =v x*

1st September 2011

To consider and adopt the Directors Report and Audited Accounts of

To declare Dividend for the financial year 2010-11.

Borrow in excess of paid-up capital and free reserves

E{ E Vi E E{x +vx 1956 E v 293 (1) (E) + E{x E l E +ix E +xSUn 22 E

Item No. 4 : Mortgage or charge on the immovable properties

Name of the Facility

Forward Contract - Export

Forward Contract - Import

ECExc C], B < <Wb < ] b

EXPLANATORY STATEMENTS TO FORM PART OF THE NOTICE

FCNR (B) equivalent

Office Building at Noida

Sterodial & ARV Drugs Plant

HINDLAB - MRI Centres in Kerala

ETD Machines and Packing Machines

HINDLAB - CGHS Network, Delhi

B +< E V {j v/+O/422, nxE 02.02.2011 E +x, E{x E +{x xn] +S {{k

]] E + <b, hVE J, ixi{ |{i ` 413.59 Eb (E S {V + n @h) E

6 Eb E i B Bx + () n @h |{i Ex E B {E |ii E { {V{{ Ex

(iii) M 15.33 BEc il Ex + ]<b + { + B + xh j vi x {

ECExc C], B < <Wb < ] b x + {EM x { |l | + ` 4 Eb E i B

(vi) n n x]E { x { |l | + ` 3.3 Eb E i B Bx + () n @h |{i

I. MANAGEMENT DISCUSSION AND ANALYSIS

Corporate Plan 2010:

Strategic Business Units:

+vE Vn,EI + |SxiE iji x E o] B E M`x xx V *

l B { Eh P j M x +Vn x 05 Vx 2011 E BSBB E

x BE =t VJ |vx xi E {J i Ex E xh * E{x, <E u +J Ex v VJ